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Foreword
As the UK Special Envoy on AMR, I welcome Professor Louise Ackers’
book, Anti-Microbial Resistance in Global Perspective. The resistance of
bacteria to antibiotics is a growing threat to modern medicine and our
ability to treat infections. It is estimated that more than 30,000 women
die each year as a result of severe infections when giving birth and the
majority of these deaths occur in LMICs. Sepsis accounts for around 10–
15% of maternal mortality and the vast majority of these deaths could
be prevented through the appropriate use and stewardship of antibiotics.
Anti-microbial resistance is an increasingly serious threat to the gains
made in health and development and for the attainment of the Sustain-
able Development Goals (SDGs) in particular, SDG 3.1 which calls for
a reduction in preventable maternal deaths. We know that the situation
will only get worse if, and when, the antibiotics that treat these infections
become less effective. We need to protect and preserve the antibiotics for
as long as possible to save the lives of millions not only for now but for
the future generations.
This book provides us with invaluable empirical evidence on how we
can promote the rationale use of antibiotics in LMICs to reduce the risk
of pregnant women dying from a fatal drug resistant infection. Through
effective infection prevention control and antibiotic prescribing based
on laboratory results, Professor Acker shows us how rates of infection
can be drastically reduced and more effectively treated. Using laboratory
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results as a basis for interventions is so important and leads to sustain-
able change. This was all achieved through a health partnership between
volunteers in NHS Trusts and health institutions in the UK and their
counterparts in Uganda and demonstrates the power of peer to peer
support, in the form of mentoring and other less traditional approaches
on formal training interventions, for effective behaviour change. We
thank our health workers, in particular those involved in this partnership,
whose great working is driving amazing progress in Uganda and beyond.
With small and low-cost stewardship interventions we can make a signif-
icant impact on maternal mortality, and ultimately reduce the impact of
antimicrobial resistance.
Professor Louise Ackers’ work was funded by the Fleming Fund, a
£265 million UK aid programme, through the Commonwealth Part-
nership on Antimicrobial Stewardship programme. The Fleming Fund
supports LMICs to generate, use and share antimicrobial resistance data
so they can optimise the use of antibiotics and reduce drug resistance. It
is committed to improving understanding of antimicrobial resistance by
raising awareness of antimicrobial stewardship in LMICs. The stewardship
of antimicrobials currently available to us is vital in order to preserve the
effectiveness of drugs for as long as possible and hence is a key component
of our response to AMR.
Professor Dame Sally Davies
UK Special Envoy on AMR
London, UK
Acknowledgments
The Maternal Sepsis Intervention was very much a team activity. We
would like to thank all the members of the Project Team for their commit-
ment and professionalism including; James Ackers-Johnson (Knowledge
for Change), Allan Ndawula (K4C), Ibrahim Mugerwa (AMR National
Taskforce), Saarah Niazi-Ali (Antibiotic Specialist Pharmacist, Tameside
General Hospital, Manchester), Clare Liptrott (Pharmacist, University of
Salford) and Allan Muwazae (Senior Pharmacist, FPRRH). Amrit Atwal
(Anthony Nolan Haematology Pharmacist at University Hospitals Birm-
ingham NHS Foundation Trust) was awarded a Chief Pharmaceutical
Officer’s Global Health Fellowship to work with the team. Chloe James
(Microbiologist, University of Salford) supervised Gavin Ackers-Johnson’s
doctoral research and provided training on the interpretation of labo-
ratory results in Uganda. Simon Sseguya (Pharmacist, FPRRH) worked
closely with the team in supplies management and as a clinical pharmacist
and joined colleagues in the UK in February 2020 for 4 months on a
Commonwealth Professional Fellowship.
The Project owes special gratitude to the K4C clinical team on
the ground including Dorothy Gashuga (K4C Lead Midwife); Rachel
Namiiro (K4C Midwife), Barbra Kamara (K4C IPC Specialist Midwife)
and Joe Odur (K4C Pharmacist). Dorothy, Rachel, Barbra and Joe have
worked tirelessly on the wards for the whole project exuding profes-




The work was supported by the presence of Professional Volunteers:
Elizabeth Pearson, Rob Harper, Caroline Hammond, Amy Cleese, Jan
Dubbink, Jemma Berwick and Harriet Earp.
Maaike Seekles provided support with data collation and analysis.
We would like to thank the Directors (past and present) of FPRRH,1
Dr. Florence Tugumisirize and Dr. Alex Adaku and the Hospital Admin-
istrator, Mr. Louis Muhindo, for their active support with all aspects of
the project.
We extend our gratitude to the health worker team on the Post-
natal and Gynaecology wards whose commitment and expertise have
been pivotal to project success. Special thanks go to the ward In-Charge,
Mrs. Gladys Acayo, Hannah Kemiyondo, Irene Lubambula, Bridget
Kyomuhendo and all the nurses and midwives.
This research was conducted during activities funded by the Depart-
ment of Health and Social Care using UK aid funding and is managed by
the Fleming Fund. The views expressed in this publication are those of
the author(s) and not necessarily those of the Department of Health and
Social Care.
1Fort Portal Regional Referral Hospital is known locally as Buhinga Hospital.
Contents
1 Introduction to Antimicrobial Resistance
and the Maternal Sepsis Intervention 1
2 Autonomy, Evidence and Methods in Global Health 11
3 The Impact of the Maternal Sepsis Intervention 37
4 Infection Prevention Control (IPC) and Antimicrobial
Resistance (AMR) 53
5 The Role of Microbiology Testing in Controlling
Infection and Promoting Antimicrobial Stewardship 81
6 Task Shifting, Midwifery Empowerment
and the Nascence of Clinical Pharmacy 103
7 Change Processes: Multi-Disciplinary Teamwork 129
8 The Knowledge Creation and Transfer Mechanism 145
9 Conclusions: Capturing, Sustaining, Spreading
and Researching Change 161
xi
xii CONTENTS




Gavin Ackers-Johnson University of Salford, Salford, UK
Louise Ackers Global Social Justice, University of Salford, Salford, UK
Daniel Kibombo Infectious Disease Institute, Kampala, Uganda
Samuel Opio Pharmaceutical Society of Uganda, Kampala, Uganda





API Analytical Profile Index
AR Action Research
BAP Blood Agar Plates
CAI Community Acquired Infection
CDC Centre for Disease Control
CME Continuing Medical Education
CPA Commonwealth Pharmacists Association
CwPAMS Commonwealth Partnerships for Antimicrobial Stewardship
DfID Department for International Development
DHSC Department of Health and Social Care
EMHSLU Essential Medicines and Health Supplies List for Uganda
FPRRH Fort Portal Regional Referral Hospital
GAP Global Action Plan
GPPS Global Point Prevalence Survey
HCAI Health Care Acquired Infection
HIC High Income Country
ICAN Infection Control Africa Network
IDI Infectious Diseases Institute
IPC Infection Prevention Control
K4C Knowledge for Change NGO
KHP Kabarole Health Partnership
LMIC Low- and Middle-Income Country
MCA MacConkey Agar
MPDSR Maternal and Perinatal Death Surveillance and Response
xv
xvi ACRONYMS
MSA Mannitol Salt Agar
MSI Maternal Sepsis Intervention
MTC Medicines Therapeutic Committee
NAMRSC National Antimicrobial Resistance Sub-Committee
NAP National Action Plan
NICU Neo-Natal Intensive Care Unit
NMS National Medical Stores
NVIVO NVivo is a Qualitative Data Analysis Computer Software Package
Produced by QSR International
ODA Official Development Assistance
PBS Phosphate Buffered Saline
PNG Post-Natal and Gynae
PPP Public Private Partnership
PSU Pharmaceutical Society Uganda
PYR Pyrrolidonyl Aminopeptidase Test
SDG Sustainable Development Goal
SSI Surgical Site Infection
THET Tropical Health Education Trust
UNHCR United Nations High Commissioner for Refugees
UTI Urinary Tract Infection
VfM Value for Money
WASH Water, Sanitation and Hygiene
WHO World Health Organisation
List of Figures
Fig. 2.1 Behaviour change theory in the CwPAMS programme
(Source Adapted from Commonwealth Partnerships
for Antimicrobial Stewardship Call for Applications
Webinar) 23
Fig. 2.2 Guidance on assessment of training (Source
Commonwealth Partnerships for Antimicrobial Stewardship
Call for Applications Webinar) 24
Fig. 2.3 Site plan of the post-natal and gynaecology wards
at FPRRH 29
Fig. 2.4 An example of action-research cycles (Source McCormack
[2015: 303]) 31
Fig. 3.1 Causes of maternal death (FPRRH) (Source Maternal
Mortality Registers and Files, January 2018–May 2020) 39
Fig. 3.2 Distances travelled to FPRRH (maternal mortality cases)
(Source Analysis of maternal mortality cases, 2019) 42
Fig. 3.3 Distances travelled to FPRRH (Admissions, 2019) (Source
Analysis of 1000 Maternal Admissions, 2019) 43
Fig. 3.4 Length of stay based on date of operation (Source Patient
Records PNG Ward FPRRH [January 2019–January
2020]) 49
Fig. 4.1 Objective 3.2.1 Strengthen Infection Prevention
and Control Programmes (Source Ugandan National
Action Plan on AMR) 57
Fig. 4.2 Empty and damaged hand gel dispenser next to Ugandan
guidelines on handwashing 60
xvii
xviii LIST OF FIGURES
Fig. 4.3 An example of the WHO Calculation Form (March 2020
Observations) 65
Fig. 4.4 Formulae for JIC dilution 71
Fig. 6.1 Supply of oral antibiotics to all wards in January
and February 2020 112
Fig. 6.2 Dispensing of IV Ceftriaxone and Metronidazole
from in-patient pharmacy to PNG wards at FPRRH
(1 December 2019–29 March 2020) 119
Fig. 6.3 Dispensing of oral Amoxicillin and Metronidazole
from in-patient pharmacy to PNG wards at FPRRH
(1 December 2019–29 March 2020) 120
List of Tables
Table 2.1 Excerpt from CwPAMS logframe 25
Table 2.2 Notification, reporting and reviews of maternal deaths
at regional and national referral hospitals 27
Table 4.1 Antibiotic Prescribing on Post-natal and Gynaecology
Wards in FPRRH (GPPS) 56
Table 4.2 Hand Hygiene Compliance in October 2019 on PNG
ward at FPRRH 63
Table 4.3 Hand Hygiene Compliance in March 2020 on PNG
ward at FPRRH 64
Table 4.4 Hand Hygiene ‘Moments’ and Compliance (March
2020) on PNG ward at FPRRH 65
Table 4.5 Results of IPC Infrastructure Audit 69
Table 5.1 Antibiotic prescribing based on laboratory results 88
Table 5.2 Volume and proportion of suspected sepsis cases sent
for laboratory testing 88
Table 5.3 Summarised data for microbiology testing on samples
drawn from post-natal and gynae wards, FPRRH (July
2019–January 2020) 91
Table 5.4 Number of isolates of each bacterial species identified
from the samples tested 92
Table 5.5 Antibiotic resistance patterns of Acinetobacter species
isolated from PNG ward 92
Table 5.6 Antibiotic resistance patterns of Escherichia coli isolated
from PNG ward 93
xix
xx LIST OF TABLES
Table 5.7 Antibiotic resistance patterns of Staphylococcus aureus
isolated from PNG ward 93
Table 5.8 Antibiotic resistance patterns of Staphylococcus aureus
from all wards at FPRRH 96
Table 5.9 Antibiotic resistance patterns of Staphylococcus aureus
isolated from hand swabs of the general public 96
Table 5.10 Antibiotic resistance patterns of Staphylococcus aureus
clinically isolated from surgical site infections at Mulago
Hospital 98
Table 5.11 Hospital Antibiogram (July 2020) showing percentage
susceptibility of isolates based on data collected
from January 2019 to June 2020 at Fort Portal
Regional Referral Hospital 99
Table 6.1 Extract from the 2020/2021 procurement plan
(with bi-monthly figures) focusing on key antibiotics
used on PNG wards at FPRRH 111
Table 6.2 Intravenous antibiotic consumption in Post-natal
and Gynaecology wards at FPRRH, December
2019–March 2020 113
Table 6.3 Oral antibiotic consumption in post-natal
and Gynaecology wards at FPRRH, December
2019–March 2020 114
Table 6.4 Order fill rate at FPRRH (2019/2020) 117
Table 6.5 Patients receiving the prescribed antibiotic dose 124
CHAPTER 1
Introduction to Antimicrobial Resistance
and theMaternal Sepsis Intervention
Abstract This chapter describes the threat to global health and security
caused by the growing resistance of infectious organisms to antibiotics
or antimicrobial resistance (AMR). Growing global connectivity ensures
that AMR is a threat to us all wherever we are and with specific impacts
on Low- and Middle-Income Countries (LMICs). The chapter outlines
international responses to AMR including the Global Action Plan and the
impact this has had on one LMIC; Uganda. It then introduces a recent
UK funding call focused on improving the management of antibiotics or
‘Antimicrobial Stewardship’.
Keywords Antimicrobial resistance · Antimicrobial stewardship ·
Infection prevention control · Universal health coverage · International
development · Global health
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Infection of the human body by an external vector, often a microor-
ganism, has been a major cause of human illness and death. The develop-
ment of antibiotics and their therapeutic use since the 1940s has played
a critical role in the prevention and treatment of infectious disease. So
much so, that there is a growing call for a shift in emphasis in global
health, towards investment in non-communicable diseases such as heart
disease, cancer or diabetes. Evidence of growing resistance of infectious
microorganisms to commonly used antibiotics has raised serious concerns
about the ability to continue to control infection and manage communi-
cable disease. Microorganisms, including bacteria, can constantly mutate
and resist the presence of antibiotics. This mutation is a naturally occur-
ring process, but it is accelerated by the inappropriate use of antibiotics.
Some of the routinely used antibiotics now have limited if any impact
on common infections. Put simply, they no longer work. This has led
to the development of newer antibiotics which are often more expensive
for users and health systems, but many of these are now also compro-
mised. The use of antibiotics by humans is a key factor shaping resistance;
however, there is growing recognition of the impacts that the use of
antibiotics in animal health—and recently in agriculture—has on human
health (and vice versa). This concern is captured by the concept of ‘One
Health’, which takes a holistic view of disease and health care across both
animal and human sectors.
The declining effectiveness of antibiotics in the treatment of infection
not only affects communicable disease; it also impacts our ability to treat
conditions such as cancer, as invasive treatment using chemotherapy, for
example, generates low levels of immunity leaving patients vulnerable to
infection.
The World Health Organization (WHO) defines antimicrobial resis-
tance (or AMR) as the process of resistance that occurs when microorgan-
isms (such as bacteria, fungi, viruses, and parasites) change when they are
exposed to antimicrobial drugs (such as antibiotics, antifungals, antivirals,
antimalarials, and anthelmintics). Microorganisms that develop antimi-
crobial resistance are sometimes referred to as ‘superbugs’. As a result
1Professor Dame Sally Davies, Chief Medical Officer England (2017) https://www.
antibioticresearch.org.uk/chief-medical-officer-calls-new-action-antibiotic-resistance/.
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of growing resistance, the medicines become ineffective and infections
persist in the body, increasing the risk of spread to others.2
A UK Review of antimicrobial resistance chaired by Jim O’Neill
describes AMR as a ‘Terrible Scenario’ posing a genuine economic and
security threat (2016: 1). With the potential to reverse decades of medical
progress in the treatment of communicable disease, AMR is one of the
biggest threats to global health, food security and development in the
world today. O’Neill reported that currently there are 700,000 global
deaths a year related to AMR which is estimated to reach as high as 10
million by 2050 (O’Neill 2016). Whilst the numbers quoted were met
with some scepticism due to the patchiness of data available, they give
major cause for concern. Whilst human health is a priority, AMR will also
have an inevitable impact on the global economy. The same study esti-
mated that between 2015 and 2050 AMR could cost globally US$100
trillion and a study published by the World Bank estimated a reduction
in global GDP of between 1.1 and 3.8 percentage points between 2017
and 2050 due to AMR (World Bank 2017).
AMR is a complex phenomenon. Science communication has failed to
increase public awareness of AMR, its causes, and the need for behaviour
change. A popular misconception amongst those people who have a
limited understanding is that it is the individual consuming the antibiotics
that become immune to their effects, rather than the microorganisms.
This can lead to a level of complacency that we have the power, through
our own actions, to protect ourselves from AMR by reducing our own
use of antibiotics and saving them for when we really need them. Whilst
this can lead to under-consumption and put some individuals at risk, it
also discourages a more global, collective, consciousness.
A report on antibiotic resistance by the Ugandan National Academy
of Sciences (2015) refers immediately to the impact of ‘increasing global
connectivity’ resulting not only in the movement of people, animals and
trade, but also ‘the rapid transport of infectious agents and their antibiotic
resistant genes’ (2015: iii). Antibiotic-resistant genes do not respect inter-
national borders and spill-over to compromise global health. O’Neill’s
report identified several ‘market failures’ affecting AMR. These included
externality (or spill-over) effects where action or lack of action in one loca-
tion impacts others. The authors argue that the rise of AMR is a global
2https://www.who.int/en/news-room/fact-sheets/detail/antimicrobial-resistance.
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problem that cannot be addressed materially without a critical mass of
countries coming together to implement consistent solutions;
Drug resistant infections spread very quickly; a person carrying a drug-
resistant bacterium can fly across the world in a matter of hours. Even if
out of pure self-interest, it may make sense for high-income countries to
support these efforts in lower income settings. (2016: 65)
Grounded in understandable self-interest, high-income countries are
increasingly aware and concerned about growing evidence of the relation-
ship between global health threats and political and economic instability
(Saha and Alleyne 2018). The experience of the global COVID-19
pandemic has triggered an overwhelming awareness of global inter-
connectivity. Human behaviour and antibiotic consumption practices
(amongst other things) in low- and middle-income countries (LMICs)
immediately impact public health in high-income countries (HICs). The
converse is of far greater concern as the over-consumption of antibiotics in
more affluent countries by humans, animals and plants leads to a reliance
upon newer, more expensive antibiotics beyond the reach of many people
in LMICs, dependent on impoverished public services.
There is also a more normative concern, articulated by interna-
tional organisations such as the United Nations and the World Health
Organization, and underpinned by ethical commitments to concepts of
regional equality and individual equity. The Sustainable Development
Goals (SDGs)3 were launched by the United Nations in 2016. SDG3
captures the commitment to ensuring healthy lives and well-being for all.
Although SDG3 refers specifically to the need to combat epidemics and
communicable diseases, there is no specific reference to the impact of
AMR. Objective 3.8 enshrines a growing commitment, in global health,
to ‘universal health coverage, including financial risk protection, access to
quality essential health-care services and access to safe, effective, quality
and affordable essential medicines and vaccines for all’. AMR presents a
major, if silent, threat to the achievement of universal health coverage in
LMICs.
3https://www.un.org/sustainabledevelopment/sustainable-development-goals/.
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Addressing Antimicrobial
Resistance on a Global Platform
Alongside surveillance of resistance patterns, there is an emerging
consensus that efforts to contain the threat of AMR should focus on
four key objectives. The first is to address the inappropriate use of antibi-
otics in both human and animal populations, with high usage being the
predominant factor in the development of AMR. Secondly, the effective
treatment of liquid waste and sewage to reduce the volumes of antibiotics
being dispersed into the environment. Thirdly, through utilising effec-
tive infection prevention and control (IPC) strategies in conjunction with
water, sanitation and hygiene (WASH) programmes, the need for antibi-
otic usage can be reduced. Finally, it is essential that effective, affordable,
and regulated antibiotics are available to those that require them to avoid
the self-prescription of uncertified alternatives. These objectives are most
effective in combination with new diagnostic and treatment technologies
(Rochford et al. 2018).
In May 2015, the World Health Assembly endorsed a Global Action
Plan (GAP) to tackle antimicrobial resistance, including antibiotic resis-
tance, the most urgent drug resistance trend.4 To achieve this goal, the
GAP set out five Strategic Objectives:
1. Improve awareness and understanding of antimicrobial resistance.
2. Strengthen knowledge through surveillance and research.
3. Reduce the incidence of infection.
4. Optimise the use of antimicrobial agents.
5. Develop the economic case for sustainable investment that takes
account of the needs of all countries, and increase investment in
new medicines, diagnostic tools, vaccines, and other interventions.
The intention was that the GAP would be aligned to the national context
of each member country that would then define a National Action Plan
for implementation purposes.
4https://www.who.int/antimicrobial-resistance/global-action-plan/en/.
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The Ugandan Antimicrobial
Resistance National Action Plan
The Ugandan National Action Plan was published in December 2018.
Echoing the Global Action Plan (GAP), it takes a ‘whole-of-society
engagement’ approach, embracing the One Health Agenda. This ensures
that AMR can be targeted at every level be it related to humans,
animals or the environment. To help provide structure and enhance
collaboration, a multidisciplinary National Antimicrobial Resistance Sub-
Committee (NAMRSC) was formed which comprises of representatives
from multiple industries including fisheries and agriculture, water and
waste management, human health, wildlife, science and research and
professional societies. Through the utilisation of such sub-committees,
it is hoped that the NAP will have a national, regional, and local impact.
Mirroring GAP, Uganda’s National Action Plan specifies five key strategic
objectives (GoU 2018):
1. Awareness
2. Infection Prevention and Control
3. Stewardship
4. Surveillance




In 2018, a consortium of UK organisations including the UK Department
of Health and Social Care (DHSC), the Commonwealth Pharmacists
Association (CPA) and the Tropical Health and Education Trust (THET)
came together under the umbrella known as the Commonwealth Part-
nerships for Antimicrobial Stewardship (CwPAMS)5 to launch a call for
applications for funding. This scheme was part of the Fleming Fund, a
wider programme managed by the DHSC that aims to help LMICs tackle
antimicrobial resistance. Uganda was listed as one of four target countries
along with Tanzania, Ghana and Zambia.
5https://www.thet.org/our-work/grants/cwpams/.
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This book traces the intervention process from initial design of an
application that would qualify for funding under the CwPAMS call and
the subsequent intervention that took place. Significant attention is given
(in Chapter 2) to project design processes in international development
and the impact of funding systems on this. This is unusual in publica-
tions which often regard the funding mechanism as ‘house-keeping’ and
simply acknowledge funders. We discuss it here as it provides a powerful
illustration of the tensions that arise in international development between
the increasingly prescriptive demands of funders, understandings of best
practice in intervention research and the ethics of global partnerships.
Chapter 2 outlines the objectives of the funders and the impact these had
on intervention design and research/evaluation methods. It explains the
reasons for focusing the work on maternal sepsis, one of the major causes
of maternal mortality and antibiotic consumption in LMICs and describes
the context within which the Maternal Sepsis Intervention took place; in
a Regional Referral Hospital in Western Uganda.
In a further break with tradition, Chapter 3 presents the key outcomes
of the intervention outlining major improvements in maternal mortality,
length of patient stays, readmission rates and hospital expenditure. These
outcomes are presented at the outset to facilitate a focus on change
processes which we regard as the key findings that will inform a scal-
able intervention model. Chapter 4 outlines a key component of change.
Ultimately, the optimal way of reducing unnecessary antibiotic use is
to reduce the incidence of infection and, particularly the very high
infection rates (or ‘adverse events’) associated directly with medical inter-
vention and hospitalisation. The concept of infection prevention control
(IPC) embraces a myriad of mundane, housekeeping practices routinely
performed by grassroots cadres that are readily overlooked in highly medi-
calised or pharmaceuticalised agendas. Just as housework or care has been
described by feminists as a ‘Labour of Love’ (Oakley 1974); constituted
by numerous small tasks constantly un-done by those we serve, so too is
basic IPC. It is the neglected foundation undertaken by underpaid and
disempowered staff.
Chapter 4 addresses some of the issues most commonly associated with
IPC; hand hygiene, waste disposal and infrastructure. It then addresses
wound management as an infection control issue. The emergence of
wound management as a central focus in the Maternal Sepsis Interven-
tion proved pivotal in shaping the pathway to antimicrobial stewardship.
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Chapter 5 moves on to discuss how wound management formed the cata-
lyst for laboratory engagement and the taking of samples for testing.
The laboratory results then created the ‘objective’ evidence-base that
facilitated and nurtured midwifery empowerment, task-shifting and multi-
disciplinary team working. Chapter 6 addresses the role that pharmacy
has and could increasingly play in antimicrobial stewardship in Ugandan
public hospitals. The existence of laboratory results has triggered the
emergence of clinical pharmacy roles with pharmacists playing an active
role in multi-disciplinary teams. Chapter 7 traces the impact of this on
prescribing behaviour (and individual patient benefits) and, more widely,
on procurement planning and hospital policies. Whilst celebrating the
progress made and viability of the model, Chapter 7 describes the struc-
tural impact that accesses to antibiotics and IPC supplies has on the
realisation of optimal change. Chapter 8 reflects on the relationship
between the knowledge mobilisation processes that have contributed to
behaviour change at an individual and organisational level. It critiques
the traditional emphasis in international development on one-off, formal,
foreign-led ‘training’ episodes and contrasts these with the more fluid,
bi-lateral, approach to learning through co-working and mentoring;
approaches that sit uneasily with the accounting methods favoured by
funding bodies. Chapter 9 summarises the overall impacts of the Maternal
Sepsis Intervention reflecting on the processes of capturing, sustaining,
and spreading best practice in antimicrobial stewardship.
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Abstract This chapter discusses the growing impact that funding bodies
have on the design, delivery and evaluation of global health interventions
with specific emphasis on the UK’s Commonwealth Partnerships for
Antimicrobial Stewardship (CwPAMS) funding programme. It explains
the reasons for focusing the antimicrobial resistance intervention on
maternal sepsis and describes the context within which the Maternal
Sepsis Intervention took place; in a Regional Referral Hospital in Western
Uganda.
Keywords Antimicrobial resistance · Antimicrobial stewardship ·
Infection Prevention Control · International development · Global
health · Maternal sepsis · Pharmaceuticalisation · Ethnography
This chapter addresses a key question: how do we create a high quality,
Fit-For-Purpose, evidence base for global health interventions that opti-
mally combines ‘change’ objectives with the generation of credible,
scientific evidence?
Evidence in International Development, as in many policy domains,
has played two rather different roles. On the one hand, it concerns the
quest for an evidence base to guide policy. On the other, it represents
© The Author(s) 2020
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a response to an increasingly cynical political environment, in an age of
austerity, that questions the efficacy of public expenditure on Aid; the
‘giant cashpoint in the sky’.1 Evaluation, as the generation of knowledge,
then merges with financial and political accountability. Moyo captures this
concern poignantly when she argues that Aid is malignant, and evaluation
has contributed to a smoke screen:
In nearly all cases, short-term aid evaluations give the erroneous impression
of aid’s success […] The notion that aid can alleviate systemic poverty, and
has done so, is a myth. (2010: xix)
Rajkotia (2018) makes a similar point referring to the enormous pres-
sure on global health institutions and the foreign aid ‘industry’ to achieve
targets. This he suggests leads to a tendency to ‘embellish’ reporting and,
worse still, fabricate or overattribute achievements (p. 1). Storeng and
Palmer (2019) detail how the pressure on donors to be seen to deliver
on investments can contribute to serious challenges to researcher inde-
pendence and even censorship of results. This, they argue, contributes to
‘tick-box evaluations designed to please donors’ (p. 185).
The emphasis on evaluation rather than research in funding calls is
indicative of this merging of two rather uncomfortable bedfellows; finan-
cial accountability and knowledge. It lies behind the emergence of an
entirely new cadre of impact assessment ‘experts’ and evaluators typi-
cally juggling identities as project managers/evaluators. The link with
accountability mechanisms has, perhaps unintentionally, centre-staged a
specific approach to evaluation that has been the subject of substantial
critique for over 50 years in academic research. The term ‘paradigm’ is
often used to describe the domination of a specific way of thinking that
shapes attitudes and behaviour. And the paradigm we are referring to here
has been known as ‘positivism’.2 Positivist methods—and the emphasis
on measurable (quantitative) outcomes or ‘ac/counting’—may meet the
1This was a comment made by UK Prime Minster Boris Johnson on 16 June 2020 to
support the decision to merge the Department for International Development with the
Foreign Office. https://www.bbc.co.uk/news/uk-politics-53062858.
2Put very simply positivism is an approach developed in the natural sciences which is
based on the idea that facts exist (and can be mathematically verified) through scientific
experimentation. It is also associated with deductive approaches and theory or hypothesis-
testing. According to this approach, a researcher starts with a theory or hypothesis about
a phenomenon or social problem and designs experiments to test that. The emphasis on
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needs for financial accountability (or Value For Money: VfM). But is it
the best approach to knowledge generation and transfer in health systems
research?
Bridget Somekh traces the parallel development of increasingly radical
social science theories and a policy context (the politics of sponsored
research) that has, ‘moved in the other direction and is ideologically framed
now in more totalitarian assumptions of traditional research practices than
was the case in the 1970s and 1980s ’ (2006: 5). Somekh goes on to critique
the positivist paradigm and, with specific reference to research on educa-
tion systems in the UK, explains how this has led to an emphasis on
technical solutions:
… we are locked in unrealistic assumptions of the application of natural
science research methods to social situations; there is a belief in a process
of incremental knowledge building to construct a technology of definite
[educational] solutions for generalised application across contexts. (p. 5)
Harding makes a similar point in the context of international development
critiquing not only the emphasis on training (a point we return to) but
also the underlying methods and conclusions they infer:
The transfer of Western scientific rationality and technical expertise from
the West to “the rest” had always been the “motor” of modernisation
theory and now drives development policy. However, many of the assump-
tions about women and poor people in the Global South - were false.
(2015: 152)
The point about generalisability is important in the current context. One
of the reasons for the emphasis on ‘measurable outcomes’ amongst inter-
national organisations, such as UKAid or the WHO lies in the perceived
need to aggregate outcomes from diverse interventions to demonstrate
cumulative impact (and benchmark change over time). How does an
organisation such as the UK’s Department for International Development
(DfID), with a budget of £14 billion and under huge public scrutiny,
capture impacts across a plethora of interventions spanning the scope
of the Sustainable Development Goals (from health, gender equality,
‘facts’ (as opposed to knowledge) sees the data collector as necessarily external to this
process—and as a potential pollutant.
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economic growth etc.)? How do we compare the efficacy of a project
on cervical cancer screening in Malawi with one on childhood disability
in Sudan?
It would be hard to question the merits of this goal and understand
the resort to metrics. But will those metrics become so generic that we
focus on the measurable at the expense of the meaningful?
This is often the challenge facing not only end of the line project imple-
mentors and researchers but also intermediary funding organisations.3
Quick fix technical approaches based on highly unreliable and ‘sani-
tised’ secondary data are more likely to caricature reality than they are to
capture genuine change and the costs associated with that. Harding, in a
seminal feminist critique of research methods, refers to the use of evalua-
tors in such situations as ‘fast guns for hire’ who can relay one version of
events about the world ‘ready-made for reporting’ [but] without listening
to women’s accounts’ (1991: 158). With reference to the claim to greater
objectivity that underpins the positivist approach, Harding makes a very
critical and relevant assertion:
Paradoxically, the more “scientific” social research becomes, the less
objective it becomes. (1991: 140)
The concept of objectivity is associated with notions of bias; it is based on
the idea that there is a single truth that exists outside of any investigation,
and the job of the researcher or evaluator is to avoid contamination of the
data (facts). The concept of subjectivity, on the other hand, conveys the
idea that a researcher is a person who interacts with the world and the
people they are studying and their values and experiences inevitably shape
the ‘data’ they generate. People have values that impact the way they see
the world and influence ‘truth’ claims. Stephen Jay Gould points to the
fundamental subjectivity of science:
Science, since people must do it, is a socially embedded activity. It
progresses by hunch, vision, and intuition […] the most creative theories
3This aggregation process has many ‘layers’. At program level, the CwPAMS can
be viewed as an intermediary organisation reporting to higher level funders. In that
respect, the first phase aggregation process seeks to align projects within a broadly similar
framework (described below) albeit in very different contexts.
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are often imaginative visions imposed upon facts; the source of imagination
is also strongly cultural. (1981: 303)
These are complex philosophical concepts and we do not attempt to
explore them in depth here; rather to illustrate their impact on the
evidence base guiding international development in general and the
conditions framing our antimicrobial resistance project in Uganda. In
a field so explicitly and necessarily focused on change and with very
powerful normative drivers (or value commitments) to universal health
coverage, gender equality and empowerment—the approach to data and
objectivity associated with positivism is simply untenable. These substan-
tive value commitments that applicants for international development
funding are required to (and should) align themselves to represent an
immediate challenge to conventional ideas of objectivity and the ‘d’ words
identified as synonyms of objectivity: disinterest; dispassion; detachment.
Harding argues that, ‘It is a mistake to assume that research shaped
by social values and interests invariably will be empirically unreliable.
Maximal objectivity and a commitment to a more democratic organisa-
tion of the research process need not conflict… they can often enhance each
other ’ (2015: 151).
The concept of partnership working embraced in the Sustainable
Development Goals and echoed in UKAid policies also presents serious
challenges and lies in genuine and significant tension with the deduc-
tive principles underlying positivism. This is particularly problematic with
short term, ‘hit-the-ground-running’ approaches to funding where appli-
cants are required to present a highly specified ‘theory of change’4
at application stage. Even where scoping work5 has been undertaken,
outlining a theory of change at the start of a complex project on antimi-
crobial resistance is precisely the kind of deductive approach that fails to
meet the principles of partnership outlined in SDG 17. The Health Part-
nership Scheme managed by the Tropical Health and Education Trust
has developed principles of partnership that all applicants are required
4The ‘theory of change’ approach whilst echoing the language of academic research
uses the concept of theory in a quite specific way (see Vogel 2012).
5Scoping visits are often of 1–2 weeks’ duration and, at best, help to establish teams
but not to understand context in any meaningful way.
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to align themselves to.6 These include ‘listening to one another; culti-
vating trust; proactively adapting to change and aligning interventions
to national planning’ and suggest the need for a far more iterative,
responsive and relational approach to both intervention and research than
is possible within a positivist, theory-testing framework. The ideas of
listening to each other resonates with Harding’s description of research
as an ‘affirmation of ordinary life’ (1991: 158).
We would argue that the specific combination of change objectives
with evaluation (research) predicated in most Official Development Assis-
tance (ODA) work are best captured through the principles of Action
Research. Action research is typically associated with more inductive
approaches to theory generation; rather than starting with theories and
trying to test them (somewhere else) ‘in the field’, action research is
driven by contextual dynamics. Although researchers and actors will come
to projects with prior knowledge (and in that sense cannot approach any
social situation with an entirely blank slate) theory generation in projects
will emerge informed by the context, ongoing review of other work
and through active inter-personal relationships (partnership engagement).
Somekh describes, ‘… the ways in which social science researchers use action
research methodology to overcome the limitations of traditional methodolo-
gies when researching changing situations. Action research combines research
into substantive issues […] with research into the process of development in
order to deepen understanding of the enablers of, and barriers to, change.
It is a means whereby research can become systematic intervention, going
beyond describing, analysing, and theorising social practices to working in
partnership with participants to reconstruct and transform those practices.
It promotes equality between researchers from outside the site of practice and
practitioner-researchers from inside, working together with the aspiration to
carry out research as professionals, with skilful and reflexive methods and
ethical sensitivity’ (2006: 1).
Perhaps, with the exception of doctoral research, most research is
conducted in partnership with funding bodies who have their own
objectives. This inevitably shapes our ability to pursue the ‘sociological
imagination’ (Wright-Mills 1959) and achieve optimal reflexivity. Harding
acknowledges the need for compromise and recognition that other values
will enter the negotiation process with funding bodies and experts:
6https://www.thet.org/principles-of-partnership/.
2 AUTONOMY, EVIDENCE AND METHODS IN GLOBAL HEALTH 17
Scientists must balance their interests with those of their funders and
sponsors even if one thinks they don’t do so as vigorously as the
anti-authoritarian and citizens science movements have been demanding.
Scientists also negotiate routinely with experts of other fields with whom
their research requires collaboration […] negotiating such relations is what
social life is about including the social life of science. (2015: 167)
Whilst we accept the need for balance, the result of this blurring of
evidence with accountability has been for increasingly prescriptive funding
calls to reduce project autonomy. This limits the scope for critical
reflexivity and meaningful contextualisation. There is also a serious risk
that high-level project management, by increasingly ‘engaged’ funding
bodies, becomes a strait jacket with outcome measures framing interven-
tions rather than permitting iterative, intelligent, approaches to influence
outcomes. In effect, the tail may be increasingly wagging the dog to the
detriment of knowledge and social change.
The specific nature of the funding stream as described above reflects
the values of the parties involved, their approach to international engage-
ment in general and AMR in particular. These have shaped the way the
Maternal Sepsis Intervention has evolved often through ‘creative tension’.
We hope that by being explicit about this we can contribute to the co-
production of more effective approaches to improve the evidence-base in
global health. Achieving optimal objectivity in social research demands
humility, honesty and the exercise of caution when making evidence
claims. This requires openness about the objectives of funders, the norma-
tive underpinnings of these and the impacts these have on project design,
implementation and outcomes.
The following section outlines the Call for Funding and the objectives
and approaches applicants were invited to align themselves in order to
position themselves for funding. The detail is presented here as an illus-
tration of the level of complexity and prescription that shapes many, if not
most, international development programs.




The Commonwealth Partnerships for Antimicrobial Stewardship
(CwPAMS) is a partnership involving three very different organisations:
The UK Department of Health and Social Care, the Commonwealth
Pharmacists Association and the Tropical Health and Education Trust.
CwPAMS was awarded £1.3 million as part of a, ‘wider commitment
by the UK Government to spend up to £265 million of UK aid to
support LMICs to enhance their surveillance of AMR by 2021’.7 The
Department of Health and Social Care manages this ambitious UKAid
programme through the Fleming Fund. Although the Fleming Fund
takes an holistic approach, there is a strong underlying emphasis on
capturing ‘surveillance’ data to show patterns of resistance to antimicro-
bials (or which antibiotics are no longer effective in fighting infections).
Despite the very serious and immediate threat that AMR poses to global
health, there is still very little understanding of international patterns of
resistance especially in LMICs where the capacity to generate and use
surveillance data is particularly weak and uneven. Ultimately capturing
resistance patterns, globally, represents the best approach to assessing
the phenomenon of AMR; its responsiveness to environments (such as
COVID-19) and interventions designed to contain it. This underlying
emphasis on surveillance of resistance is expressed quite succinctly:
The aim of the Fleming Fund is to get data relevant to AMR in the
hands of decision makers. We want to support countries generating the
data they need to inform policies and practices which will optimise the use
of antimicrobial medicines.8
The Fleming Fund programme is made up of Country and Regional
Grants and a Fellowships programme (administered by the Manage-
ment Agent Mott MacDonald) and a variety of Global Projects managed
directly by DHSC of which CwPAMs is one. The parent Fleming Fund
includes extensive independent evaluation with an emphasis on:
7https://www.thet.org/our-work/grants/cwpams/.
8https://www.flemingfund.org/about-us/.
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• how much the quantity and/or quality of data on AMR at country
level has increased, and to what extent the Fleming Fund has
contributed to this increase
• to what extent the Fleming Fund’s investments have been aligned
with other relevant investments at country level
• how sustainable the country level data quantity and/or quality
increase is likely to be
• whether improved AMR data has influenced (a) changes in national
policies/regulations, and/or (b) changes in practice and attitudes in
each country
• how much the quality of data shared and reported internationally has
improved, and whether the Fleming Fund has contributed to this
• whether the Fleming Fund’s investments at country level offer value
for money
The Tropical Health and Education Trust (THET) is a UK-registered
charity focused on health system strengthening in LMICs through,
‘training and educating health workers in Africa and Asia, working in part-
nership with organisations and volunteers from across the UK’.9 THET
was appointed as operational partner for the CwPAMS programme and
allocated the funds through its established and prestigious ‘Health Part-
nership’ model. Twelve new and established Health Partnerships across
four African countries (Ghana, Uganda, Tanzania, and Zambia) shared
£600,000 of the £1.3 million in direct project funding.10 Through, ‘reg-
ular short-term visits’ the partnerships were designed to, ‘leverage the
expertise of UK health institutions and technical experts to strengthen
the capacity of the national health workforce and institutions to address
predefined AMR challenges’.
The Commonwealth Pharmacists Association (CPA), on the other
hand, is focused on Commonwealth countries and on improving the
quality of pharmacy practice.11 The CPA have acted as a technical partner
9https://www.thet.org/about-us/what-we-do/.
10The CwPAMS programme is subject to an additional evaluation managed by THET.
In terms of VfM measures, the outcomes associated with the 12 projects sharing the
£600,000 would be expected to demonstrate VfM for the full £1.3 million placing quite
significant pressure on individual projects.
11https://commonwealthpharmacy.org/.
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to THET on CwPAMS. Their role includes carrying out a scoping anal-
ysis, developing or providing assistance in the development of AMS
resources, supporting grant holders with bespoke advice in AMS, and
developing and analysing programme-level AMS reporting tools and data.
The predefined challenges referred to above were aligned to three
of the Fleming Fund Objectives, with a specific focus on antimicrobial
stewardship and the use of antimicrobials.12
Fleming Fund Priorities Identified by CwPAMS
• Support the development of National Action Plans for AMR
• Developing and supporting the implementation of protocols and
guidance for AMR surveillance and antimicrobial use.
• Building laboratory capacity for diagnosis
• Collecting drug resistance data
• Enabling the sharing of drug resistance data locally, regionally, and
internationally
• Collating and analysing data on the scale and use of antimicro-
bial medicines
• Advocating for the application of data to promote the rational
use of antimicrobials
• Shaping a sustainable system for AMR surveillance and data sharing
• Supporting fellowships to provide strong national leadership in
addressing AMR
The emphasis is on quite programmatic features with a strong assump-
tion that LMICs need support in developing protocols and implementing
these. Secondly, an emphasis on data and specifically antimicrobial
consumption data. Finally, a strong normative assumption that this data
will form the basis of effective advocacy for more rational use of antimi-
crobials. The Guidance to potential applicants added further complexity
identifying three ‘Themes’; with a requirement for each applicant to
address Themes 1 and 2 (but not 3):
12Antimicrobials is a wider term referring to medicines that are active against microbes
in general—including fungal and viral infections. The project has focused on bacterial
infections and the use of antibiotics to treat those.
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CwPAMS ‘Themes’
1. Antimicrobial stewardship, including surveillance – requirement!
2. Antimicrobial pharmacy expertise and capacity – requirement!
3. Infection Prevention Control
Theme 1 reinforces the emphasis on stewardship recognising the rela-
tionships between stewardship (use of antimicrobials) and surveillance (of
resistance patterns). Theme 2 adds a specific twist on this immediately
identifying the role of pharmacy as the key discipline in antimicrobial use.
The Guidelines then specified several outcomes:
CwPAMS Outcome Specifications
• Institutions and workforce demonstrate improved knowledge and
practice related to AMS prescribing practice and IPC
• Evidence of effective AMR interventions, with standardised tools
and guidance being used by local institutions and/or national
partners
• NHS staff demonstrate improved leadership skills and a better
understanding of the global context of AMR in their work
It is interesting to note that, although IPC was not a required ‘theme’,
outcomes in relation to IPC were listed.13 Outcome 1 anticipates both
a knowledge premium (the ability to evidence knowledge acquisition
amongst LMIC health workers) and improved practice (knowledge
application or utilisation) with a very specific emphasis on ‘prescribing
practice’. Echoing the Fleming Fund Objectives, Outcome 2 specifies a
focus on the development of standardised tools. The emphasis on ‘stan-
dardised’ tools stands in some tension with the commitment to ensure
contextual compatibility which lies at the heart of effective implementa-
tion. Whilst alignment with national or even international standards and
explicit recognition of where such alignment is not possible is important,
a ‘one-size fits all’ approach to something as complex as AMR is unlikely
to be successful.
13CwPAMS hoped to embrace IPC through the programme as a whole but not
necessarily in every project.
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Outcome 3 draws on the Department of Health and Social Care’s
commitment to building the expertise of the UK health workforce
(through volunteering). This introduces a welcome bilateral component
to mutual learning but infers a difference in the type of knowledge to
be acquired by the UK nationals and LMIC health workers. Whilst the
knowledge premium for LMIC staff was anticipated in prescribing prac-
tice and IPC; the emphasis in UK volunteer learning was on leadership
skills and an understanding of AMR in global context.
Later in the same guidance document Project Outcomes are re-stated
but this time with a new emphasis on microbiology data which was not
highlighted in the Fleming Fund Objectives. And IPC is very much
present in this ‘expectation’.
Outcomes Expected from Projects
in the CwPAMS Call
14
What Outcomes Are Expected from You Through CwPAMS?
Partnerships should strengthen workforce in:
• Antimicrobial prescribing practice
• Use of microbiology data to inform decision making
• Infection Prevention Control
• Antimicrobial stewardship including surveillance of antimicrobial use
A further set of ‘Scoping Requirements’ placed a strong emphasis on
‘antimicrobial consumption and behavioural drivers of inappropriate use’.
This emphasis on antibiotic consumption and the behaviour of individual
prescribers could be interpreted as falling within what Denyer Willis and
Chandler (2018) characterise as a ‘pharmaceuticalisation’ model centred
on pharmaceutical distribution and individual behaviour change. There is
a strong emphasis in the ‘Scoping Requirements’ on the role of clinical
pharmacy:
14These outputs were again expected across the programme and not necessarily
within each project.
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Project Activities should, ‘Build on initiatives in the 4 countries for
knowledge transfer and bidirectional learning to develop AMS as part of
the clinical pharmacy role.’
Importantly, the final ‘Scoping Requirement’ specifies a particular
leadership model:
Multidisciplinary team led/co-led by pharmacists that model best practice
of multi-disciplinary working, especially nurses, pharmacists and doctors
working equally.
Behaviour change was also high on the CwPAMS agenda with an
emphasis on individual behaviour change as conceptualised in the Com-
B Framework approach (Michie et al. 2011). And behaviour change
scientists were enabled to join some of the funded projects to support
implementation of this approach (Fig. 2.1).15
The approach should consider…. 





Fig. 2.1 Behaviour change theory in the CwPAMS programme (Source
Adapted from Commonwealth Partnerships for Antimicrobial Stewardship Call
for Applications Webinar)
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Fig. 2.2 Guidance on assessment of training (Source Commonwealth Partner-
ships for Antimicrobial Stewardship Call for Applications Webinar)
The Guidance also presented applicants with possible models of inter-
vention and associated evaluation mechanisms with a powerful emphasis
on ‘measurable’ outcomes. Figure 2.2 illustrate the anticipated/preferred
approach and the emphasis on pre and post ‘training’ assessments.
It is important to note that the diagram presented above was for
‘guidance’ purposes only. However, successful applicants are required to
complete a ‘logframe’ reporting template. UKAid has produced guid-
ance on log frames and describes them as a multi-purpose tool combining
‘regular project monitoring with annual review processes, project comple-
tion reports and evaluation’.16 The description in the UKAid guidance of
the ‘results chain’ as a ‘logical (linear)’ tool and subsequent reference to
‘objective’ measurement; the necessity of baseline data, attribution, and
verification all point in the direction of what Denyer Willis and Chandler
refer to as a ‘counting’ approach (2019: 2).
Although the guidance on log frames acknowledges the value of qual-
itative data it does so within an implicitly deductive, linear-planning
perspective. The logic of the logframe methodology is expressed in
Table 2.1 designed to capture the outcomes of the CwPAMS project.
Securing funding is a highly competitive process and potential appli-
cants would ignore the guidance offered by funding bodies at their peril
(Storeng and Palmer 2019). It is within this context that the project
team designed their application for funding. To put the ambitious goals
15It is important to note that the COM-B Framework is only one approach to
behaviour change theory (Ackers and Ackers-Johnson 2016).
16https://www.ukaiddirect.org/wp-content/uploads/2016/04/UKAD-Guidance-Log
frames.pdf.
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Table 2.1 Excerpt from CwPAMS logframe
Output 1 Output indicator 1.1
LMIC healthcare workforce strengthened in
areas of AMS and antimicrobial prescribing
practice
No. of LMIC healthcare staff trained in
AMS, antimicrobial prescribing practise
and consumption surveillance (based on
WHO competency framework)
Output indicator 1.2
No. of LMIC healthcare staff trained
and tested demonstrating improved
knowledge after training
Output indicator 1.3
No. and % of LMIC healthcare staff
able to demonstrate how to practise
their new knowledge
Source Commonwealth Partnerships for Antimicrobial Stewardship Call for Applications Webinar
in context, the scheme launched on October 31st, 2018 with a submis-
sion deadline of January 4th, 2019. Grants were due to commence in
February 2019. In practice, funding17 was allocated in April 2019 with
completion due on April 30th, 2020.
Whilst the value positions of funders will steer project design, the
project team may be heavily influenced by recent research findings or
alignment with their own partnership objectives and expertise. Research
and interventions are often cumulative building on pre-existing work and
relationships. Indeed, continuity is listed as one of THET’s principles of
partnership. The Kabarole Health Partnership (KHP), by way of example,
had developed a strong area of expertise and associated relationships in
maternal health and were acutely aware of the mortality associated with
maternal sepsis. This introduces yet more complexity and ‘steer’ into the
project planning process.
1712 projects were awarded between £30,000 and £75,000 each; the MSI received
£60,000.
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Why Maternal Sepsis?
A recent review of research on antibiotic stewardship (Cox et al. 2017)
found limited evidence of effective and feasible stewardship interventions
in (LMICs) and, where examples of effective interventions were identi-
fied, emphasized the essential need for contextualization. From a hospital
management and health worker perspective, outcomes focused on stew-
ardship and antibiotic consumption do not immediately align with urgent
and tangible service priorities. A key priority for Fort Portal Regional
Referral Hospital18 in 2018 was to reduce maternal mortality. As a Health
Partnership, we were acutely aware of this priority and need.
Data from the Ministry of Health’s most recent analysis of maternal
and perinatal deaths (MOH 2019) indicate that, in the Financial Year
2018/2019, there were 1,180,321 deliveries in health facilities and
1083 maternal deaths. The majority of these deaths were reported from
General (472) and Regional Referral Hospitals (334) and, of these, Fort
Portal Regional Referral Hospital reported the second highest maternal
mortality rate (Table 2.2).
According to this report, obstetric haemorrhage remains the leading
cause of maternal deaths in Uganda accounting for 46% of all maternal
deaths reported, followed by Infections/Anaemia/HIV & other condi-
tions not related to Pregnancy (13%) and hypertensive disorders (11%).
The 2019 MPDSR Report found that:
Institutional maternal mortality ratios are highest at the regional and
national referral hospitals (RRHs) (382/100,000 deliveries). This could be
as a result of late and critical referrals from lower facilities, over-stretched
resources (human, financial, equipment), inadequate essential supplies like
blood and lifesaving commodities and the delays to access services at the
referral sites. The institutions also received high numbers of patients in
critical (near death) conditions. (2019: 24)
Ngonzi et al.’s study (2016) in Mbarara Hospital, Uganda reports puer-
peral sepsis19 as the most frequent cause of maternal mortality responsible
for 30.9% deaths as compared to obstetric haemorrhage (at 21.6%). Most
cases of sepsis following childbirth can be characterised as Surgical Site
18FPRRH is often referred to locally as ‘Buhinga Hospital’.
19Relating to the period up to 6 weeks after childbirth.
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Table 2.2 Notification, reporting and reviews of maternal deaths at regional
and national referral hospitals
Source The National Annual Maternal and Perinatal Death Surveillance and Response (MPDSR)
Report FY 2018/2019, Ministry of Health Uganda (September 2019)
Infections arising as a direct result of medical intervention (caesarean-
section). A project focus on stewardship in relation to maternal sepsis had
numerous attractions:
1. Sepsis is a major cause of maternal mortality
2. Sepsis is highly preventable through improved Infection Prevention-
Control
3. Sepsis is associated with very high antibiotic consumption
The proposal is built on pre-existing work by the Kabarole Health Part-
nership (KHP). KHP engages a range of stakeholders in Uganda and
the UK including Knowledge For Change (K4C), an NGO registered
in the UK and Uganda; the Universities of Salford and Mountains of
the Moon; Kabarole Health District and Fort Portal Regional Referral
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Hospital (FPRRH). K4C functions in an operational role implementing
projects on the ground and has a strong local presence in facilities. K4C’s
continuous presence on the ground and growing recognition of our prin-
ciples of partnership and co-presence has led to strong relationships. In
order to extend existing relationships to embrace pharmacy and ensure
active engagement with the Ugandan National Action Planning process,
the partnership expanded to include joint leadership with the Secretary
General of the Pharmaceutical Society of Uganda (PSU) and the NAP
Team. We also brought in pharmacy expertise from the University of
Salford, linking directly to the non-medical prescribing programme20 and
the lead AMR pharmacist in Tameside and Glossop Hospital Trust.
Based on prior experience, the team proposed a ‘Complex Interven-
tion,’ whole-systems, approach that built on pre-existing knowledge and
explicitly allowed for flexibility in response to local contextual dynamics.
McCormack describes the dual focus of action research (AR), combining
the quest for new knowledge with the goal of achieving social change,
as a reason for considering AR in the implementation of complex inter-
ventions (2015: 300). He further argues that much of the complexity in
complex interventions arises from the context within which any evidence
is to be implemented and, citing Bates, suggests that, ‘nothing exists, and
therefore can be understood, in isolation from its context’ (2014: 3). The
following section outlines the context within which the MSI developed.
Study Context: The Post-natal
and Gynaecology Wards at FPRRH
The Kabarole Health Partnership (KHP) had an active presence on the
maternity wards at Fort Portal Regional Referral Hospital. There are two
postnatal wards in FPRRH. One is designated for women who have had
vaginal births, the other for those who have had caesarean sections. Our
focus was on the women on the caesarean section post-natal ward. If these
women recovering from c-sections become unwell, they are transferred
to the adjoining gynaecology ward or High Dependency Unit. Suspected
20Non-medical prescribing is possibly one of the most inappropriately named task-
shifting programs. In practice, non-medical prescribing means prescribing by non-
medical cadres and is actively supported in the UK through an accredited training
programme; https://www.rcn.org.uk/get-help/rcn-advice/non-medical-prescribers. No
such programmes exist in Uganda.
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Fig. 2.3 Site plan of the post-natal and gynaecology wards at FPRRH
sepsis cases are managed in an isolation area at the far end of the ward as
indicated on the site plan (Fig. 2.3).
The public maternity wards at FPRRH have an average of 800 deliv-
eries per month with a c-section rate of around 20% (160/month). The
adjoining post-natal and gynae wards have 40 beds. It is common to have
between five and ten floor cases at any one time. There are six nursing offi-
cers and five midwives staffing the wards on three shifts with two on duty
at any time. Three Senior doctors are employed to work on maternity as
a whole: two medical officers and two intern doctors.
The Intervention
The intervention can best be described as an exploratory ‘journey’ navi-
gated by a multi-disciplinary co-working team. K4C employs Ugandan
health workers to support its activities in health facilities; with the same
strict guidelines applied to professional volunteers, to ensure co-present
working and guard against labour substitution. Two K4C midwives were
already working in labour ward. At the start of the project, we relo-
cated these two midwives to post-natal and gynae (PNG). They were
joined initially by a UK junior doctor and several months later, a nurse
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from the NHS with specialist experience in wound care.21 This team
began to establish close relationships with staff on the wards and across
the hospital to understand the context and observe and discuss the
management of sepsis. This process stimulated an immediate focus on
Infection-Prevention-Control as a preliminary to all other activity. The
journey is traced in more detail in the following chapters.
Within the quite prescriptive framework of the CwPAMS funding, the
priorities of the hospital and the learning gained from initial scoping work,
the team re-defined its objective as follows:
How can we improve antimicrobial stewardship in a Ugandan public
referral hospital in a way that improves patient outcomes (in this case asso-
ciated with maternal sepsis) and demonstrates sustainability through cost
effectiveness?
Methods Used in the Maternal Sepsis Intervention
Action research moves away from being on people (as objects) to being
research that is participatory, with people and for people (Reason, 1988 as
cited by Meyer 1993). Such an approach aligns with THET’s Principles of
Partnership. We noted that action research embraces the need for agency
from all participants (Meyer 2000). This inclusive approach encouraged
and supported individuals to make their own unique contribution to
the change process, which in turn promoted group cohesion and the
development of relationships between local health care workers and with
overseas colleagues. Furthermore, using action research allowed us to
move away from the didactic approach to learning that is commonplace
in LMIC settings. In action research, the intervention moves together
with the research in an iterative and reflexive process. McCormack (2015)
describes this as an example of action-research ‘cycles’ with an action trig-
gering a phase of research which then leads to the next action and so forth
(Fig. 2.4).
21Part of the iterative quality of interventions involving deployment of UK volunteers
is contingent upon recruitment processes; the characteristics and timing of volunteer stays
inevitably shapes interventions. The lack of lead time in this project, as is usual, restricts
the ability to plan in advance. Despite major efforts, we were unable to recruit a long-
term pharmacy volunteer for the first 12 months and then the volunteer was unable to
travel out due to COVID-19.
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Fig. 2.4 An example of action-research cycles (Source McCormack [2015:
303])
Whilst this is a very helpful way of understanding action research, the
idea of defined cycles with a clear starting point and closure is an over-
simplification of the messiness of research (Hantrais 2009).
Mutale et al. (2016) emphasise the value of systems thinking in
complex interventions in LMICs with specific attention to the generation
of unintended consequences, interactions and interdependencies. They
critique what they term reductionist approaches that attempt to ‘dissect a
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complex process and study the individual parts’ (p. 112). Systems theo-
rists engaged in complex interventions, they suggest, prefer a ‘general
science of wholeness addressing structures, patterns and cycles in systems
rather than seeing only specific events’ (p. 112). Although the language
they use is different, the approach proposed resonates with that adopted
in this action research intervention.
Our methods can best be described in terms of a multi-method
ethnography, commencing, as always, with participating observational
work on the ground. Observational work was undertaken on a co-
researching basis with a lead role played by K4C staff and volunteers,
supported by repeated and extended site visits by the Principal Investi-
gator and virtual co-presence over a 15-month period. The team were
joined by the Ugandan lead and attended Hospital IPC meetings on two
occasions. Observations complemented by ongoing WhatsApp and Skype
conversations were recorded in notebooks, minutes, reports, and emails
and entered into NVivo1222 for storage and analysis.
This observational research generated theory inductively which, in
turn, stimulated the search for other sources of data and honed the
focus. Although we had anticipated accessing facility data on antibiotic
consumption, we could not have known or understood the complexity
of this process and the challenges of even defining consumption in a
public hospital setting prior to the start of the project. In such situa-
tions and given the essentially inductive quality of ethnographic research,
simple a priori (deductive) hypothesis setting is inappropriate. In that
respect, a process of conceptualisation, theory generation and data collec-
tion took place simultaneously. Every attempt to record or collate data
stimulated intense ongoing discussions about the recording processes and
the nuances of its interpretation. In most cases, it led us to new lines of
enquiry (theories) and approaches to data collection. Much of the data,
as is normal in this context, was not collated and had to be manually
and painstakingly searched for from casefiles or records books. Files were
often missing or incomplete. The very poor quality of documentation in
patient files and subsequent records management is a critical dimension of
context with implications for AMR. Allegranzi et al.’s systematic review
of health-care-associated infections in LMICS notes the lack of data and
poor quality of many studies contributing to what they term the ‘hidden
22NVivo is a qualitative data analysis computer software package produced by QSR
International.
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and serious burden on health systems and patients’ (2011: 236). Study
quality in their sample was related to very poor-quality record keeping
and documentation as a result of ‘inaccuracy of information from patients’
records, and a paucity of electronic records or databases for surveillance
of health-care-associated infection’ (p. 235).
Data collection became a process of exploration, involving forms of
local capacity-building along the way on methods of organising and
storing hospital records and entering them into excel spreadsheets. In
this context (as in many others), much of the facility-based data could
not be interpreted at face value as facts; but rather artefacts reflecting
their (social) construction. Facility data has been collected from a wide
range of sources. Firstly, data on drug orders and supplies from National
Medical Stores (NMS), was obtained through an online national phar-
macy database, known as the Rx system, the use of which was func-
tionalised through the project. This was supplemented by data from
paper-based records (the Dispensing Log) of supplies distributed from
the central hospital stores to the wards. Further, the hospital laboratory,
itself supported by the Infectious Diseases Institute (IDI), proved a key
partner both in the intervention itself, with laboratory results providing a
critical stimulus to multi-disciplinary team working, but also in gener-
ating research data. This commenced prior to the project as part of
Ackers-Johnson’s microbiology doctorate (Ackers-Johnson 2020) and has
continued throughout, generating valuable data on resistance patterns.
The laboratory provided data on test results of samples taken from the
PNG wards in 2019.
Whilst we would contend that facility-based data at FPRRH cannot
be understood as ‘facts’ but rather social constructs contributing to a
partial truth, this is not the case with the microbiology (surveillance) data
generated under stringent laboratory controls. Although human error can
affect the accuracy of this form of data; it is not relational in the same way
as facility data. The objective status of the microbiology test results has
played a powerful role in breaching disciplinary hierarchies and promoting
effective team-working (see below).
This complemented a data set generated from 142 cases of suspected
sepsis between January 2019 and February 2020 that were identified
through a manual search of paper-based patient records. In January 2020,
a phase of qualitative interviewing took place to capture perceptions of
the impact and effectiveness of the intervention. Twenty-five interviews
were conducted with all cadres involved in the MSI, including 50% of the
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nurses, midwives, intern doctors, laboratory technicians and pharmacists
working on the PNG wards, two hospital managers and three UK volun-
teers. The interviews were transcribed and thematically analysed using
NVivo 12. Ethical approval for the work was gained from the University
of Salford, Makerere University, and the Ugandan National Council.23
Somekh suggests that not only is the action research process a
continual one, it never naturally ends until a decision is taken to take stock
and publish its outcomes ‘to date’ (2006: 6). Once again this has clear
resonance with the emphasis on continuity that we feel is a feature of the
principles of partnership in international development research. Although
work has and will continue, this book represents the situation at the end
of the initial funding period.
The following chapter presents key outcomes arising from the Maternal
Sepsis Intervention and the methods outlined above.
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CHAPTER 3
The Impact of theMaternal Sepsis
Intervention
Abstract This chapter presents data on maternal mortality in Uganda
and the contribution that sepsis makes to mortality. Against this backdrop,
it identifies key outcomes of the intervention including major improve-
ments in maternal mortality and reductions in the length of patient stays,
readmission rates and hospital expenditure.
Keywords Antimicrobial resistance · Antimicrobial stewardship ·
Infection Prevention Control · Maternal mortality · Maternal sepsis
It is common in ODA projects to be required to produce ‘outcome indi-
cators’ related specifically to ‘beneficiaries’. As noted in the discussion on
methods, the expectation is usually for quantitative metrics. The funding
call and associated guidance, unusually for UKAid projects, did not specify
patient outcome indicators but focused more on stewardship processes
and antimicrobial consumption data. It is also more usual, in research, to
discuss the intervention processes in more detail and report the findings at
the end. The project proved to be more impactful than we had anticipated
with significant reported impacts on maternal mortality, patient stays and
hospital budgets.1 We have chosen to report these outcomes first and
1It may be interesting to note that these outcomes were not predicted or described
in the MSI application or present in the logframe as we felt they would have seemed
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then to try to unpack the processes contributing to these outcomes. As
we noted in the methods chapter, funding bodies and researchers are
as much concerned with attribution (and change processes) as they are
outcomes. And in such complex interventions many variables will inter-
vene to influence attribution and outcomes. In action research, some of
these variables will come directly from iterative responses to ethnographic
understandings of context; others will come from external, often hidden,
processes.
Maternal Deaths from Sepsis at Fort Portal
Regional Referral Hospital (FPRRH)
Allegranzi et al.’s systematic review (2011) reported the very poor quality
of facility data on health-care-associated infections and associated impacts:
Unfortunately, in studies retrieved findings related to increased length
of stay and attributable mortality and costs associated with health-care-
associated infection were fragmentary. (2011: 236)
Qualitative interviews with health workers and stakeholders repeatedly
referred to the fact that there had been no deaths from sepsis at FPRRH
since the MSI became operational. Many of the respondents alluded
directly to reductions in maternal deaths and the effects of this on the
reputation of the wards:
FPRRH was identified once again as the RRH in Uganda with the highest
maternal mortality rate. It was in the newspapers and the Director is very
concerned and embarrassed about this so any improvements on the ward
are very welcome. (midwife)
Health workers were keen to cite examples of patients whose lives had
been saved because of (their) improved practice. They were not only
delighted and highly motivated by their ability to save these women’s
lives, but the experience also provided direct affirmation of the value of
behavioural changes on the wards:
overly ambitious had we been required to deliver on them. This process could lead to an
under-statement of impacts in ODA projects.
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We have had 4 complicated cases (this week). We thought the patients
would die and they walked out happy. There was a patient we thought
would pass away, but she survived as she got the appropriate antibiotics.
(midwife)
These responses, supported by our observations on the wards, encouraged
us to undertake a review of maternal deaths. In practice, it proved difficult
to find all the cases and to identify a clear causal factor in the files. After
detailed analysis of the documentation, Fig. 3.1 documents a reduction in
deaths from sepsis over time since implementation began in June 2019.
We tracked the data back to 2018 to assess trends and this revealed some
unexplained peaks and troughs.
Although most responding health workers referred to the sharp decline
in deaths, analysis of the maternal mortality data indicated the persistence
of deaths associated with sepsis. We could describe the method here as a
forensic ethnography, and an example of where a mismatch in perceptions
and data led us to delve deeper. The data support the contention that,
since implementation, there have been no deaths from sepsis amongst
those women having c-sections in FPRRH. One of the ‘training’ mech-
anisms the project team have instigated involves regular audit meetings
on the wards; these include all cases of maternal death or serious sepsis
and provide an opportunity to assess practice and monitor outcomes.
Each of the sepsis deaths discussed in these meetings have involved
























Fig. 3.1 Causes of maternal death (FPRRH) (Source Maternal Mortality
Registers and Files, January 2018–May 2020)
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primarily in refugee camps. These women face major referral pathway
delays and arrive at the hospital late at night often in a very critical
condition.
‘The Road to Death’2: Understanding
the Impact of Geography and Delays
Regional Referral Hospitals have a particular role to play in the Ugandan
public health system. That role is predicated on the efficacy of the referral
system as a whole and the functioning of lower level referral facilities so
that only those cases that need treatment at a specialised facility should
be referred there. This system is barely functioning. One of the major
problems facing FPRRH is congestion caused by systems malfunction and
significant delays in referrals with many women dying shortly after arrival.
The only deaths from maternal sepsis during the project have involved
late referrals from distant facilities and refugee camps. These cases either
stemmed from or bypassed facilities with responsibility for Emergency
Obstetric Care that should have been able to treat them in a timely and
effective fashion. At the request of the hospital director, we undertook an
analysis of the residence of women who die at FPRRH. This illustrates
the distance many had to travel before reaching FPRRH.
Aware of the impacts of such deaths on the reputation of the hospital
the Director encouraged the team to explore this issue in more detail.
Analysis of a further 1000 admissions onto maternity evidenced similar
referral patterns.
This data was not planned for in the application but provides critical
context to an understanding of sepsis (and AMS) at the hospital. The
interviews with health workers and stakeholders illustrate the problems
associated with travelling long distances to access FPRRH. One intern
doctor commented:
Our ward is very small, and the volume of patients is overwhelming
because the nearby hospitals are not doing c-sections. We have patients
now coming from Kyenjojo hospital where they are not doing sections;
they just put on the form that they have no anaesthetists.
2Filippi et al. (2005).
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Other respondents talked about the problems of having women referred-
in especially from Kyenjojo (50 km away) and Mubende (145 km away);
facilities which have theatres and post-natal wards.
But why are the doctors not working there? We have heard it is because the
anaesthetists are not on the ground. They are bumping the cases down here
simply because their anaesthetists are not there. In the referring centres you
will find zero deaths – they will keep a mother there until she is now risky
and between leaving there and arriving here… most women die within 1 h
of arriving. (stakeholder)
Another (stakeholder) respondent referred the importance of distin-
guishing those sepsis cases arising from local operations and those coming
in through referrals or, as is often the case, self-referrals:
Of the patients operated in Buhinga fewer are having sepsis. We should
distinguish these from those coming from outside of Buhinga; we have 2
separate entry points.
Sadly, a sepsis-related death occurred in February 2020. The case illus-
trates the challenges facing a hospital when women face extensive delays.
In this case, the woman travelled some 77 km from Rwamwanja Health
Centre, near Kamwenge. This area supports a refugee camp. The case was
reported to us as follows:
The 18-year-old woman was referred to FPRRH 6 days after an emer-
gency C-section apparently for obstructed labour and a still birth. When
she arrived late at night doctors removed a retained swab and started
antibiotics. The following morning, she was found to have intra-abdominal
sepsis and needed another operation to wash the pus out and remove her
uterus which was the source of the infection. You could smell the infection
from metres away. We took her to theatre, washed out her abdomen, and
removed her uterus, which was severely infected and necrotic. We then put
her on meropenem, our strongest possible antibiotic. She later died.
Causes of death: Poor monitoring of labour and delayed caesarean at
the health centre, leading to foetal death and increased risk of infection.
Likely poor asepsis and retained swab during the caesarean leading to post-
operative infection. Delay in recognition that she was not getting better
resulted in delays in referral to FPRRH. Possible antibiotic resistance meant
that any initial empirical treatment was not enough and possibly there was
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even resistance to meropenem (though she might have been too far gone
by the time she reached us).
Figure 3.2 shows that six of the maternal deaths in 2019 came from this
refugee camp as well as a large volume of admissions (Fig. 3.3). Respon-
dents have advised us that, although health facilities in such camps are
typically better resourced and ring-fenced UNHCR funds are available for
transport to FPRRH, drivers obtain greater funding for night visits and
are therefore inclined to delay transportation of very sick patients until
night-time. Other respondents suggested drivers may wait until they have
3 or 4 cases to transport, especially if any of those cases are local Ugan-
dans who do not come with a budget. It has also been reported that
where local Ugandan women do manage to get access to this transport
to FPRRH they are not permitted to travel back via this route. What-
ever the reasons, late referrals such as this one leave little opportunity for
staff at FPRRH to save lives and this also directly impacts antimicrobial
stewardship.
The impact of late referrals on maternal mortality from sepsis is
confirmed by Ngonzi et al. (2016) in Uganda and Kongnyuy et al.
(2009) in Malawi. Seni et al. (2013) put another twist on this relationship
between late referrals and SSI incidence reporting an ‘alarming’ preva-
lence of SSI in Uganda amongst ‘emergency surgeries which accounted
Fig. 3.2 Distances travelled to FPRRH (maternal mortality cases) (Source
Analysis of maternal mortality cases, 2019)
3 THE IMPACT OF THE MATERNAL SEPSIS INTERVENTION 43
Fig. 3.3 Distances travelled to FPRRH (Admissions, 2019) (Source Analysis of
1000 Maternal Admissions, 2019)
for more SSIs cases as opposed to elective surgeries’ (2013: 5). Very few
Health facilities in Ugandan run elective list for non-fee-paying cases.
All the referrals coming into FPRRH are for obstetric emergencies. It is
easy to understand the hospital director’s concerns about these cases and
the attribution of blame. The relationship between adverse patient safety
events and reputational damage is noted by Slawomirski et al. (2017) in
a report on the economics of patient safety (2017). The authors cite the
results of several studies in High Income Settings illustrating the impact of
adverse patient safety events on prolonged hospital stays. They conclude:
Hospital-acquired sepsis accounts for a large proportion of additional
hospital days, standing out as one of the most expensive and most clinically
complex conditions to treat. (2017: 16)
The data presented above and the discussion about referral cases could be
seen as a distraction from the main focus of the research. We believe it
illustrates the importance of a very deep and intuitive approach to context.
On the one hand, the ability to evidence the source of sepsis cases has
supported local policy and underlined the need to invest in these referral
facilities and, potentially, extend the intervention to such sites. On the
other, the data and mapping process has served an important function in
challenging the basis of media coverage of the hospital (and its position
in maternal mortality league tables). This has proved a real motivation for
hospital managers and health workers alike.
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One of the studies cited by Slawomirski et al. (2017) (above) reported
patients staying 10.2 days longer in Dutch hospitals as a result of adverse
patient safety events (Hoonhout et al. 2009). Seni et al. (2013) report the
relationship between very high levels of SSI in Uganda with ‘substantially
longer hospital stays and higher treatment costs’ (2013: 6). The following
section evidences reductions in patient stays as a result of the MSI.
Impacts on Patients, Their
Families, and Livelihoods
Spending time in hospital is a significant burden in low resource settings
especially amongst the poorest of patients. During their time in hospital,
they are unable to undertake any economic activity or caring responsibil-
ities themselves and often have up to five or six attendants residing in or
near the hospital to support them, providing food and routine care. Many
patients admitted to a Regional Referral Facility will have travelled some
distance from their home village. The large number of women described
in the notes as ‘running away’ (or self –discharged) prior to completion
of their treatment3 (and at high risk of readmission or mortality) do so in
order to care for children and family and to enable their families to return
to their activities. Extended stays in busy referral facilities also contribute
directly to congestion. This presents a challenge in terms of maintaining
adequate IPC. Congestion is often manifested in floor cases making it
hard to clean facilities effectively and for over-stretched staff to deliver
efficient and respectful care. The fact that every patient will have a number
of attendants many of whom sleep and eat amongst the patients on the
floors is a further hazard. Zulfiuqar et al. (2013) reported concerns about
the security and infection risks posed by the presence of in-patient atten-
dants at a tertiary hospital in Karachi. Most patients in their study had
at least one attendant with 85% attendants staying for the duration of
the patient stay and performing critical care duties for patients including
feeding, washing and administering of medications. Extended stays of
patients and accompanying attendants create the conditions for the spread
of Healthcare Associated Infections some of which have shown multi-
drug resistance (Acinetobacter). Where extended stays are due to delays
3These cases contribute to the poor quality of antibiotic consumption data as we have
no way of knowing if they complete their prescribed dose.
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in closing wounds (secondary closure),4 this also creates opportunities for
secondary infections.
Most respondents expressed the view that patients were staying for
shorter periods on the ward and they were experiencing fewer readmis-
sions due to sepsis. The following midwife suggests that the project has
had a significant impact on length of stay:
These days the patients do not stay on the ward for very long. At first
those ones with sepsis they could spend 2 weeks or 4 weeks on the ward
but now you find a mother has come with sepsis – you do the dressing -
a mother will not even spend a week on the ward. Because they remove
a swab – they take it there – we get the results – the doctor comes and
investigates and the good thing we are doing closure now in our room
– we are not now taking them to theatre because thanks to K4C we now
have the instruments to do them there and to sterilise them.
This observation is backed up by the laboratory:
Patient stays have really reduced on the ward and we produced evidence
on this last year. Patients were staying for over 30 days on the ward prior
to the project – now in many cases after culture and sensitivity testing5
and closing the wounds they can then go home after 10 days. We have
reduced patient stays on the ward and even in terms of costs, shorter stays
and fewer attendants on the wards.
One midwife explains how reductions in length of stay are a combined
result of improved wound care, improved prescribing in response to labo-
ratory results and the infrastructural improvements that have improved
the functionality of the evacuation room. This involved the provision
of additional instruments, sterilising equipment and storage cupboards
and has enabled intern doctors to close (re-stitch) wounds on the ward
4Secondary closure is a term used on the ward to describe cases where the original
c-section wound opens as a result of infection. In some cases, the staff have to re-open
infected wounds. Some of the wounds on the ward gape openly with a diameter of up to
10cms. They then must be debrided (removal of damaged tissue) and dressed until the
infection is gone and they are able to re-close them.
5Culture and Sensitivity Testing is the term used to describe the process of taking
a sample from a patient; growing the bacteria from that sample in a laboratory and
then testing the susceptibility of (or responsiveness to) any bacterial growth to available
antibiotics.
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without sending women to surgical theatre. Theatre days for elective
wound closure are only available twice a week and if a woman misses
that date, she may have to remain on the ward with an open wound
for another 4 or more days. The savings in such cases include not only
shorter stays but reduced use of precious theatre time. As one doctor
put it, ‘wound closures cannot be a priority for theatre time’. This also
reduces the risks associated with moving patients around the hospital. An
intern doctor describes the changes he has witnessed on the ward:
The instruments in the evacuation room means we can now do procedures
that used to take a long time as we had to sterilise equipment between cases
so mothers can be treated much more quickly, get better and leave the next
day. This takes pressure off theatre too. We now dress (the wounds) and
when they are ready, we do the secondary closures – they don’t need to
go to theatre. We have been able to move women out of the ward more
quickly which has reduced congestion as women heal more quickly now.
We do it in the evacuation room and now we disinfect it and we know
we have to reach higher standards so we can close the wounds there. The
doctors are doing most things now – the interns will do some without
supervision apart from difficult wounds then they take to theatre and the
senior doctors are there. They will assess the wounds and we do what we
can here.
[Were the doctors doing this before?]
Actually, they were doing some closures, but it would take some time
– they had to wait to disinfect the equipment but now it is streamlined.
It has really improved now; the numbers of mothers that need to go to
theatre has reduced a lot – because what happens – the mother comes with
a bad wound - these guys do the dressing and manage the mothers and
the wound becomes small and easy to suture so we can do it here now on
the ward. The sepsis has really gone down but maybe out of 5 we can now
take 2 to theatre and the other 3 we can close the wounds here. Before
the number was big and all mothers were being taken to theatre to close
the wounds. In fact, in the last 2 months we have had a situation where
the septic mothers’ section is empty – the place is clean – you have done
a great job.
Another intern refers to improvements in patient recovery and length of
stay:
What [MSI] has brought to reality is that – actually when samples are taken
and followed up then things get better more quickly – as observed you will
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note that this side has very limited sepsis now – there are few and even
those that are there are improving so quickly and we are doing secondary
closure so quickly. Before we had patients on the ward with a wound for
over a week and as you bring in a new patient, they get a hospital acquired
infection but now hospital stay has been reduced from 2 weeks to 5 days…
we really could quantify this. We now have fewer infected wounds to dress
and fewer secondary closures and we can do many of these now on the
ward. Before every infected patient was cross-infecting the next patient –
the longer they are on the ward the more this happens. We have outgrown
waiting to go to theatre.
The doctor also refers to the benefits of having a new trolley and instru-
ments but, importantly, the impact of leadership and improved human
resource management:
Most of the secondary closures are being done on the ward now. Now
we have the instruments and the trolley – before there wasn’t anyone who
would take responsibility to wash the instruments so there was a delay –
now the instruments are enough – the challenge was for someone to take
responsibility for washing and sterilising them. Now we do the closures as
soon as they are ready – before the room was not sterile for secondary
closures but now it is ready. There are now few cases going to theatre
unless it is more serious like a burst abdomen. Before in the evacuation
room the instruments were lying in jik (disinfectant) so you had to wait.
Then the patients can become septic again. Now you can’t spend a day
waiting.
Another midwife adds the observation that this has also reduced the
volume of readmissions:
The wounds get better and then the interns can do the secondary closures
and we have had no evidence of readmission of these cases.
When the project started, we were advised that many of the cases on
the post-natal and gynae wards were re-admissions; that is women who
had been treated on that ward and discharged and then had to return
due to infection. In March 2020, the midwifery team decided to track
every woman coming onto the ward with an infected wound for a period
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of 3 weeks. Of the 121 cases tracked, there was no evidence of re-
admission.6 These perceptions are backed up by the evidence drawn from
facility records. In a pain staking process and with support from the
hospital administrator, the team have worked with the records office to
reorganise a mass of files into date order and entered data into a spread-
sheet of every case of sepsis in 2019–2020. This has provided a rich
database enabling us to assess, objectively, the impact of the intervention
on patient stays.
Impact on Patient Stays
The following section reports on an analysis of all cases of suspected sepsis
recorded over a 13-month period from January 2019 up to and including
January 2020. 142 cases were identified in patient records which recorded
patient stays from the date of operation (usually a c-section) to discharge.
A t-test was done to determine whether there was a difference in hospital
stays between those patients who had received a culture swab and those
who had not. It was found that hospital stays were significantly lower
in patients for whom culture swabs were completed (M = 21.28, SD =
1.17) than those for whom this was not done (M = 27.35, SD = 1.67): t
(128) = 2.99, p = 0.003. On average, the group that was swabbed stayed
in hospital for 6 days less, following their operation.
The records included another potential ‘start’ date, the date of diag-
nosis. A t-test was also performed to determine whether there was a
difference in hospital stays from the date of diagnosis, between those
patients who had received a culture swab and those who had not. It was
found that hospital days were significantly lower in patients for whom
culture swabs were completed (M = 13.44, SD = 1.08) than those for
whom this was not done (M = 19.38, SD = 1.51): t (129) = 3.31 p =
0,.0016. On average, the group that was swabbed stayed in hospital for 5
days less, after suspected diagnosis of sepsis. Figure 3.4 shows the overall
pattern of patient stays since the project commenced.
6We do not have statistics from the pre-intervention phase on this. Women were
tracked, where possible post-discharge by telephone. Tracking proved difficult in around
20% cases with some women not responding to calls. However, re-admission would have
been evident through ward-based reporting.
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Fig. 3.4 Length of stay based on date of operation (Source Patient Records
PNG Ward FPRRH [January 2019–January 2020])
As noted above, these reductions in patient stays will be associated with
multiplier reductions in the volume of attendants staying in and around
the wards.
Impacts on Hospital Budgets
Finally, and inevitably, extended stays represent a major cost to the
hospital in terms of infrastructure, staffing and consumables. The effect
of these improvements has been welcomed by the Senior Administrator
who comments on the efficiencies this has generated:
When sepsis is managed then the resources used to manage these patients
reduce drastically. By reducing long stays which brings about savings you
have contributed to the hospital budget with real term savings. That’s an
area for me now to look into. We should be able to see in real terms how
much savings we have been able to make.
Allegranzi et al. (2018) noted the paucity of studies identifying in any
systematic way, the costs involved in managing health care associated
infections and the cost-savings associated with effective interventions. The
MSI did not set out to undertake detailed cost-benefit analysis. Never-
theless, as the project has evolved, and cost savings were remarked upon
by respondents and senior managers, we started to explore the potential
for integrating cost-benefit analysis in future work. This would provide
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critical impetus for sustainability and future investment. Our findings
confirm Weber et al.’s assertion that strengthening WASH services in
Togo was cost-minimal. Although key barriers cited by Weber’s respon-
dents referred to costs this was more a matter of institutional priorities
than actual costs which are in reality very low and, importantly, could
be managed within existing budgets, ‘without significant external finan-
cial or material support’ (2018: 1). The authors also recommend greater
attention to cost-effectiveness and budget expenditures in future research
(p. 64).
Patient Experiences
It is difficult to gauge patients’ perceptions of the project’s impact mainly
because most will have nothing to compare their experience to. However,
several midwives reported positive patient feedback:
The mothers have noticed the project because we had a mother who had
sepsis. It was her second child and she had delivered in Buhinga before
but that time she didn’t have sepsis. She said, ‘hey you people this ward
has changed’. In the first pregnancy she delayed on the ward. This time
she got sepsis, so we moved her from post-natal to gynae and she said ‘hey
you nurses why have you changed? You have changed me to gynae ward
– now what is taking place?’ We told her be calm and after a few days
we worked on her and she went home. She said the hospital has changed!
Nowadays they know.
The in-charge also noted genuine changes in the attitudes of staff towards
their patients:
Some used to treat a death of a mother as if it were the death of a chicken.
Now they see our patients as their sisters or mothers and care for them.
Before some staff were hard to deal with; they barked at patients. The care
in this ward is critical care and a woman could lose her life in one minute.
We need the best and most caring staff.
The following chapter examines some of the constituent interventions and
impacts that, together, contributed to the improvements described above.
We start with a discussion of infection prevention and control. The ‘con-
trol’ dimension and the focus on wound management merges seamlessly
into a discussion about antimicrobial surveillance and stewardship.
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CHAPTER 4
Infection Prevention Control (IPC)
and Antimicrobial Resistance (AMR)
Abstract This chapter outlines a key component of improved AMR;
namely infection prevention control (IPC). It addresses some of the
issues most commonly associated with IPC including hand hygiene, waste
disposal and infrastructure. It then addresses wound management as an
Infection Control issue. The emergence of wound management as a
central focus in the Maternal Sepsis Intervention proved pivotal in shaping
the pathway to antimicrobial stewardship.
Keywords Infection Prevention Control · Maternal sepsis · Wound
management · Surgical Site Infection · Health Care Acquired Infection ·
Hand hygiene
‘Prevention First’
In 2017, the WHO adopted a Resolution focused on improving the
prevention, diagnosis, and management of sepsis. Reinhart et al. under-
line the importance of recognising sepsis as a global health priority.
They go on to suggest that progress towards ‘a world free of sepsis’
requires recognition of the key role of prevention (2017: 416). Infec-
tion prevention reduces the overuse of antibiotics which drives resistance.
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Infection-Prevention-Control (or ‘IPC’) has featured strongly on the
global health agenda for many years with significant emphasis on those
infections that patients (and health workers) acquire within health facil-
ities. Whilst attempts to tackle the source of infection in the home and
workplace have formed the basis of HIV-awareness and public vaccination
programmes, the phenomena known as ‘Health Care Acquired Infection’
(HCAIs) and its cousin, ‘Surgical Site Infection’ (SSIs) have focussed
concern on ‘adverse’ events associated with hospitalisation.
What Is a Health Care Acquired Infection?
The World Health Organisation’s Patient Safety Fact File (2019) defines
‘Health Care Associated Infection’ as follows:
Health care-associated infections, or “nosocomial” and “hospital” infec-
tions, affect patients in a hospital or other health-care facility, and are not
present or incubating at the time of admission. They also include infections
acquired by patients in the hospital or facility but appearing after discharge,
and occupational infections among staff.1
The Fact File reports health care associated infection rates of 10% amongst
hospitalised patients in LMICs (2019: 9). Allegranzi et al.’s systematic
review of health-care-associated infection in developing countries found
that the prevalence of health-care-associated infection is ‘much higher’
in LMICs than HICs and concluded that Surgical Site infection was the
‘leading health care-associated infection in the developing world’ (2011:
28).
What Is a Surgical Site Infection?
The Centre for Disease Control (CDC) defines a Surgical Site Infec-
tion (SSI) as, ‘an infection that occurs after surgery in the part of the
body where the surgery took place’ and occurring within 30 days after
the procedure (or 12 months in the case of orthopaedic implants).2
Seni et al.’s (2013) analysis of 314 SSI cases at Uganda’s national
referral hospital reported a much higher incidence of SSIs amongst
1https://www.who.int/gpsc/country_work/gpsc_ccisc_fact_sheet_en.pdf.
2https://www.cdc.gov/hai/ssi/ssi.html.
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women (76.1% of their sample) and a preponderance of cases in obstet-
rics and gynaecology wards (62.1%). Caesarean-section and laparotomy3
accounted for more than three quarters of all surgical procedures in their
study. They conclude:
The predominance of SSIs in obstetrics and gynaecology wards is quite
alarming and thus, a need to institute stringent infection prevention and
control measures in this setting, more especially in emergency surgeries
which accounted for more SSIs cases as opposed to elective surgeries.
(2013: 5)
A similar study in Tanzania (Mawalla et al. 2011) reported SSI rates
of 26% amongst patients undergoing surgery and similarly noted the
gendered impact of SSIs largely reflecting the volume of women having
surgery in the first place.4
Following the award for the MSI, the funding bodies added an addi-
tional ‘request’ that each team conduct a Global Point Prevalence Survey
(G-PPS).5 This is a standardised survey of antimicrobial use amongst all
in-patients in a hospital on a given day designed to deliver comparative
data for international benchmarking. It captures that data through docu-
mentation in patient records (which may be an inaccurate reflection of
practice). The MSI team undertook the GPPS on May 7th, 2019. It
involved all 42 patients on the post-natal and gynae wards at 8 am (22 in
gynae and 20 in post-natal). The GPPS found that 94% patients on post-
natal ward were prescribed antibiotics for surgical prophylaxis (94%) with
one case involving suspected Community Acquired Infection (CAI).6
The picture in the adjoining gynae ward was quite different. Here, 45%
3A laparotomy is a surgical incision into the abdominal cavity, for diagnosis or in
preparation for major surgery and is commonly used in obstetrics and gynaecology cases.
4Mawalla recorded a significantly higher SSI rate amongst those men who did have
surgery which they suggested may be due to multiple risk factors such as smoking and
HIV infection.
5http://www.global-pps.com/ The value of the GPPS process is discussed below.
6Patients who come into the hospital with a pre-existing infection are regarded as
having acquired that from the ‘Community’ which may imply their home environment.
In many cases, these patients will have acquired an infection from a previous health facility
and referred on to the hospital. In such cases CAI and HCAI are conflated and difficult
to distinguish.
56 L. ACKERS ET AL.




Total no of patients 22 20
Percentage of patients on antibiotics 45 90
Percentage of antibiotics for Community acquired infection 20 6
Percentage of antibiotics for Health-care-associated infection 50 0
Percentage of antibiotics for medical prophylaxis 0 0
Percentage of antibiotics for surgical prophylaxis 10 94
Percentage of antibiotics for unknown indication 20 0
Source Results of G-PPS, May 2019 as reported to FPRRH IPC Committee
patients were prescribed antibiotics and 50% of these were related to a
suspected health care associated Infection (Table 4.1).
Infection Prevention and Control
in the Ugandan National Action Plan
The Ugandan National Action Plan on AMR outlines its ‘One Health’
approach arguing that, ‘Prevention is the most effective, affordable way
to reduce risk for and severity of resistant infections’ (2019: 6). Strategic
Objective Two identifies key actions to improve infection prevention
and control. These span four inter-linked areas: IPC in healthcare facil-
ities; IPC in the community; biosecurity in agriculture and vaccination
programmes. Action 3.2.1 sets out key objectives to ‘Strengthen Infection
Prevention and Control Programs in Healthcare Facilities’ and is the area
of most direct relevance to the Maternal Sepsis Intervention (Fig. 4.1).
Objective 3.2.1 reiterates well-rehearsed (if neglected) IPC goals: to
raise awareness; improve hand hygiene, basic infrastructure, and waste
disposal. Goals 4 and 6 add a specific AMR ‘twist’ and illustrate the imme-
diate connection with the surveillance objectives outlined in Strategic
Objective 4. The creation of guidelines to limit the spread of multidrug-
resistant organisms and timely diagnosis and treatment of drug-resistant
organisms requires strong multi-disciplinary team working with labora-
tory scientists, pharmacists, doctors, nurses and midwives.
This chapter reports first on the more familiar aspects of IPC
concerned primarily with creating an environment on the post-natal and
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1. Maintain up-to-date infec on preven on guidelines and standards of professional prac ce and ensure their 
availability in all healthcare facili es 
2. Ins tute/strengthen and support minimum standards for infrastructure in healthcare facili es that promote 
IPC 
3. Ins tute/strengthen and support proper func oning of Infec on Preven on Control (IPC) and Medicine 
Therapeu c (MTC) commi ees 
4. Create and promote specific guidelines for limi ng the spread of mul drug-resistant organisms 
5. Support availability and proper use of infec on preven on materials and supplies
6. Encourage mely diagnosis and treatment of drug-resistant microorganisms
7. Promote hand hygiene and other hygienic prac ces and behaviours that prevent transmission of infec ous 
disease. 
8. Promote campaigns for infec on control at healthcare facili es 
9. Ins tute systems of incen ves or rewards that monitor and uphold good IPC prac ces 
10. Promote safe waste disposal and safe treatment prac ces in healthcare facili es
11. Create and strengthen coordina ng ac vi es at all levels from local level facili es to the Ministry of Health 
for IPC 
12. Improve human resource systems, education, and commitment to professionalism  
Fig. 4.1 Objective 3.2.1 Strengthen Infection Prevention and Control
Programmes (Source Ugandan National Action Plan on AMR)
gynaecology wards that reduces opportunities for women entering that
ward to acquire a health care-acquired infection as a direct result of prac-
tices on that ward. The ‘control’ component of IPC is often neglected;
IPC is not just about prevention; it is also about controlling infection.
Many women arriving on the PNG will already have been exposed to
risks of HCAI and SSI either in the operating theatres and labour wards
at the same hospital or in the referring facilities they pass through on
their journey into the hospital. In such cases, the focus on the PNG is
on early identification of infection and appropriate management. Wound
management has emerged as a key concern in the control of infection
for those women with infected wounds; for the women and attendants
around them and for the health workers caring for them as they become
a source of infection to others.
IPC in the Maternal Sepsis Intervention
7
The project team were aware of the central importance of IPC to antimi-
crobial resistance when we applied for funding. Arguably the emphasis
in the literature on AMR has focused too much on the management of
7A version of this chapter has been written up as a policy document
for the hospital and includes photographs of the ward and more details of the various
interventions and associated costs. This can be found at www.knowledge4change.
org.uk/.
58 L. ACKERS ET AL.
antibiotics by individual health workers and patients which, to use a collo-
quial expression from the UK, amounts to, ‘locking the door after the
horse has bolted’. Denyer-Willis and Chandler emphasise the importance
of preventive approaches:
Antibiotics have become …. a quick fix for hygiene in settings of minimised
resources. (2019: 1)
This is particularly relevant in LMICs, where, they argue, antimicro-
bials are, ‘put to work to correct the fractured infrastructures of care,
water and sewage, hygiene and demands for ever increasing [health worker]
productivity’ (p. 2).
We have seen this in previous K4C work on antibiotic stewardship.
Women at a health centre III were being routinely prescribed prophy-
lactic antibiotics following vaginal birth as a mechanism to protect against
uncertainty surrounding hygiene and sanitation in both the hospital
setting and the home setting (Welsh 2019).
Denyer-Willis and Chandler (2019) emphasise the importance of
‘connectivities’ and underline the need for multi-disciplinary teams and
methods (including social science and anthropological approaches) in
order to present an holistic and accurate picture of the deeply contextual
factors contributing to AMR and potential responses. Prevention must be
the starting point of all holistic AMR interventions; it is also the most
cost-effective.
Hand Hygiene
Maina et al. describe water, sanitation, and hygiene (WASH) as the key
foundations of AMR in Kenyan hospitals:
Poor WASH increases hospital-associated infections and contributes to the
rise of antimicrobial resistance. (2019: 1)
The survey tool developed by Maina et al. and piloted in 14 general hospi-
tals in Kenya showed major performance variations between hospitals and
wards reflecting differences in the built environment, resource availability
and leadership. They identify waste management and (healthworker) hand
hygiene as ‘critical indicators’ with hand hygiene achieving an aggregate
score across all facilities of only 35% (p. 1). Allegranzi et al. report even
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lower levels of hand hygiene compliance of around 20% in LMICs (2011:
235). Hand hygiene compliance at FPRRH was observed to sit at a mere
17.4% in 2018 (Mbabazi 2018).
K4C previously held a grant (awarded in 2015) from the Tropical
Health and Education Trust which focused on IPC in the Kabarole
region. In keeping with our experience of behaviour change in Uganda,
the hand hygiene project combined formal training with continuous
mentoring whilst commencing quality controlled local manufacture of
alcohol-based hand sanitiser. Providing training without ensuring that
health workers had access to the opportunity to exercise that knowledge
was, we felt, arrogant and insulting. The hand hygiene project achieved
a considerable shift in health worker behaviour; but only for as long as
K4C was in a position to fund the costs of the hand gel. Despite persua-
sion, facilities proved unwilling to contribute in any way at all to the
constituent (and cheap) ingredients for hand gel production. When the
MSI commenced, we immediately expected and noticed the absence of
hand gel. The juxtaposition of a broken and empty hand gel dispenser
next to the Ugandan guidelines on hand hygiene on entry to the ward
can only have had a demotivating impact on health worker behaviour
especially when dealing with highly infectious patients (Fig. 4.2).
Denyer Willis and Chandler echo this sentiment:
The saddling of responsibility for hygiene with individuals who have limited
ability to change the environment in which ‘good hygiene behaviour’ is
expected to operate leaves these individuals to find solutions that are more
feasible and within their control, such as the use of antibiotics. (2019: 3)
Another potential solution to the individual risk the health workers face
is to decide not to uncover and dress infected wounds (see below). The
COM-B behaviour change model presented in the Application Guid-
ance (Fig. 1.1) emphasises the importance of ‘opportunity’ to behaviour
change. In our experience providing training in hand hygiene without
access to resources fails to translate into improved behaviour (unsurpris-
ingly) and acts as further demotivation as it underlines the failure of
institutions to honour their duty of care to protect employees.
This chapter reports on the process of improving the IPC infras-
tructure. This has been achieved through continual discussion and
co-decision-making. Informed by our previous experiences of formal
training (Ackers et al. 2016), the team resisted the temptation to wade
60 L. ACKERS ET AL.
Fig. 4.2 Empty and damaged hand gel dispenser next to Ugandan guidelines
on handwashing
in and ‘train’. This does not mean that no education or knowledge
creation/mobilisation took place. Rather that it evolved through team
working.8
Concerns about hand hygiene and the sustainability of our (previous)
intervention stimulated a proposal (at the start of the project) to the
hospital which would have supported the co-production and co-financing
of IPC consumables and infrastructure repairs to support implementa-
tion of the hand hygiene protocol throughout the whole hospital. The
proposal was based on principles of Public–Private Partnership, as envi-
sioned by the Ministry of Health’s Strategic Plan. Unfortunately, at that
point, the hospital felt unable to agree to this proposal.9 However, given
8Our approach to knowledge mobilisation in the MSI is discussed in more detail in
Chapter 8.
9We return to the PPP discussion in Chapter 9.
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the existence of project funding and the importance attached to reducing
infection risks both for patients and health workers, the team agreed to
continue providing hand gel for the ward. This has involved placing more
robust dispensers on the walls in key locations (such as the sepsis area) but
also, in December 2019, providing health workers with their own refill-
able personal dispensers. One of the intern doctors interviewed on the
ward showed us his dispenser, attached to his uniform. It is interesting
to see how he specifically refers to using the gel after a procedure and to
protect himself:
IPC is improving - even when we cannot wash our hands, we all now
have our own hand gel so after any procedure or examination we use this
alcohol. It has made life safer for us. What they send through National
Medical Stores is not enough – at least now we have this. This has really
helped us improve patient care.
The mechanism used to improve hand hygiene on the ward has priori-
tised infrastructural repairs and supplies of running water, soap and hand
gel. We firmly believe that Ugandan health workers are aware of the
importance of hand washing both to their own well-being and that of
their patients. Formal training courses (referred to locally as Contin-
uing Medical Education or CMEs) conveying that knowledge at this
stage in the project would have been inappropriate. We are also aware
that health workers in Uganda (as in the UK) do not always exercise
exemplary behaviour (they do not apply their knowledge to practice). In
our experience, effective and continuous role modelling and mentoring
in the context of good leadership is the only way to build an IPC
culture. The project team included a Ugandan medical educationalist
and midwife who had previously worked with us on the hand hygiene
project and undergone high-level training in IPC through the Infection
Control Africa Network (ICAN) programme.10 This midwife is Ugandan
and comes from the local region so is fluent in the main local language
(Rutoro). This has enabled her to build excellent relationships on the
ward supporting staff with wound dressing and other duties whilst also
developing a contextually appropriate version of the WHOHand Hygiene
10This involved a one-week training program in South Africa and another in Cameroon
with an emphasis on infection prevention to improve on hand hygiene, sanitation and
health care waste.
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Compliance Tool and Infrastructure Audit Tool.11 The in-charge nurse
noted the effectiveness of this approach and, perhaps surprisingly, the fact
that local staff did not feel threatened by her presence:
[K4C midwife] is on the wards at times watching them hand wash and
pulling them up. Not criticising but making them constantly aware of the
importance of hand washing to themselves and the patients.
One of the intern doctors noticed the improvement:
The project has really improved on IPC. These days it is a must to clean
your hands and staff are using the hand sanitiser.
The following midwife echoes a concern we were familiar with from our
previous project; namely the challenge of drying wet hands where there
are no disposable towels12:
We have improved hand hygiene because we have the sinks repaired and
we have enough alcohol sanitiser – there is soap and running water. Now
if you don’t wash your hands that is your attitude.
[Do people wash their hands now then?]
Actually, it has changed – some do, and some feel hand washing takes
time to dry but with the sanitiser you can move quickly between patients
and wash hands after the procedures. There are no towels, so we use pieces
of gauze.
The K4C midwife suggests that whilst much improvement has been made
on hand hygiene compliance there is room for more:
I’m seeing a bit of improvement – they are using hand sanitiser – I can
identify this from the WHO forms. I can identify areas they tend to forget.
At least most of them remember the hand sanitiser but there is gap when
they go to a new patient. Those who forget – previously they worked on
11https://www.who.int/gpsc/5may/moment1/en/.
12The Hand Hygiene project piloted the use of re-usable single-use hand towels. This
has remained effective only in the smaller Health Centre 3 facility that K4C is partnering
with. In FPRRH, the risks associated with abandoned dirty towels and the demands of
apportioning staff to wash them in the absence of laundry machines outweighed the
potential gains.
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patients without having it in mind to clean their hands and some of them
it is still in their trait.
[So, should we put more sanitisers on the walls?]
It is working for some, but we are looking at the distance between the
beds and the sanitiser and we need one fixing to the wall in the sepsis area.
The WHO Hand Hygiene Observation Tool13 was used to audit hand
hygiene compliance. Observation took place during day shifts where most
procedures are performed. The common procedures include operations
such as bed-cleaning, patient examination, wound dressing and drug
administration. Hand Hygiene compliance was assessed twice; first in
October 2019 and secondly, in March 2020 (Table 4.2).
Table 4.2 Hand Hygiene Compliance in October 2019 on PNG ward at
FPRRH
Hand Washing Hand Gel




Midwives 54 18 33 54 23 43
Intern
Doctors
36 2 6 36 8 22
Senior
Doctors
12 2 16 12 4 33
Source Adapted WHO Hand Hygiene Compliance Audit
The results show relatively poor adherence to WHO Hand Hygiene
targets in the first observation period. We did not assess compliance
prior to the project so this will represent a marked improvement on
the previous period especially when sinks were not working, and hand
gel was not present on the wards. It is interesting to note that compli-
ance with hand gel use is stronger than hand washing, and midwives and
nurses have higher compliance rates than doctors. Maina et al.’s study
in Kenyan hospitals reported qualitative findings suggesting that, ‘nurses
are more conversant with infection prevention issues’ and complaints by
nurses that, ‘doctors don’t embrace the issues of IPC’ (2019: 13).
13https://www.who.int/gpsc/5may/tools/en/.
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Table 4.3 Hand Hygiene Compliance in March 2020 on PNG ward at FPRRH
Hand washing Hand sanitiser




Midwives 26 20 76 26 23 88
Intern
Doctors
12 7 58 12 11 91
Nurses 12 8 66 12 7 58
Source Adapted WHO Hand Hygiene Compliance Audit
Table 4.3 shows the results for a second phase of observation in March
2020. By this point, all staff had personal hand gel bottles as well as access
to dispensers at the entrance to every ward. The observer in this phase
distinguished nurses and midwives (which we had not done previously)
and as is common, no senior doctors were present on the ward during
observations.
The nurses and midwives received informal feedback after the previous
observations and were aware that observation had been taking place.
Table 4.3 shows marked improvement in the second observation phase
especially amongst intern doctors who show a strong preference for
using alcohol gel with compliance increasing from 22 to 91%, and hand
washing, from 6 to 58%. Higher levels of compliance were observed
among midwives than nurses. The placement of hand sanitiser on the
trolleys, on walls and in the health workers’ possession have improved
compliance. Observation also indicated very strong compliance with
guidelines on the use of gloves (which are generally available). In both
observation periods, glove utilisation was at 100%. Table 4.4 identifies
compliance rates at key opportunities for hand hygiene in the second
observation.
Analysis of the 56 ‘moments’ identified during this observation period
showed that 95% of health workers washed hands after body fluid
exposure and 75% remembered to wash their hands after touching the
patient’s surrounding. Some chose to use hand gel rather than hand
washing (Fig. 4.3).
Figure 4.2 gives a flavour of how the tool has worked in practice. It
also shows differences in the use of hand washing and hand gel. Before
touching a patient, there is a mix of staff using hand washing and hand
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Table 4.4 Hand Hygiene ‘Moments’ and Compliance (March 2020) on PNG
ward at FPRRH
Action/‘Moment’ Number Percentage
Before approaching a new patient 09 45
Before aseptic action with patient 13 65
After body fluid 19 95
After completing a procedure with a patient 15 75
Total 56
Source Adapted WHO Hand Hygiene Compliance Audit
Fig. 4.3 An example of the WHO Calculation Form (March 2020 Observa-
tions)
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gel whereas staff are more likely to use hand gel before commencing an
aseptic procedure. Nearly all staff washed their hands after exposure to
body fluids. Hand gel is much more likely to be used after touching
a patient or touching patient surroundings. The results indicate a high
level of compliance with IPC advice and efficient combination of the two
dimensions of hand hygiene. Monistrol et al. identify hand hygiene as the
‘most important procedure’ in preventing HCAI (2011: 1212). Their
intervention in a tertiary hospital in Spain, focused mainly on educa-
tion and training, demonstrated marked improvements in hand hygiene
compliance (also using the WHO Tool) with compliance improving from
54.3 to 75.8%. This improvement was witnessed in a facility where rooms
were shared by only 2 or 3 patients and alcohol hand gel was available
at every bedside. Given the far more restricted access to hand gel in the
PNG, the rate of improvement is remarkable. It is interesting to note that
Monistrol et al. also found poor physician compliance in comparison to
nurses and, post-intervention greatest improvement amongst physicians.
These findings are echoed in our study particularly with hand gel use. The
use of hand gel on unsoiled hands is described by Monistrol et al. as the
‘new standard of care’; it is also far easier to implement in resource-poor
environments with weak infrastructure. It is interesting to see the results
of the ‘5 moments of hand hygiene’ in the Spanish study with lowest
compliance ‘before patient contact’. The authors describe this as evidence
that hand hygiene compliance is highest when health workers feel that it
is protecting them (rather than the patient); ‘self-protection was the main
driver for performing hand hygiene’ (p. 1217). This would explain the
high rate of compliance in the moment after connecting with patients’
body fluids (Table 4.4).
IPC Infrastructure
The emphasis on identifying an intervention model for future scalability
led to continuous improvement of audit tools to ensure optimal contex-
tualisation. This meant that results are not directly comparable. The
action-orientation of the MSI and our concern to develop and trial appro-
priate tools was more important than achieving a controlled, comparative,
sample. We are also very aware that K4C presence on the wards may have
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contributed a ‘Hawthorn Effect’14 (as reported by Monistrol et al. 2011).
Our concern to identify optimal methods of knowledge mobilisation,
through co-presence and co-working relationships no doubt accentu-
ates this effect. The presentation of hand hygiene audit data here is to
illustrate trends; the quantitative data are heavily influenced by the inter-
vention and we firmly believe that this type of data is best complemented
by on-going observation and qualitative interviewing. Clearly the infras-
tructural investment made in supplying hand gel was a major driver of
change. The provision of hand gel was a ‘quick fix’ preliminary interven-
tion that stimulated an unfolding identification of other infrastructural
IPC concerns.
The WASH FIT initiative is one of the World Health Organisation’s
responses to critical concerns about Patient Safety.15 Weber et al. (2018)
identify key aspects of infrastructure in LMICs that undermine progress in
improving patient safety. They cite a study by Cronk and Bartram (2018)
based on aggregated information from 78 LMICs which reports that 50%
of health facilities studied lacked piped water; 33% did not have improved
sanitation; 39% did not have soap and water for hand washing and 39%
lacked proper medical waste management.
During preliminary observational phases of the MSI, we were increas-
ingly aware of serious infrastructural challenges that would undermine our
ability to bring about those behaviour changes required to reduce and
manage hospital acquired infections effectively. The project team, led by
the midwives on the ground, made an initial assessment of the ward infras-
tructure which was later followed up during a field visit by the project
leads. This confirmed the need for certain investments to promote IPC
on the ward, in the designated sepsis area and in a partitioned area (known
as the evacuation or procedure room) used for minor procedures such as
wound closing which we later identified as an intervention focal point.
The team also discussed the contextual relevance of the existing WHO
Infrastructural Survey Tool16 which colleagues felt was too focused on
14The Hawthorne effect is a term used to describe the possibility that individuals
involved in an experiment or study modify their behaviour in response to their awareness
of being observed.
15The WHO define Patient Safety as ‘the absence of preventable harm to a patient
during the process of health care’, https://www.who.int/patientsafety/en/.
16https://www.who.int/gpsc/5may/tools/evaluation_feedback/en/.
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hand hygiene and neglected issues like signage and the status of furnish-
ings (closing cupboards and doors etc.). We also had concerns about the
section in the WHO Tool on provision of clean drinking water. This
is very rarely provided in Ugandan public health facilities unless a local
donor does so. We were acutely aware of the value of providing access
to clean drinking water to ensure women are hydrated. However, having
discussed this with local staff and the ward in-charge we made the decision
not to provide clean drinking water given the serious problems associated
with large numbers of visitors on the wards (see below). One of the K4C
midwives reported back to the UK lead on this on-going discussion:
I talked to [the in-charge] about the issue of drinking water for patients.
She did not welcome it, based on the behaviours of both patients and
attendants. She felt the attendants are unruly, and she looked at the possi-
bility of them using the drinking water for brushing and other things.
She also felt sustainability may be a question. The other concern was IPC
related and we should not commit ourselves by introducing drinking water
on the ward.
This illustrates the ethnographic quality of the work continuing even at a
distance and the value of this approach in guarding against the unintended
consequences (externality effects) of seemingly easy and benevolent inter-
ventions. Some 12 months later, stimulated by ongoing concerns about
the impacts of poor hydration on wound healing in several severe sepsis
cases, we agreed to provide a large water boiler in the nursing station to
enable staff to boil tap water and provide it to patients. This intervention
may obviate the need for cannulation in cases where intra-venous fluids
are given in Uganda as a substitute for oral hydration but carry their own
HCAI risks (and costs).
We also had concerns about the sections of the WHO Tool auditing
provision of paper towels and a waste basket for used paper towels. To our
knowledge, no public health facilities in Uganda have paper towels. We
therefore decided to remove these two sections of the WHO Tool from
our audit. The Modified Infrastructure Audit Tool includes a list of key
components with a scoring column that supports a quantitative overall
score for audit and comparison purposes.17
17The team extended use of this tool across the whole hospital to support of COVID-
19 intervention.
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Improvements in the Infrastructure Score
A first audit, using the original WHO Tool, was completed in October
2019. This identified concerns around the sterility of equipment and
instruments, ready access to hand sanitiser and healthcare waste. We also
noted the absence of adequate hand-washing facilities, lack of labelling of
soap bottles and display of hand hygiene posters. By this time, the project
had already provided hand gel. The general patient environment was also
much improved. However, we noted weaknesses under the equipment
heading in terms of broken trolleys, cleaning of medical devices and re-
use of single use items. Although gloves were generally available and used,
there were concerns about access to eye shields and protective masks.
Concerns were also expressed about the quality of waste management
with health workers failing to sort waste properly and waste bins often
over-loaded with poor adherence to management of sharps. These obser-
vational findings echoed Maina et al.’s conclusion that waste management
is one of the weaker aspects of IPC (2019). Another continuing and
persistent challenge has been in improving very poor-quality documenta-
tion and record-keeping. The Infrastructure Audit was repeated 3 times;
in October 2019, January 2020 and March 2020. The overall results are
presented in Table 4.5.
Audit 3 raised several residual issues (inadequate cleaning of equipment
between patients; lack of labelling of waste boxes and lack of data on in-
service IPC training). The following section summarises the ‘problems’
identified. Interventions took place in cycles gradually reducing gaps and
improving the opportunities for effective and holistic IPC. Quite often as
one problem is solved another emerges either simply because it opens a
new process but also because of the kinds of externality effects referred to
above.
The intervention kicked off with an early decision to re-decorate the
ward. This was largely cosmetic but gave the opportunity for a thorough
Table 4.5 Results of IPC Infrastructure Audit
Score Percentage
Audit 1 (October 2019) 37/63 58.7
Audit 2 (January 2020) 50/63 79.4
Audit 3 (March 2020) 61/63 96.8
Source Infrastructure Audit
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deep clean. The process was also designed as a motivational exercise to
promote staff and patients’ sense of well-being and team working. In
response to concerns about the ‘openness’ of the existing sepsis area
wooden doors were fitted to isolate the sepsis area and try to prevent
attendants sleeping and eating on the floor. The state of the mattresses on
the ward was a great concern to heath workers as the condition enabled
body fluids to enter and soak into exposed foam. The team purchased
20 new waterproof mattresses and an additional 12 waterproof covers for
the mattresses that were least damaged. In response to a request from
midwives and nurses, hard wearing washable aprons were provided for
staff to use during wound dressing procedures to protect themselves and
the patients.
Chapter 6 discusses the problem of stock-outs in the hospital not only
of drugs but also essential IPC consumables. At regular intervals, the
hospital runs out of ‘JIK’, a bleach used ubiquitously in differing dilu-
tions for many aspects of cleaning and disinfection in Ugandan hospitals.
As a rule, K4C does not provide consumables to facilities as we believe
this to be unsustainable. However, we did make a personal donation of
2 large bottles when the hospital ran out. One of the problems in the
use of JIK was not simply its absence, but the tendency to use it far too
concentrated, which damages materials and equipment. Use of JIK in this
way had caused major damage to examination beds, hospital screens and
instruments on the ward. This illustrates the merits of continuous obser-
vational engagement and an acute understanding of context. When we
asked the hospital pharmacist about this, he reported that health workers
found it hard to understand the formulae for JIC concentration on the
wall in PNG (below). When we assessed this guideline, we immediately
understood the major weakness in this attempt at science communication
expressed as a knowledge gap on the part of nursing staff. The guideline
was replaced with a simple plastic measuring jug, marked to guide the
proportion of JIK to water, and buckets and training in the use of these
and the problem was immediately resolved (Fig. 4.4).
Continuous engagement on the ground has enabled us to identify
some of these simple problems and rectify them. The issue of dilution
was picked up again once the project had purchased a new examination
couch. K4C has witnessed very rapid rusting on such beds in the past
where staff use neat JIK to clean metalwork. Pharmacy have provided
advice on appropriate dilution of JIK for cleaning of infrastructure and
furnishings and advised cleaning the bed with hand gel. Advise was also
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Fig. 4.4 Formulae for JIC dilution
provided on the correct dilution of hydrogen peroxide which is used
when dressing septic wounds. When not correctly diluted, this can cause
harm by delaying healing processes. Staff are now continually trained and
mentored using this guidance.
Repair of Sinks
Staff were conscious that there were only 2 sinks on the wards and one
of these, in the evacuation room where secondary closures and other
procedures take place, was not functioning. Lengthy discussion took place
about the pros and cons of providing an additional sink. Although this
immediately seemed like a good idea to the foreign team, local staff recog-
nised that sinks can themselves become a source of infection, especially
when simultaneously used as a sluice for disposal of body fluids. On that
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basis, the local team decided to repair the one sink in the evacuation room
and not to provide an additional sink on the main ward.
They also identified the need for new trolleys in the evacuation room
and on the ward as existing trolleys failed to move (their wheels did not
work) and were very old and rusted. Staff also used the same trolley for
both septic and non-septic wounds (a practice which has now changed).
Cupboards were also placed in the evacuation room and stainless steel
(sterilisable) galley pots were provided to maintain sterility. Additional
instruments were purchased so that work could continue when one set
were in the process of being sterilised. At that time, there was no steril-
isation equipment on the ward and the only autoclave in maternity was
not working. Midwives had to walk up to the surgical ward and wait until
the sterilising unit there was available wasting valuable staff time on the
ward and reducing the use of the procedure room. The following excerpts
indicate appreciation of interventions and the impact on behaviour:
Nowadays I’m happy because we have sterile swabs. We didn’t have instru-
ments, so you put your hands in (the wounds). Now we have instruments
we can do it properly.
[Do you feel that protects you as well?]
Yes, because nowadays we have really improved on hand washing.
We have hand gel, aprons and masks. They are giving hand gel now to
improve on infection because after dressing you use gel and you are free
of infections. At first, we didn’t have those things.
[When you said some of the midwives didn’t want to change dress-
ings because they were smelly, do you think they were also worried about
catching infections themselves?]
Yes, because at first when you said, ‘who is going for dressing?’’ she
would reply; ‘Who is going there? I am not protected.’ They were fearing
infection from the patient to them. You would go there without an apron
(gloves were there) but still most people would not like to go there. Now
this has improved (Midwife).
A laboratory scientist echoes this view:
IPC has changed for the best. This is very positive and has been sustained
through support with materials.
The following midwife notes benefits in terms of health worker safety and
productivity:
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The new trolleys have really helped. We can now sort our equipment out
and this eases our work. The instruments in the evacuation room means
we can now do procedures that used to take a long time to do as we had
to sterilise equipment between cases. Mothers can be treated much more
quickly, get better and leave the next day. This takes pressure off theatre
too. We now have enough instruments and receivers to use (a receiver is
like a kidney dish). We had very few so if we used them, we had to wait
for another cycle to sterilise them before we used them again.
K4C staff expressed concern that the system of disinfecting instruments
requires further improvement:
In the evacuation room some of the instruments are being left lying in jik
– they should only be left in jkc for 10 minutes. We are trying to improve
on it. They know they should remove the instruments from the jkc. If they
put them in, by the time they have finished getting the patients ready to
go back on the ward they should take them out. We had that discussion
in the last staff meeting and it was agreed that if the doctors have finished
the procedure, they have to make sure they alert the nurses to wash the
instruments and hand over the evacuation room and then they should lock
it.
This quote shows how IPC issues are raised at most (every) staff meeting,
not always as a distinct training intervention but within the normal course
of events. At this time, midwives had to carry instruments, gauze, etc.
to surgical theatre for sterilisation. This involved staff leaving the ward
and often waiting in surgical theatre for the steriliser to be available. The
project has now provided a dedicated autoclave to speed this process and
reduce unnecessary movement of people and instruments between wards.
The discussion above illustrates the incremental and progressive approach
we have taken, gradually identifying and responding to many small issues
to improve both IPC and productivity. Despite the above interventions,
the in-charge remained concerned at the level of over-crowding:
We are currently faced with ‘overwhelming numbers’ and yesterday there
were 56 patients in a ward with a bed capacity of 40 so this is an on-going
problem. This meant that there were many floor cases in the gynae area
and into the sepsis zone.
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This overcrowding is continuing to occur despite reduced patient stays.
In many respects, it is outside of the hospital’s control as many patients
continue to be referred from other health facilities including Hospitals
and Health Centre IV facilities who should be able to cope with c-sections
and post-natal patients. Overcrowding, combined with lack of hospital
beds leading to floor cases, and inadequate sterilisation of hospital tools
are factors that Denyer-Willis and Chandler (2019: 3) suggest contribute
to HCAI and unnecessary prophylactic antimicrobial prescribing.
Infection Prevention and Control
and Wound Management
Flexibility and reflexivity are critical to high impact action-research. These
are respected qualities in complex intervention research (Moore et al.
2015; Richards and Hallberg 2015). As noted above, this can cause some
creative tension with funding bodies who, for accountability purposes,
are keen to adhere as closely as possible to projected activities, associated
budgets, and international protocols. The success of the MSI has derived
from its very grounded, inductive, approach and the acute attentiveness to
contextual dynamics. The comments of the Senior Administrator that, ‘No
little thing is ignored’ capture this attention to context and to processes
on the ground that together contribute to antimicrobial resistance and
shape our ability to respond effectively to it.
Although the decision to focus on surgical site infections and take
samples for laboratory testing had been planned for some time, the ratio-
nale for this focus was that many of these women would be otherwise well
and that this would enable us to identify hospital acquired infections. And,
although we had planned to swab c-section wounds as the basis for the
laboratory testing and our AMR surveillance activity, we had not antici-
pated how important wound care itself was to infection control and the
management of antimicrobial resistance. The opportunity to engage more
actively in wound management, as a key constituent of an holistic AMR
intervention, was neither mentioned in the Call Specification, in our appli-
cation or indeed in the National Action Plan. It came about as a result of
the recruitment of one of the first UK volunteers to the project; a nurse
who had extensive experience of working on surgical site infection studies
in a London hospital and a strong interest in wound management. This
midwife was a ‘diaspora’ volunteer; a Ugandan national fluent in the local
language (Rutoro). This, coupled with her commitment K4C’s approach
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to active co-working, really helped to establish rapport. On arrival, she
immediately noticed patients with very badly infected, gaping wounds,
and poor practices in terms of wound care. As in the case of IPC, rather
than immediately commence ‘training’ or design protocols, she worked
alongside local staff to understand the context within which SSI wounds
were developing and contributing to sepsis. The team spent an inten-
sive two weeks engaging in structured observation and follow-up of 71
women who had had a c-section at FPRRH during that period. This
enabled them to identify a number of concerns including; the lack of any
consistent approach to the cleaning, dressing and swabbing of wounds;
patient observations (essential to the early identification and management
of infection and sepsis) and prophylactic antibiotic use (with prophylactic
doses not completed in 94% of observed cases).
This initial observational phase also identified concerns about IPC
processes (discussed above) including the use of unsterilized gauze for
wound dressing; the disposal of infectious waste; the lack of sealed
containers and cupboards for storage of sterilised gauze and instruments
and poor management of materials on badly rusted and dysfunctional
trolleys. Analysis of the 71 cases revealed a re-admission rate of 10%
confirming the findings of subsequent interview data that many women
were leaving the ward and returning several days later with badly infected
wounds.
It was for this reason that the team embarked on intense, continuous,
mentoring on wound care. One of the local midwives had already taken
an active interest in wound management which she described as the most
neglected area on the ward. She suggested that, when she arrived on the
ward, her focus on wounds was perceived negatively:
I found the ward stinking. There was so much sepsis I went to where the
smell was worst. The staff were running away from the bad smell. Some
women stayed for over 2 months. There were staff shortages and many
patients. I said, ‘let me look at these wounds’ so I started there. Some
midwives were dressing wounds, but they were reluctant. The work was
too much. It depends on someone’s interest, but it was a major priority
for me. Gynae was somehow neglected; everyone was shying away because
of the smell. They knew it was smelling but didn’t know what to do.
Staff were encouraged to get into the habit of documenting and reading
patient notes, dressing wounds, and using simple tools developed to
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observe and evaluate the effectiveness of their approach. They created
their own medication records following receipt of laboratory results and
started a Ward Report Book. The in-charge echoes the observation
discussed above:
The staff are now identifying and dressing wounds; when I arrived and
before the project started the midwives didn’t do this. This resulted in a
terrible smell throughout the ward which has now gone; you can smell the
place is better?
She commented on the work K4C had introduced on wound cleaning:
Before that the midwives didn’t do it – midwives often focus on the
pelvis18 and not on bedside nursing. I am a midwife and a nurse and
appointed as a nurse in my role. Midwives would have been taught the
theory of dressing wounds in their training but had never used those
skills in practice. K4C staff really encouraged staff to start to identify
wounds and treat them. The number of cases going back to theatre as
a result of infected wounds has dropped significantly; they can now be
better managed on the wards. This has been important in decongesting
theatre and was better for the mothers. All the local staff are now engaged
in wound dressing; there has been a real change in staff attitudes. Before
there was no one to remind them of their knowledge and skills. They did
not have the idea to manage wounds, some did not have the knowledge
and there was resistance by midwives who felt it wasn’t their role. Then
those of [K4C] came and this has made the job a lot more pleasant; people
are enjoying work more.
It is wonderful to see not only the impact on patients’ wounds and the
decongestion of the theatre but also to hear that health workers on the
ward were beginning to enjoy work; this is the environment that creates
meaningful opportunities for behaviour change. Another local midwife
who has become actively involved in wound dressing speaks of how prac-
tice in this area has been transformed and suggests that this is also a
reflection of improved IPC and provision of basic materials which protects
them:
18We assume that the reference to pelvis here is not anatomical as such but an indication
that midwives focus on deliveries rather than wound management.
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Wound dressing has totally changed. At first, we used not to dress the
wounds every day for sure. Nurses didn’t want to dress the wounds because
they were stinking. Sepsis had increased on the wards but nowadays staff
want to do dressing because the wounds are not smelling like at first.
[Did you know how to do wound dressing?]
Yes, we were taught how to sterilise gauze and do dressings but the
problem when we reach the ward you just stop because you don’t have
things to use on the wards. Nowadays I’m happy because we have sterile
swabs. We didn’t have instruments so you put your hands – now we have
instruments – we can do it properly. At first when they said ‘who is going
for dressing’ she would reply; ‘I am not protected so they were fearing
infection from the patient to them so you go there without an apron –
gloves were there – but still most people would not like to go there. Now
this has improved because we now do dressings twice a day, they don’t get
smelly.
Another local midwife, also actively involved in wound dressing on the
ward, was proud to report on the case of a mother who ‘ran away’ from
another health centre (Kamwenga, a 65 km distance); ‘She came here and
we dressed her wound and were able to make her better’. She said that
she used to dress wounds but had learnt new techniques and the impor-
tance of documentation and, when a patient appears unwell, of taking
vital signs19:
We just tried to clean the wounds. With the guidance of the K4C
colleagues we really now know that we have to take vital observations. We
call them baseline bedside observations. Then if the temperature changes
or the pulse we know something is happening, so we know to do vitals.
We document them to find if they are stable or not. With the help of
[K4C midwife] we have time. When these people are there, we can do
this so right now we do. I knew wound dressing before, but I have learnt
higher techniques and also recording exactly what you see on that day in
the notes. Documentation is sometimes a problem, but we are trying to
improve. If you come and dress the wound and don’t document no one
else will know but now it helps team working. Your colleagues will also
come and if you REALLY document then someone else will come – and
if the wound is still bad after 3 days of wound dressing we can ask – why
is this wound not getting better?
19Whilst in other settings vital signs will be taken for all patients, the practice in this
context is to take vital signs when a patient is showing signs of deterioration.
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One of the intern doctors also remarked on improved wound dressing
comparing practices favourably to other hospitals he had worked in:
Wound management has improved greatly. Before and in other hospi-
tals I’ve worked in we recommend twice a day dressing and they are
not changed even once. Wound management has improved greatly, and
mothers are receiving twice daily dressings, so they improve so quickly.
The staff have developed a trait to inherit – it’s a great impact.
The use of the phrase ‘trait to inherit’ would indicate a degree of contin-
uous behaviour change or culture change in practices on the ward. The
point about the smell on the ward is repeated by many respondents both
in interviews and in casual conversations on the ward. Certainly, the ward
no longer smells, and this has improved the working environment for all
staff and patients. There has been lengthy debate on the ward about the
use of honey and sugar in wound care. Whilst the use of honey is more
widely accepted as having an evidence base (and antimicrobial qualities)
the use of sugar, instigated by one midwife following several years of expo-
sure to wound treatment in other settings, has received conflicting views.
The midwives on the ward are clear that applying both sugar and honey to
the wounds speeds healing and significantly reduces odour. Intern doctors
and pharmacists are less convinced of sugar’s healing properties with one
referring to its use as ‘bush medicine’. Having said that there was no
suggestion that using sugar had a negative effect.20
This chapter has addressed the issue of infection-prevention and the
contribution that quite simple and cost-effective interventions can have
in reducing the incidence of infection on the wards and managing
those infections that do exist more effectively. Improved IPC reduces
the volume of wound infections per se. This is clear from the marked
reduction in readmissions onto the ward with infected wounds. Wound
management is also a dimension of IPC with an emphasis on the control
aspect. And it is this attention to observing and managing wounds
that created the opportunity for collection and analysis of antimicrobial
resistance and, subsequently, antimicrobial use.
20This is an ongoing debate which we will return to in due course.
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CHAPTER 5
The Role ofMicrobiology Testing
in Controlling Infection and Promoting
Antimicrobial Stewardship
Abstract This chapter discusses the Role of Microbiology Testing in
Controlling Infection and Promoting Antimicrobial Stewardship. It
details the role that culture and sensitivity testing has played in creating
the ‘objective’ evidence base that facilitated and nurtured midwifery
empowerment, task shifting and multi-disciplinary team working. The
chapter presents findings of resistance patterns of isolates from women
with suspected sepsis.
Keywords Antibiotic resistance · Culture and sensitivity testing ·
Isolates · Rational prescribing · Empirical therapy · Antibiogram
Objective 3.2.1 of the Uganda National Action Plan (Fig. 4.1) outlined
key components of IPC. All the familiar ‘good housekeeping’ aspects
of IPC are listed. Sub-Objective 6 encouraging ‘timely diagnosis and
treatment of drug-resistant microorganisms’ stands out as a less usual
element of IPC. It expresses the ‘control’ dimension of IPC and forms
an essential interface with the stewardship aspects of the National Action
Some of this material has been published in Ackers et al. (2020).
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Plan demonstrating the need for holistic approaches to AMR. Objec-
tive 3.3 of the Action Plan combines a concern to ‘Optimize Access to
Effective Antimicrobial Medicines’ with access to ‘Diagnostics in Human
Health’. This latter objective overlaps with Sub-Objective 6 (above) and
is focused on (1) ensuring availability of affordable and accurate diag-
nostic tools to all health facilities and (2) enhancing systems for financing
access to diagnostics and antimicrobial medicines. Achieving progress in
Sub-Objective 6 requires identification of the microorganisms present in
infected wounds using appropriate diagnostic tools and using those results
to make evidence-based and contextually relevant clinical and prescribing
decisions. The success of this rests fundamentally on high-functioning,
multi-disciplinary teams.
We noted (above) how the Call for Funding identified 3 of the 10
Fleming Fund objectives as priorities. This explicitly excluded the Fleming
Fund Objective of ‘building laboratory capacity for diagnosis’. Further-
more, the reference to multi-disciplinarity did not refer to laboratory
science. However, the outcomes expected from projects did include ‘the
use of microbiology data to inform decision-making’. This illustrates both
the mixed messaging coming from the Call and the underlying challenge
of attempting to isolate specific components of AMR.
Most public hospitals in Uganda lack the capacity (equipment and
consumables), human resource and expertise to undertake effective,
timely and free microbiology testing. One of the intern doctors inter-
viewed had trained and worked in Mbale Regional Referral Hospital in
north-east Uganda (520 km from Fort Portal). This enabled him to draw
interesting comparisons between the two facilities in swabbing practices:
The main thing we are doing here is blood culture, swabs and culture and
sensitivity testing so at least we are able to prescribe the best antibiotics.
[Was it like that in Mbale?]
No – it wasn’t easy. We did culture and sensitivity testing there
but we had to use a private laboratory that charged 30,000 shillings
per case1. About 50% of people were able and willing to pay for this
service. The hospital microbiology laboratory did not function; they lacked
consumables, culture medium ….
[Did patients understand the reason for the testing?]
Yes, they did – it was more a question of money.
1About £6.
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FPRRH is an exception. The laboratory at FPRRH is supported by the
Infectious Disease Institute (IDI) with funding from a range of interna-
tional partners. As such, it offers excellent laboratory facilities. The IDI
team has invested considerably in encouraging health workers in FPRRH
to send samples to the laboratory for ‘Culture and Sensitivity Testing’.
Relationships with the IDI laboratory pre-dated the MSI. We were aware
that IDI had found it very difficult to persuade local health workers to
take swabs and samples for testing. A presentation by the IDI team to the
IPC Committee in 2018 noted the absence of microbiology testing until
2016. The significant refurbishment of the laboratory in 2018, coupled
with capacity-building, improved power supplies and a constant supply
of reagents and general supplies created new opportunities. Despite this
situation, the presentation concluded that: There is very limited utilisation
of the microbiology laboratory at FPRRH.
A subsequent presentation in 2019, and despite significant attempts
by the laboratory team to raise awareness on the wards through short
training sessions, echoed this concern:
There is low up take of available microbiology diagnostics at FPRRH.
Prior to the commencement of the intervention, most of the patients in
FPRRH were prescribed antibiotics on the basis of experiential knowledge
(of clinicians). This is influenced by prior education, reference to clinical
guidelines and heavily circumscribed by what is available, and perceptions
of what is available, in pharmacy stores. This process is termed ‘empirical
therapy’.2 There is increasing evidence that many of the most commonly
used (and cheaper) antibiotics available in low resource settings (including
public hospitals in Uganda) are no longer effective in treating infections;
the bacteria have become resistant to them. Continued and extended
use of these antibiotics on resistant infections will fail to deliver positive
patient outcomes and waste antibiotics, contributing to AMR and hospital
costs. Where, as in many RRHs in Uganda, there is no capacity for labo-
ratory testing, doctors have little choice but to throw what is available at
2Empirical therapy refers to, ‘Treatment given without knowledge of the cause or nature
of the disorder and based on experience rather than logic. Sometimes urgency dictates
empirical treatment, as when a dangerous infection by an unknown organism is treated
with a broad-spectrum antibiotic while the results of bacterial culture and other tests are
awaited’ https://medical-dictionary.thefreedictionary.com/empirical+treatment.
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patients. The use of microbiology testing in the hospital is beneficial both
for individual patient management (ensuring they get the optimal antibi-
otic for the infection they have) and for creating evidence-based policies
to guide empirical antibiotic use.
Bacteriology-Based (Individualised) Prescribing
The priority for the MSI, in the first instance, was to create the oppor-
tunity for individual rational prescribing based on culture and sensitivity
testing. From the point of taking a wound swab or blood sample, it can
take 5–7 days for antibiotic susceptibility results to be returned to the
ward. Taking this into account, alongside the urgency of treating sepsis
without delay, many women are prescribed an initial empirical antibiotic
regimen until test results are received and communicated to a prescriber.
In the Ugandan context, this means waiting for a doctor to reassess the
patient and prescription. And it could take many days for the same doctor
to review that case.
Facilitating Culture and Sensitivity Testing
The qualitative interviews with health workers on the PNG ward indicate
the priority that they all now ascribe to culture and sensitivity testing.
Indeed, it is the normalisation of this process, through substantial and
sustained behaviour change, that has underpinned the emergence of
highly effective team working. And this, in turn, lies at the heart of inter-
vention success (discussed below). The following midwife describes how
this change has happened and the complex chain of events involved:
If we see pus, we do a swab – but those things have just come.
[So, you were not swabbing before?]
We were not taking swabs – because if you took a swab it stayed in the
laboratory for a month and there was no one to follow up. Patients stayed
with us for over a month and there was no follow up at all. Those people
(K4C midwives) do follow up and within 3 days they have results. They
bring them to the doctor, so the doctors are ready to work on them and
that’s how we have reduced sepsis on the wards. It’s great indeed I’m very
happy.
[So, before the project – was it that there was trouble in the laboratory
or that no one here was picking the results from the laboratory – was it a
communication problem?]
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Yes at first we sent the swabs there and it could stay there 2 weeks with
no one to follow up the swabs – the laboratory had a problem - they could
tell you we don’t have things to use –‘you wait’ – but nowadays things are
there to use – you go and they bring back the results when they are out.
[Does having the phone on the ward help?]
Yes, now we use the phone that was bought for us to call the laboratory
and also to receive results – it is TOO GOOD! Before we had the phone,
we had to move from our ward to the laboratory - if we wanted to speak
to the laboratory or take a sample we had to walk up there.
[And did people do that?]
No - some did, and others refused especially when we are alone on
duty. So to do all those things – you are tired - you are alone – now [K4C
midwife] has come, she can go to the laboratory and they are helping with
dressing so for you – you are giving treatment – you are recording in the
files – the work now is easy.
[Is it only K4C midwives contacting the laboratory? If they were not
there would you do that?]
Yes, these days I’m used to it. We go there – we get the results – we
call the doctor – we have the phone - Now we can call a doctor and get
immediate follow-up.
[What happens when the results are back?]
We give the results to the doctor – he is the one to decide if they have
resistance or not and if they have resistance to some antibiotics they change
– if not they continue.
Although she refers to earlier experiences and perceptions of laboratory
functionality, there are also issues concerning leadership and roles in terms
of taking swabs in the first place and ensuring these physically get to
the laboratory without delay. To put this in context, the laboratory is
about a 10-minute walk from the ward and often there are only two
midwives working on the ward. Leaving critically ill patients for a period
of about 30 minutes is a real problem. This is another example of the
mundane, minutiae of operational practice on the ward captured through
continual observation and dialogue that would be missed using many
other research methods and yet indicated a significant systemic weakness
and facet of behaviour. The process of taking the swabs to the laboratory
has now been streamlined with the laboratory collecting samples after the
morning ward round. This also provides an opportunity to engage with
the team on the ground. Where necessary, the midwives will physically
take swabs to the laboratory during the day. This has been facilitated by
the additional human resource provided through the project.
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We also found at an early stage in the project that there was a major
problem with the communication of results between the laboratory and
the ward. The laboratory was attempting to contact the doctor who orig-
inally signed the swabbing forms. In practice, the presence of senior
doctors on the ward is, at best, sporadic and it is intern doctors who
are present for signing. But intern doctors inevitably move around and
rotate. Guided by previous experience of an initiative to co-design and
implement maternal early warning scores in Mulago Hospital (Ackers
and Ackers-Johnson 2016), we were aware that reliance on the personal
mobile phones of these doctors and health workers, who receive no
funding to cover phone costs, leads to severe communication breakdown.
We were concerned too at the impact of having midwives leave the ward
perhaps several times a day to physically visit the laboratory for results. On
that basis, the project supplied a landline in the nursing station to facil-
itate smooth and efficient laboratory-ward communication. This initially
worked well but on a later visit we found the phone in a cupboard as some
staff had been using it for other calls. We later provided fixed housing for
the phone on the desk and a book to record calls.3
A representative of the laboratory echoes the midwife’s perception of
improved behaviour change in swabbing and prescribing practices.
I have seen a very great improvement. Yes, there are bottlenecks, but we
have really achieved a lot. Restricting our discussion to post-natal; the util-
isation of diagnostics in regard to microbiology previously was very low.
The staff didn’t appreciate the value of prescribing on the basis of a labo-
ratory report. Prescribing practices were poor; how often did the doctors
come to check patients? They were wasting time. People believed we can
use antibiotics the way the Ministry has put them into the clinical guide-
lines but some of these are not working so they really need to be guided by
the bacterial reports. The uptake is really good. The number of samples has
increased. Patients are being investigated along the lines of bacteriology –
they really endeavour to pick results and the results are directly influencing
prescribing behaviour. Although it’s not been documented, the reactions
from the nurses give us good news. The patient stay on the ward is actu-
ally reducing. We evidenced this last year when we monitored some few
patients who had stayed up to 30 days on the ward without getting a bacte-
rial report. From the time they prescribed on the basis of the bacteriology
3The lack of land lines in Ugandan health facilities is a major factor inhibiting
communication both with patients and other health facilities.
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report it took only 7 days for the patient to improve and finish treatment.
On the 8th day they were able to close the wound and on the 9th the
patient was discharged. This was during the project – last September. We
have worked with the K4C team to do CMEs on IPC and swabbing. The
main impact has been on rational prescribing – on a scale of 1-10 I’d say
we are now at 7.8! It has helped us to inform the clinicians on best prac-
tice in terms of prescription and having done that we have reduced patient
stay on the ward and then even in terms of costs – shorter stays on the
wards and having fewer attendants on the wards.
The impact of the focus on wound care and culture and sensitivity testing
is explained by a local midwife. She had taken a particular interest in
the use of sugar in wound care prior to the project (in Sudan) and had
previously worked alongside K4C staff and British nursing students on
the labour ward, so relationships were strong. She describes the impact
the project has had on her personally and on the ward and patients.
She notes that, prior to the project, empirical prescribing of antibi-
otics was not effective, and this lack of effectiveness was compounded
by prolonged prescribing of the same antibiotics. Importantly, she also
specifically recognised the role that clinical pharmacists are now playing:
You came in at a critical time [and] brought new skills. Before there was no
culture and sensitivity testing. Some of us knew about it but had never used
it – even the doctors. When you came in it is me who benefitted most;
I was carrying a very heavy burden and you helped me. You came as a
combined team. We have not lost any women from sepsis since the project
started. [Ugandan midwife employed by K4C] came. I had worked with
her on labour ward with your students. Even the laboratory has started to
respond – the burden was lifted, and everyone started getting involved.
We did use culture and sensitivity tests in Mulago (National Referral
Hospital) but with not much emphasis and sometimes you have your inter-
ests on other things and we left it to the doctors. Here much of the
things are now done by nurses/midwives – like doing culture and sensi-
tivity tests. We knew culture and sensitivity would get results. Now I try
to do the septic patients first. Before we noticed some were not getting
better and we did not pay much attention to how this woman has been on
this treatment for so long and you just gave her more antibiotics. […] now
[the pharmacist] comes on the ward daily and looks around and helps us
as sometimes the intern doctors are busy and lack supervision. Before we
used the same medicines – same – same – we just gave what was prescribed.
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The Global Point Prevalence Survey completed in May 2019 monitored
the use of microbiology testing in prescribing behaviour. At this point,
prior to project engagement, no laboratory results were recorded in the
files of those patients in the gynaecology or post-natal wards who had
been prescribed antibiotics and 100% of antibiotic prescribing was on an
empirical basis (Table 5.1).
We have previously noted the remarkable and very rapid improvement
in wound management and swabbing once the MSI began to engage.
The FPRRH laboratory has excellent documentation systems in place.
The results from the laboratory indicate major behaviour change on the















Source Results of G-PPS, May 2019 as reported to FPRRH IPC
Committee
Table 5.2 Volume and proportion of suspected sepsis cases sent for laboratory
testing












76 74 (2 had missing data) 95
Source FPRRH Laboratory
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Laboratory results from these tests were subsequently located in the
files of 67 of the 74 (90.5%) patients who had had a swab taken.4
Although this emphasises the need to further improve record-keeping,
this level of documentation represents a remarkable achievement in the
context.
Utilising Laboratory Data and Antibiograms
to Improve Empirical Therapy
In addition to providing the opportunity for an individualised treatment
regime, the submission of samples to the laboratory builds up a wider
evidence base of resistance patterns specific to that hospital setting. This
evidence base enables microbiologists to identify more general resistance
patterns that determine the expected efficacy of individual antibiotics. The
collection of a sufficiently robust evidence base enables the hospital to
generate what is known as an ‘antibiogram’. An antibiogram is a collec-
tion of data, based on laboratory testing of the pathogens in a specific
facility that summarises patterns of resistance to different antimicrobial
agents (or antibiotics). Although international and national trends in
resistance patterns can be identified, regional and facility-specific patterns
enable even closer targeting of antibiotics. The intern doctor who had
moved from Mbale hospital (above) reported his perception of regional
differences in resistance patterns:
The challenge here is that bacteria are more resistant than in Mbale. Here
bacteria are often resistant to more than one antibiotic. We have been
culturing E.coli here and there is much resistance.
Where a hospital antibiogram exists, initial prophylactic and empirical
prescribing can be informed by local evidence and has a much higher
chance of success. The presence of an antibiogram with associated aware-
ness raising and sensitisation amongst all staff and especially medical
interns would have major impacts on empirical prescribing across the
hospital. Not only can it help reduce the reliance on and overuse of
4For four patients, the results had gone missing from the file; for two patients, the test
was not completed because the IDI laboratory was closed over Christmas and New Year
and one patient’s lab test was not completed because the patient had discharged herself
against medical advice.
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specific antibiotics, a driver of resistance, it can act as a guide for procure-
ment of more potent antibiotics at the hospital. The MSI has played an
important part in creating the evidence base for a hospital antibiogram.
Prior to the MSI, FPRRH did not have the volume of laboratory results to
create the necessary evidence base for a hospital antibiogram. A member
of the pharmacy team describes how this has changed:
If you go to maternity, you will notice a very big change. The ward sends
the biggest volume of swabs now to the laboratory because those people
[midwives] are aware.
The laboratory scientist confirms this:
On the basis of the increased swabbing we hope to be in a position to
have an antibiogram. This will be very informative. The sample size is now
very adequate. The antibiogram will be good for the clinicians to guide
prescribing and it will be good for the patients.
He goes on to refer to the contribution that swabbing has made to an
understanding of health care acquired infection and IPC monitoring.
That week had seen 3 cases of Acinetobacter, a multidrug-resistant
organism on PNG ward:
Having the bacteriology reports coming through has also helped us. We
want to share a report that will be coming next week on the trends of
pathogens being identified and sensitivity patterns to see if this is the same
organism from one patient to another so we can have targeted interven-
tions when it comes to IPC. We can also see if it is airborne or a contagious
organism and then we can improve on the IPC. Now we don’t have that
good background on IPC. It has helped us to do localised epidemiology
on hospital acquired infections.
Not only has the practice of sending samples to the laboratory improved
dramatically over the period of the project, the laboratory reports that
PNG is responsible for nearly all of the laboratory testing that is taking
place in the hospital and contributing to the forthcoming antibiogram.
The specific impact of team working with IDI has underpinned all of
these developments:
[Have you noticed more swabs being taken from other wards?]
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Table 5.3 Summarised data for microbiology testing on samples drawn from
post-natal and gynae wards, FPRRH (July 2019–January 2020)
Sample type No. Samples Growth No growth Contamination
Pus swabs/Aspirates 82 52 28 2
High vaginal swabs 16 10 6 0
Blood 16 1 15 0
CSF 1 0 1 0
Urine 1 0 1 0
Total 116 63 51 2
Source FPRRH/IDI Laboratory
Actually no – it is mainly post-natal and surgical (IDI has had a project
on surgical). IDI cover the whole hospital, but we have had some real
challenges persuading people of the value of prescribing on the basis of
laboratory results. Some people don’t have the time to really investi-
gate these patients – some base prescribing on clinical guidelines. OK,
but they see what is in those guidelines is no longer working. We are
coming up with a highly resistant Acinetobacter and we should not be
prescribing certain antibiotics – all these forces will come if we have the
right information.
In the time since this interview took place, an operational antibiogram
has been produced by laboratory staff at FPRRH, shown in Table 5.11.
This data set, drawn from the laboratory, includes wound swabs and
other samples illustrating the more extensive growth in sampling on
the ward. Due to laboratory capacity constraints commonly seen in
lower-income countries, samples are only grown and tested aerobically,
meaning the possible presence of any anaerobic bacteria5 is missed. Of
the 116 total samples sent to the laboratory, 63 (54%) reported posi-
tive growth6 and 51 (44%) reported no growth. Only 2 samples had
probable contamination highlighting the success of laboratory protocols
(Table 5.3).
A single sample may be attributed to a single bacterial isolate,
or less commonly, multiple bacterial isolates indicating a polymicro-
bial infection. This explains the higher number of isolates reported in
5Bacteria that thrive in the absence or minimal presence of oxygen.
6 Indicating that bacteria are present.
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Table 5.4 Number of
isolates of each bacterial
species identified from
the samples tested















Table 5.5 Antibiotic resistance patterns of Acinetobacter species isolated from
PNG ward
Acinetobacter species (n = 17)
Antibiotic agent Susceptible Intermediate Resistant Resistant
(%)
Imipenem 1 1 15 88
Cefepime 0 1 16 94
Cefotaxime 0 1 15 88
Trimethoprim/sulfame 2 5 10 59
Doxycycline 11 1 5 29
Ciprofloxacin 2 0 15 88
Amikacin (n = 9) 8 0 1 11
Piperacillin/Tazobactam (n = 9) 0 1 8 89
Gentamicin 1 0 16 94
Source FPRRH Laboratory
Tables 5.4, 5.5, 5.6, and 5.7 relative to Table 5.3. Culture identification
(Table 5.4) and antibiotic sensitivity testing were performed for all posi-
tive isolates7 grown. The most common organism isolated was Escherichia
7The term isolate refers to the isolation of a particular bacterial colony from amongst
others on the agar plate.
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Table 5.6 Antibiotic resistance patterns of Escherichia coli isolated from PNG
ward
Escherichia coli. (n = 26)
Antibiotic agent Susceptible Intermediate Resistant Resistant
(%)
Imipenem (n = 25) 25 0 0 0
Gentamicin 19 1 6 23
Chloramphenicol 22 1 3 11
Ampicillin 2 0 24 92
Cefotaxime 5 1 20 77
Ciprofloxacin 17 1 8 31
Doxycycline (n = 23) 2 3 18 78
Piperacillin/Tazobactam (n = 19) 16 1 2 11
Trimethoprim/sulfame (n = 25) 2 0 23 92
Cefuroxime 4 1 21 81
Source FPRRH Laboratory
Table 5.7 Antibiotic resistance patterns of Staphylococcus aureus isolated from
PNG ward
Staphylococcus aureus (n = 15)
Antibiotic agent Susceptible Intermediate Resistant Resistant
(%)
Chloramphenicol 14 0 1 7
Gentamicin 14 0 1 7
Cefoxitin (n = 13) 11 0 2 15
Trimethoprim/sulfame 9 1 5 33
Ciprofloxacin (n = 14) 11 0 3 21
Clindamycin 15 0 0 0
Erythromycin (n = 13) 6 1 6 46
Source FPRRH Laboratory
coli (28%), followed by Acinetobacter species (18%) and Staphylococcus
aureus (16%). This corresponds with a study of 314 surgical site infec-
tions at Mulago National Referral Hospital, where 23.7% of isolates were
E. coli, 21.1% were S. aureus and 17.1% were Acinetobacter species (Seni
et al. 2013). The resistance patterns of these bacteria are further explored
in Tables 5.4, 5.5, 5.6, and 5.7.
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The antibiotic susceptibility of isolates was tested utilising the disk
diffusion technique against a specific panel of antibiotics to best determine
its resistance potential. The two antibiotics most commonly prescribed
in the PNG ward: ceftriaxone and metronidazole, are not specifically
mentioned in the tables below. These antibiotics are often prescribed
together prophylactically prior to any laboratory testing. Metronidazole is
commonly used to treat anaerobic bacteria (Smith 2018; Shafquat et al.
2019) and as such testing for this antibiotic requires laboratories capable
of simulating anaerobic conditions. This is not possible at FPRRH. Ceftri-
axone, on the other hand, is a member of the cephalosporin group of
antibiotics. In this case, other members of the same family (such as
cefepime or cefotaxime) with similar mechanisms of action can be used
to infer resistance.
Table 5.5 evidences an alarmingly high level of resistance across all
antibiotics tested against the 17 Acinetobacter isolates with the exception
of doxycycline and amikacin (5 and 1 resistant isolates, respectively). That
there were no isolates susceptible to cefepime or cefotaxime, fourth- and
third-generation cephalosporins, respectively, is cause for concern. Not
only are these some of the most recent iterations of antibiotics, but the
fact that the primary antibiotic of choice on the ward is ceftriaxone shows
Acinetobacter infections could leave people vulnerable. Equally, once an
infection is present, few other antibiotics are shown to be effective.
The most prevalent bacterial species identified from the tests was E.
coli. Table 5.6 shows that E. coli displays mixed levels of resistance, leaning
towards being either highly susceptible or highly resistant depending
on the antibiotic of choice. Again, there is high resistance to cefo-
taxime (20/26) as well as cefuroxime (21/26), a second-generation
cephalosporin, which adds to the concern that ceftriaxone is losing its
effectiveness. Thankfully, imipenem8 has been shown to be 100% effective
against the isolates tested, promoting its use as a secondary option.
The third most prevalent isolate was S. aureus. (Table 5.7) which
showed minimal resistance to all antibiotics with the exception of
erythromycin and trimethoprim/sulfame. Additionally, clindamycin was
shown to be 100% effective against the isolates tested. Of particular note
is cefoxitin which performed strongly with 11 susceptible and 2 resis-
tant isolates. Cefoxitin is a second-generation cephalosporin and acts as
8We note the increased ordering of meropenem in the hospital procurement plan in
Table 6.1.
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an indicator for MRSA (methicillin-resistant S. aureus), a key metric for
AMR.
Utilising Local Staphylococcus
aureus Populations as a Case Study
to Investigate Trends in Resistance Patterns
Carried by roughly 30% of the human population, Staphylococcus aureus is
a Gram-positive coccus found frequently in the nasopharynx, respiratory
tract and on skin. Whilst commonly found as a commensal9 organism,
S. aureus is also a major human pathogen with the ability to cause a
wide range of clinical infections resulting in skin (where the skin has
been broken, for example, from a wound or surgery) and respiratory
diseases (Tong et al. 2015). Infections occur most regularly in hospitalised
patients where the consequences can be severe. Though often easily
treated with antibiotics, if left neglected the infection can worsen and
spread. S. aureus is one of several organisms commonly linked to blood-
stream infections and cases of sepsis. A large meta-analysis of community
acquired bloodstream infections in Africa examined 5578 patients with
non-malaria bloodstream infections, where 531 (9.5%) cases were due to
S. aureus (Reddy et al. 2010). That being said, treatment has become
increasingly complicated due to the rise of methicillin-resistant S. aureus
(MRSA) which is now often multi-resistant. As such, methods of infection
prevention are becoming more valuable (Kluytmans et al. 1997).
With a better understanding of where and how resistance arises, steps
can be taken to prevent it. Ongoing research forming part of Ackers-
Johnson’s microbiology doctorate (Ackers-Johnson 2020) investigates in
depth the mechanisms of antibiotic resistance and their respective relation
to different strains of S. aureus. As part of this, S. aureus isolates obtained
clinically from across all wards at FPRRH were investigated (Table 5.8),
as well as isolates obtained from the hands of healthy members of the
public (Table 5.9)—all within the hospital catchment area.
As previously noted, production of an accurate antibiogram requires
a large number of samples. Whilst the antibiotics’ effectiveness relative
to each other remains largely similar, a greater percentage of resistant
isolates can be seen when assessing the 70 samples acquired from across
9Can live naturally on human skin without causing harm.
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Table 5.8 Antibiotic resistance patterns of Staphylococcus aureus from all wards
at FPRRH
Staphylococcus aureus (n = 70)
Antibiotic agent Susceptible Intermediate Resistant Resistant
(%)
Chloramphenicol (n = 59) 53 0 6 10
Gentamicin (n = 68) 54 2 12 18
Cefoxitin (n = 21) 13 0 8 38
Trimethoprim/sulfame (n = 57) 25 6 26 46
Ciprofloxacin (n = 69) 51 4 14 20
Clindamycin (n = 62) 62 0 0 0
Erythromycin (n = 69) 47 1 21 30
Tetracycline (n = 53) 24 0 29 55
Source These bacteria were clinically isolated from samples across all wards at FPRRH between August
2017 and April 2019. Whilst 70 isolates were assessed, not all could be tested against all antibiotics
due to supply constraints as the laboratory was in its initial stages of increasing capacity
Table 5.9 Antibiotic resistance patterns of Staphylococcus aureus isolated from
hand swabs of the general public
Staphylococcus aureus (n = 125)
Antibiotic agent Susceptible Intermediate Resistant Resistant
(%)
Chloramphenicol (n = 124) 87 0 37 30
Gentamicin (n = 123) 116 0 7 6
Cefoxitin 98 0 27 22
Trimethoprim/sulfame 54 4 67 54
Ciprofloxacin 81 0 44 35
Clindamycin (n = 124) 24 53 47 38
Erythromycin (n = 124) 39 28 57 46
Tetracycline 57 31 37 30
Source Ackers-Johnson (2020)
the hospital (Table 5.8) compared to the 15 samples from the PNG ward
(Table 5.7). In the case of gentamicin and cefoxitin, the rates of resistance
are more than doubled. Interestingly, even when observing the larger
sample size, clindamycin has still been shown to be 100% effective.
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Observing the resistance profiles of S. aureus found on the hands of
healthy members of the public within the catchment area of FPRRH
highlights how AMR is not a problem reserved exclusively to hospi-
talised patients. Table 5.9 shows relatively high levels of resistance across
all antibiotics tested with the exception of gentamicin at 6%. More-
over, clindamycin, which was shown to be 100% effective against isolates
obtained clinically at FPRRH, has much higher levels of resistance within
the local community at 38%. With such levels of resistance present, the
requirement for effective IPC is further emphasised to reduce the inci-
dence of infection from harmful resistant bacteria already present on skin.
This raises questions about the role that attendants may play as vectors
of infection on the wards especially when they are involved in clinical
roles (wound and canula management) and the impact of stock-outs of
iodine on surgical safety practices in theatre.10 Hsieh et al. (2014) gener-
ated a theoretical model to predict the impact of hospital visitors on
nosocomial transmission and spread to the community concluding that,
‘transmission rates of infective residents in the community and of infective
visitors at the healthcare facility have a decisive impact on disease eradi-
cation/persistence’ (2014: 20). These concerns are emerging in current
research on COVID-19 (Halbfinger 2020; Hsu et al. 2020; Wee et al.
2020).
Comparing the situation at FPRRH to that of the National Referral
Hospital (Mulago Hospital, Table 5.10), the results again seem relatively
similar with trimethoprim/sulfame exhibiting exceedingly high levels
of resistance, with gentamicin and chloramphenicol being amongst the
strongest performing antibiotics. Conversely, of particular note is clin-
damycin. 40.6% of S. aureus isolated from surgical site infections at
Mulago hospital displayed resistance to clindamycin, similar to that of
the community hand swabs in Fort Portal (38%), whilst clinical isolates
from FPRRH were 100% susceptible. Such data emphasises the need for
further advanced research.
Tables 5.5, 5.6, 5.7, 5.8, and 5.9 highlight the necessity of micro-
biology testing in controlling infection and promoting antimicrobial
stewardship. It is clear from the data that there is no antibiotic ‘silver
bullet’ available in this local setting capable of treating an infection of
unknown identity. All the bacteria assessed at FPRRH had some level of
10At one point during stock-outs, staff had only saline to use.
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resistance to all antibiotics tested, except for imipenem (100% effective
against E. coli) and clindamycin (100% effective against S. aureus). As
such, prescribing without the respective laboratory data could well prove
to be in vain. The unchecked overuse of these ineffective antibiotics not
only compromises patient safety and acts as an economical burden, but
also further drives the development of resistance—with increased levels of
antibiotics in the local environment it is possible that other bacteria unre-
lated directly to the cause of infection can progress to acquire resistance
causing issues in the longer term. The construction of the antibiogram
(Table 5.11) will go a long way to address these problems, the reliability
of which itself has been greatly aided by the increased volume of samples
being taken as a by-product of effective patient care.
The antibiogram displays the percentage susceptibility of isolates recov-
ered from microbiological samples analysed at FPRRH. The first column
indicates the organisms that were assessed, with the remaining columns
indicating the antibiotics that they were tested against, the percentage of
isolates that were susceptible to the antibiotic, and (n)—the total number
of isolates tested. It is worth noting that data where fewer than 30 isolates
have been assessed are less reliable and hence any conclusions/prescribing
should be done with caution. These have been marked with an asterisk
(*) and highlighted yellow.
As previously mentioned, a wide range of resistances to various antibi-
otics can be seen across the data. As a general rule, if an antibiotic has
been shown to be less than 80% effective against a particular organism,
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then it should not be prescribed as an empirical therapy for serious infec-
tions. As per the antibiogram, a number of antibiotics fall short of this
benchmark. With relatively more expensive and less commonly prescribed
antibiotics (e.g. Amikacin and Imipenem) often outperforming those that
are frequently used, it is important that the antibiogram plays a role in the
hospitals’ antibiotic procurement plan as particular treatments are simply
not health or cost-effective. Whilst budget constraints may not be able
to permit the frequent use of such tailored antibiotics, clear policies and
guidelines should be put in place by the MTC to govern their usage in
the care of critical patients.
Whilst there is a definite value in utilising an antibiogram, it is also
useful to point out that it has limitations. Being used for empirical
diagnoses, there are no guarantees that the antibiotic of choice will be
effective even if it has a very high theoretical rate of success. This could
be due to the performance of the antibiotic (and antibiotic quality)
or the (mis)identification of the causal bacteria. As such, the presence
of an antibiogram does not remove the essential need for clinicians to
utilise the laboratory services available to provide definitive information
in conjunction with patient observations to deliver optimal treatment.
The growth in wound management coupled with increased laboratory
testing has created task-shifting opportunities (and workloads) for nurses
and midwives as staff providing continuity of care on the wards. It has
also created new opportunities for the engagement of clinical pharmacy.
Chapter 6 discusses these issues in more depth and then assesses one
of the major, structural, barriers to further improvement: supply chain
dynamics in Ugandan public hospitals.
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and the Nascence of Clinical Pharmacy
Abstract This chapter addresses the role that the intervention has played
in shaping professional engagement within the multi-disciplinary team.
The existence of laboratory results has triggered the emergence of clin-
ical pharmacy roles. The chapter traces the impact of this on prescribing
behaviour and on procurement planning and hospital policies. Whilst cele-
brating the progress made and viability of the model, it describes the
structural impact that access to antibiotics and IPC supplies has on the
realisation of optimal change.
Keywords Antimicrobial stewardship · Maternal sepsis · Task shifting ·
Clinical pharmacy · Pharmacotherapy · Antibiotic consumption ·
Antibiotic susceptibility · Procurement planning · Stock-outs
In addition to describing the importance that swabbing and testing have
made to progress, the midwife in the previous chapter alludes to a major
change in team working and task shifting with midwives and nurses
now playing a very central role in these processes. This has been crit-
ical to the effectiveness of the MSI. Endorsed by the WHO (2007),
task shifting has been implemented in the global health care setting in
an effort to combat healthcare worker shortages, increase efficiency and
cut costs. In general terms, task shifting is the delegation of a specific
task to a lower cadre (WHO 2008). Utilising the available workforce
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in this manner promotes the more effective and efficient use of human
resources. With greater numbers of healthcare staff being able to offer
certain aspects of care or perform certain clinical procedures, it follows
that there is an increased ability to provide healthcare services, coupled
with improvements to healthcare worker skills, greater efficiency within
the healthcare system and cost savings (WHO 2007). Task shifting in
the West implies an increase in remuneration and substantial investment
in continuous professional and career development. The reference to
non-medical prescribing1 is a case in point. The same cannot be said in
LMICs where healthcare professionals are often burdened with additional
responsibilities without being compensated accordingly. Nonetheless, task
shifting is recommended as a method to reduce healthcare worker short-
ages in the maternity setting (WHO 2012). Despite a lack of policy
framework to support task shifting in Uganda, it has been unofficially
practised in the country since 1918 (Baine et al. 2018).
Whilst it is the responsibility of all healthcare professionals to act as
antibiotic stewards, we have found that although midwives and nurses
are barely mentioned in the NAP, they have, by means of informal
task shifting, taken on a significant role in advocating for antimicro-
bial stewardship. In the Ugandan context, their active engagement and
empowerment are absolutely essential to AMS, not least because they
are most often the only cadres continually present on the ground. The
presence of senior doctors is at best sporadic with rotating and largely
unsupervised intern doctors providing most medical input (Ackers et al.
2016; Tweheyo et al. 2019). This evidence adds weight to Brink et al.’s
proposal for new nurse-led models of AMS in Africa (2016).
A midwife respondent explains how the new knowledge, combined
with team working and support, has facilitated effective task shifting on
the ward:
Before [the project] staff did not have the idea about wound swabbing;
they didn’t understand culture and sensitivity testing. That’s where a lot
of improvement has come. They now understand the science and take an
interest and ask, ‘why is this mother not getting better?’ They have learnt
about resistance. Midwives are now taking the lead in managing patients;
they used to wait for doctors to make decisions, but the doctors only
appear once in a while, so they waited for them instead of acting. Now
1See note 31.
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they act. They used to say, ‘that one is for the doctor – what has killed
this mother?’
The intern doctors on the ward have also observed marked changes in the
behaviour of the midwives—and their own practices. One intern doctor
commented that, when he arrived:
We found a lot of sepsis on the ward but during that period there was a
scarcity of things to use – antiseptics, saline; then the staff started taking
off cultures. You have really helped us. Your team has done a lot to reduce
sepsis here. They assess the wounds – take off the culture – bring the
results as to which microorganisms are resistant, so we cleared all septic
mothers.
[Has swabbing practice changed?]
Yes, it has changed – the nurses2 do it perfectly now.
[Would you say most wounds are now being swabbed and going to the
laboratory?]
In fact, all of them. Once we get a septic mother they will be swabbed.
Immediately the first thing is to do a pus swab.
Another intern doctor acknowledges that behaviour change has been
evident amongst all cadres:
I really think we did have that knowledge before, but we did not appreciate
its significance
[When you say ‘we’ do you mean the doctors or midwives?]
I think you should consider all of us. We did not do as much as we
should have been doing. As long as we dressed the wounds once a day
and I prescribed antibiotics the rest of the things would take their course.
So, what K4C has brought to reality is that – actually when this is done,
and samples are taken and followed up then things get better more quickly.
[You said before people were aware of culture and sensitivity testing
– they had the knowledge but didn’t appreciate its significance?]
Exactly. [K4C midwives] take the swabs and we get results now in three
days. They also get you the pharmacists on the ward so we can target that
specific organism.
2It is common in Uganda for doctors to use the term ‘nurse’ generically to include
midwives.
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The intern doctor in the quote above notes the role that the midwives
play in anchoring pharmacy into the MDTs. One of the most important
changes brought about as a direct result of increasing wound manage-
ment and culture and sensitivity testing has been the way that this has
facilitated clinical pharmacy. Since the project commenced, pharmacy has
been directly involved in patient management and prescribing decisions
as part of a proactive multi-disciplinary team. It is important to note that
the pharmacists were fully aware of the benefits of this approach prior
to the project and had taken steps to actively encourage it. There was no
evidence of a knowledge gap as such. However, until this became a reality
on the ward, their ability to utilise their expertise in clinical pharmacy was
limited. Chapter 1 reviewed predefined metrics set out by the funding
body. Pharmacists on the ground were highly sceptical of the value of
antibiotic consumption metrics in this environment stating that:
We cannot measure performance by zeroing on antibiotic [consumption]
only.
They proposed instead what they felt was a more relevant indi-
cator, namely the ‘Review of Pharmacotherapy’ by pharmacists. We are
concerned here with the extent to which pharmacists are directly engaged
in multi-disciplinary decision-making following the receipt of laboratory
test results. Prior to the MSI, it was rare to have pharmacists present
on the ward. A K4C midwife explains the importance of the culture
and sensitivity testing process to the harnessing of clinical pharmacy
engagement:
Pharmacy will tell you there is no point in them coming unless there are
cultures.
The data collated from patient notes showed that, once the intervention
was in place, pharmacists reviewed the pharmacotherapy in 91.8% of cases
where test results were taken and showed a bacterial growth.3 The regular
presence of pharmacy on the ward has in turn formed a critical part of the
mentoring and knowledge transfer amongst the whole team (and explic-
itly including the K4C staff and UK volunteers). One of the pharmacists
3Patient Records (January 2019–January 2020).
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describes the changes in practice and the role that laboratory results have
played in this:
Culture and sensitivity testing has been very important especially in post
– c-section sepsis. We need to know what we are dealing with. Antibiotic
selection is a big issue in AMR. Before they were making a blind selec-
tion. They were using only the antibiotics they were used to, the standard
arrangement of routine antibiotics. Patients were staying for an extended
period of time; the drugs were not working. They never figured it out
that they were using the wrong antibiotics. Now it has become standard
practice that you take a sample and send it to the laboratory and wait
for the results to come. We have now moved to individualised antibiotic
selection based on the laboratory results. We know what [the infection] is
susceptible to.
He goes on to outline the need for more support through informal
mentoring and formal training to enable all cadres to interpret the
laboratory reports:
Most of the problems now are how to interpret and apply the [lab.]
reports. It is important we all agree on the value of that report and how
to interpret it and do things in accordance with the findings.
The project responded to this explicit request for training by organising a
small session for staff on the PNG ward. Later, the pharmacy team took
the initiative to organise a larger training workshop for representatives of
the entire hospital at a morning meeting with intern pharmacists taking
the lead.
The MSI has achieved optimal pharmacy engagement (in a RRH
context) on the PNG ward. The impact of laboratory testing has played
an important role in empowering pharmacy. This is evident in the new
policy, initiated by pharmacy with strong support from the laboratory, of
only permitting use of high-end antibiotics when laboratory test results
are available:
Clinicians are not allowed to change antibiotics now without cultures.
Discussions have taken place in the hospital’s IPC committee to extend
this policy to all wards illustrating the wider impact of the MSI on the
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hospital. The laboratory respondent welcomes this achievement which
reflects the growing recognition of pharmacy in the hospital:
The policy of only prescribing high end antibiotics to patients who have
had culture and sensitivity testing has really worked; these antibiotics are
being guarded jealously now. In fact, (the pharmacy team) are very strict
on that. I really feel this could work on other wards. It is only working on
post-natal ward at present because they have laboratory reports.
The extent to which microbiology results have been understood, valued
and applied by midwives on the ward is exemplified in the following
excerpt:
After Christmas (2019) we didn’t have many septic patients but a week
after four of them had the same isolates with the same results. We
wondered how come four people worked on separately can come in with
the same isolates? They came from different places. How can we get to
know the source? We took the swabs off immediately. We did discuss with
the laboratory people, but we were concerned so we looked at it ourselves.
Is it the hygiene of the patients or the surroundings? Are there other possi-
bilities? We know it is a HAI; Acinetobacter is not an organism you can
find outside the hospital. The challenge is it is airborne – we spoke to
the pharmacist and the laboratory. Having 4 cases with the same isolate
is more of an outbreak. Maybe the laboratory could swab surfaces, or we
could fumigate?
Ultimately, the model that has evolved on PNG ward has demonstrated
the potential to significantly reduce infection, improve prescribing prac-
tice, reduce antibiotic consumption and overcome some of the effects
of AMR on patient outcomes. To that extent, significant progress has
been made to put systems in place to facilitate evidence-based prescribing.
Ultimately, the impact of these systems hinges on access to antimicrobials.
Strategic Objective Three (NAP) highlights the issue of Optimal
Access to essential antimicrobials and states very clearly that, ‘the major
modifiable driver of AMR is the use of antimicrobial agents’ (p. 14).
Sub-objectives focus on distribution and supply chain mechanisms.
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Procurement and Supply Chain Dynamics
in Regional Referral Hospitals
The following section outlines critical problems in the supply chain system
influencing the availability of antibiotics in Ugandan Regional referral
hospitals. These include:
1. Budget Constraints: the hospital may only order against a budget
prescribed by the Ministry of Finance and held centrally by National
Medical Stores (NMS).
2. Limited Options: the hospital can only order antibiotics from a
prescribed catalogue which excludes many of the antibiotics indi-
cated as necessary from laboratory results and present on the Essen-
tial Medicines and Health Supplies List for Uganda (EMHSLU).
3. Failure to deliver on orders: major and unpredictable discrepancies
exist in what is ordered and what is delivered (‘Order Fill Rates’).
4. As a result of the above, most IPC supplies and antibiotics run out
half-way through the bi-monthly supply cycle (Stock-Outs).
In Uganda, the funds for procurement of drugs and supplies in the
public sector are highly centralised and inadequate. NMS procures and
distributes supplies to health facilities based on a centrally allocated
Annual Supplies Budget. Each hospital is required to produce an Annual
Procurement Plan. Once agreed, this Plan is fixed and cannot be varied
over the year reducing the opportunity for flexibility and responsiveness
to the hospital laboratory results and any changes indicated by a future
antibiogram. This budget is held by NMS. With the exception of private
wards, it is not possible for a RRH to source supplies from elsewhere.
NMS deliveries take place bi-monthly.
During the annual procurement process, the hospital may only order
those items authorised by the EMHSLU. However, not all essential
drugs feature in the NMS catalogue. A hospital pharmacist describes the
situation as follows:
As much as we may desire a certain antibiotic, we can’t plan for it if it is
not present in the catalogue. A case in point is Amikacin and Moxifloxacin.
Out of the nine antibiotics tested against Acinetobacter samples in the
laboratory, only two, doxycycline and amikacin, showed greater levels
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of susceptibility than resistance. Given the much higher success rate of
amikacin, it is paramount that the antibiotic can be obtained for cases of
severe Acinetobacter infections where other avenues have failed.
When the project started, the procurement plan for the financial year
2018/2019 was already in place. At that time, the plan did not take
account of antibiotic susceptibility as reported by the laboratory, resulting
in a lack of high-end antibiotics required to treat resistant bacterial strains.
The evidence generated through the MSI, supported by the engage-
ment of the K4C pharmacist, contributed to the procurement planning
process for 2020/2021. Table 6.1 presents an extract from the hospital’s
procurement plan to indicate key antibiotics used on the post-natal and
gynae ward. It evidences significant changes in antibiotic ordering and
consumption arising directly from the intervention, where antibiotics in
red denote project-related increases and those in blue denote decreases.
For now,4 we draw the reader’s attention to column 5 (average past
consumption). This shows the predominance of a small number of antibi-
otics including amoxicillin, metronidazole, ciprofloxacin, ceftriaxone and
chloramphenicol.
Antibiotic Distribution at Ward Level in FPRRH
When supplies arrive at FPRRH from NMS, they are taken to the main
stores. At this point, supply data is recorded electronically in the online
ordering system (Rx). When we first visited pharmacy stores at the start of
the project, we found the Rx system unused. The Rx initiative is a national
programme designed to improve supply chain management and provide
an online database linking the hospitals to NMS. When functional, it
would provide a systematic method of stock utilisation and recording
providing high-quality data to the hospital. It was clear that the phar-
macy team had the expertise to use the software but there was no printer
ink available. Two donated printers sat unused as they had no ink and
obtaining cartridges for these was very complex. This illustrates the prob-
lems of managing donated devices in LMICs especially when they are not
integrated in any way to local supply chains. The hospital had ink in stock
but for very different printers and could not provide the printer ink to
the stores. In this instance, the MSI provided a printer and printer ink
4We return to discuss the impact of the MSI on Procurement Planning in due course.
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Table 6.1 Extract from the 2020/2021 procurement plan (with bi-monthly











1000 5,4100 101 134 90 4,869,000
Ampicillin/cloxacillin
capsules
100 14,400 30 42 50 720,000
Metronidazole
tablets
1000 17,100 50 70 70 1,197,000
Chloramphenicol
250mg tabs
1000 10,0200 0 0 5 501,000
Ciprofloxacin 50mg
tablet
100 10,500 70 118 70 735,000
Ceftriaxone 1g vials 1 1700 6000 6000 5000 8,500,000
Ampicillin/cloxacillin
250mg inj
50 33,000 0 2 1 33,000
Meropenem 500mg
inj
100 71,700 2 5 2 143,400
Gentamycin 80mg
inj
1 16,000 0 92 150 2,400,000
Ciprofloxacin IV
200mg
100 32,800 40 0 0 0
Metronidazole
500mg infus
50 33,000 100 217 150 195,000




1 13,400 1 767 0 0
Chloramphenicol 1g
inj.
10 11,400 5 4 5 57,000
50 80,200 0 0 5 401,000
aIn this table, the column ‘unit’ shows the number of doses per unit as sold. ‘Price’ is the price
per unit in Ugandan Shillings (1 USD = 3780 UGX, May 2020). The column ‘2019/2020 plan’
shows the number of units that were ordered for delivery every other month in 2019, with ‘past av
consumption’ detailing the average bi-monthly consumption of the past year for each antibiotic. The
column ‘2020/2021’ details the set number of units ordered every other month for this year, with
the corresponding bi-monthly cost reported in the final column
Source Hospital procurement plan, 2020–2021
for the duration of the project to enable the Rx system to become part
of the organisational culture in pharmacy stores. Since then, the hospital
has employed a dedicated stock manager to work with this system freeing
up the senior pharmacist to engage in clinical pharmacy roles. We have
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discussed what may seem a mundane supplies issue in some depth here as
this is precisely the kind of problem that lies behind major systems fail-
ures in Uganda, the diseconomies of ‘donations’ and the ease with which
organisations become dependent on donor support. It also illustrates one
of the underlying causes of data quality problems.
The process of distributing supplies within the hospital is, unfortu-
nately, not presently covered by the Rx electronic system. Instead, the
in-patient pharmacy (located a short distance from the stores) orders from
the stores. Individual wards then visit the in-patient pharmacy to requi-
sition supplies, and this is recorded manually on forms and in a records
ledger book (the HMIS Dispensing Log).
Figure 6.1 presents data obtained from the in-patient pharmacy on
the distribution of oral antibiotics between the main hospital wards. We
recorded this data for the months of January and February 2020 to
gain a picture of the distribution of injectable and oral antibiotics over
the 2-month supply cycle and put PNG ward consumption patterns in a
whole-hospital context. As can be seen, the level of antibiotic consump-
tion on the PNG wards as a proportion of overall consumption is high
and indicates the importance of this to overall antimicrobial stewardship:
Tables 6.2 and 6.3 identify antibiotic consumption on the PNG wards
in more detail over a 4-month window. Table 6.2 provides data for Intra-
venous Antibiotics and evidences the predominance of metronidazole and
















Outpa ents TB ward
Amoxicillin 250mg Ampicillin + cloxacillin 250 mg
Metronidazole 200mg Ciprofloxacin 500mg
Fig. 6.1 Supply of oral antibiotics to all wards in January and February 2020
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Table 6.3 Oral antibiotic consumption in post-natal and Gynaecology wards at




































December 7477 2400 732 410 144 0
January 8298 5436 220 102 182 10
February 1812 2308 235 20 153 0
March 7474 4860 0 650 88 0
Total 25061 15004 1187 1182 567 10
dominance of metronidazole and amoxicillin. Both sets of data show large
fluctuations in consumption over the 4-month period with particularly
depressed consumption in February:
The fluctuations identified above suggest serious supply issues deter-
mining access to antibiotics. With current systems in place, the major
challenge facing the MSI model is access to the right antimicrobials at
the right time. The laboratory scientist is clear about this:
Antibiotic stock-outs remain a serious constraint; in many cases patients can
only be given the right antibiotics if they pay and many of them can’t pay.
We have to be very clear, antibiotic stock-outs are a key factor fueling
AMR. If we look at the scenario where we have investigations done and
antibiotics are available, and the outcomes are good, but we have done the
investigations and the antibiotics are out of stock we won’t have a good
outcome.
There is a bigger concern here too; if supplies are not available and
the ward staff are unable to respond effectively to laboratory results,
this can be predicted to have a major impact on staff motivation and
the behaviour change gains achieved. Problems of access critically restrict
pharmacy’s ability to engage in rational prescribing (prescribing the drug
most likely to work according to laboratory results). This in turn leads to
over-consumption of poorly performing (and often cheaper) antibiotics
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and poor patient outcomes. The pharmacy team involved in procurement
planning pointed out the severe budgetary constraints they faced when
attempting to order new antibiotics in response to laboratory results.
In practice, this meant making difficult ‘trade-offs’, especially when the
new antibiotics are so much more expensive than those they were able to
reduce. The reduction in supply of amoxicillin, for example, is explained
as follows:
We realised that the majority of patients using amoxicillin were mothers
discharged after giving birth. They are usually given amoxicillin as prophy-
laxis to prevent infection. Some were being given for a longer duration
than necessary. As pharmacy staff, we intervened so that the duration of
treatment would be reflective of the nature of risk. This led to a reduction
in use. We had to increase certain antibiotics or include new antibiotics as
well. Due to budget constraints, it was agreed during the planning stage
that we cut on the quantity of Amoxicillin to free up some budget to cater
for other needed antibiotics.
The laboratory results indicated very high levels of resistance to both
amoxicillin and ampicillin, both of which are derived from penicillin.
Based on these assumptions, ampicillin and amoxicillin will have minimal
effects on the three primary bacterial causes of infection. Significant
changes in planned use of meropenem can also be directly attributed to
the MSI, where imipenem was shown to be 100% effective against E. coli.
The pharmacist explains that consumption of this drug over the past year
has been reliant entirely on donated supplies (it was not ordered in 2019):
[The increased order] can be supported by evidence generated by the labo-
ratory. Due to the increased culture and sensitivity reporting, we noticed
that there was improved sensitivity to meropenem. This ensured that we
were able to convince members involved in planning to include it on the
2020/2021 plan. We were able to get some donations last year and that’s
why it shows that we consumed it. What’s more, we wrote to NMS to
allow us to procure it, even though it’s not in the current plan.
This action, of communicating directly with NMS on procurement,
represents one example of where the pharmacy team have attempted to
advocate as a result of the MSI. The impact of this procurement may
be to the benefit of other hospitals if NMS are influenced to place it on
their catalogue in future. The decision to increase orders of meropenem
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required the team to make stark choices which led to the reduction in
orders of cefotaxime:
Just like Meropenem, this particular consignment of Cefotaxime (used in
2019) was a donation. It wasn’t in the procurement plan. While working
on the 2020/2021 plan, we had to prioritise between Cefotaxime and
Meropenem. We had to go with Meropenem. We did factor in the cost
and resistance profile per the lab reports.
Cefotaxime has shown high levels of resistance in the laboratory tests. The
marked rise in procurement of ciprofloxacin is also directly attributable to
the MSI although the pharmacy team were concerned about the volume
needed:
What we require is actually a lot more. Again, [the increase] can be
explained by the results of culture and sensitivity. There seems to be less
resistance to ciprofloxacin.
The pharmacist sums up the impact that the project has had on procure-
ment planning and the constraints the team had to work with:
We had to reduce the quantity of Ceftriaxone by a significant margin.
This was supported by laboratory data which showed a lot of resistance
to ceftriaxone. Some of the monies freed up were used to plan for chlo-
ramphenicol and meropenem, drugs which are showing less resistance as
per lab reports. There is no significant increase in the incoming budget
for drugs and medical sundries. It’s therefore painstaking to reallocate
priorities in terms of drugs while maintaining the same budget. Our
[MSI] efforts to encourage and support Culture and Sensitivity testing and
sharing this with the procurement planning team lead us to include some
much-needed antibiotics (Meropenem and Chloramphenicol) in next year’s
plan and reduce the procurement of antibiotics with a lot of resistance
(Ceftriaxone).
Table 5.11 also provides an indication of the cost implications of the
changes in antibiotic procurement because of the MSI. Most of the
increases in procurement involve more expensive antibiotics. The procure-
ment plan reflects the negotiations the pharmacy team have engaged into
balance the need for rational prescribing against the cost implications of
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Table 6.4 Order fill rate at FPRRH (2019/2020)













Source Rx on-line medicines management system (NMS do not provide data on fill rates for specific
medications)
buying more expensive antibiotics. Unfortunately, the constraints of the
NMS budget-line are not the end of the story.
Discrepancies Between Order
and Supply (Order Fill Rates)
In practice, not all that is ordered by the hospital from NMS is supplied.
The ‘Order Fill Rate’ gauges the delivery performance of total number of
items ordered against the total number of items delivered. As clearly seen
in Table 6.4, NMS supplies about 75% of orders. More specific discrep-
ancies may also arise. Unusually, NMS failed to deliver ceftriaxone in
September 2019, for example.
Key Challenges to Sustained Behaviour
Change: The Impact of Stock-Outs on AMS
Stock-outs (the exhaustion of supplies) are a feature of Ugandan public
health facilities at all levels and a major factor contributing to sepsis deaths
in maternal and new-born health (Bua et al. 2015). Inevitably, bi-monthly
deliveries tend to be exhausted quite rapidly and often by the end of the
first month:
For example, when we get 6000 vials of Ceftriaxone, we consume all of it
in maybe 4 weeks, then we stay without for another 3-4 weeks. And the
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following cycle, we get the same quantity. Therefore [consumption data]
are merely an average of what is not enough.
Stock-outs are caused by a combination of misuse and overall shortfalls.
The pharmacists noted that the project had improved antibiotic use on
the wards:
When these antibiotics are received [from NMS] they tend to run
out quickly. Again, this is attributed to the small budget and probably
misuse/irrational prescribing. However [MSI’s] endeavour to link the
ward, pharmacy and the Lab has to a great extent solved the issue of
irrational antibiotic prescribing.
The issue of stock-outs remains a serious block to progress. An intern
doctor describes the shortages affecting his work that are likely to result
in Surgical Site Infections:
We always have challenges with supplies from National Medical Stores
(NMS). We have them, then for 2 months we don’t have any. They deliver
every quarter but in the last 6 weeks we have none – there is no oxytocin
now. We have no iodine in theatre, so we are just using saline and during
that time we need some help until NMS provide for us. We order for
3 months but things get used before 6 weeks. These are the challenges
that make us get sepsis on the ward.
To illustrate the breadth of this shortfall, on February 18th, 2020, the
PNG ward contacted K4C to request support in the purchase of gauze.
Without this, they would not be able to continue with the wound dressing
established on the ward. This would have resulted in increased infec-
tion and sepsis (and antibiotic consumption). We were aware during the
project visit in January 2020 that the hospital had also run out of disin-
fectants, iodine and spinal needles (amongst many other things). In such
circumstances, the only option is for staff to ask patients to pay for the
necessary items, and if they are unable to pay, then operations will not
happen, and major delays occur in treatment. On February 19th, 2020,
we established that 13 key items for use on the PNG ward were out of
stock and had been for over a month:
1. Ceftriaxone injection
2. Intravenous metronidazole
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Ce riaxone (IV) Metronidazole (IV)
Fig. 6.2 Dispensing of IV Ceftriaxone and Metronidazole from in-patient
pharmacy to PNG wards at FPRRH (1 December 2019–29 March 2020)
3. Intravenous normal saline 0.9%
4. Intravenous ringers lactate
5. Intravenous ciprofloxacin
6. Meropenem 1 g injection
7. Gentamicin 80 mg injection
8. JIK (sodium hypochlorite) solution
9. Alcohol hand gel
10. Chlorhexidine gluconate 4%
11. Cotton wool 1 kg (hospital quality)
12. Gauze (hospital quality)
13. Povidone Iodine.
The next supplies were expected on February 25th, 2020.
We have listed the items to illustrate the profound impact of such
stock-outs on ward cleaning; hand hygiene5; the ability to clean and dress
wounds and prescribe necessary antibiotics. Figures 6.1 and 6.2 present
data collected manually from in-patient pharmacy on key antibiotics used
in the PNG wards. NMS deliveries were made on December 13th, 2019,
and February 24th, 2020. The dispensing patterns show stark evidence
of stock-outs.
5K4C makes up this shortfall.
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The greater consumption of metronidazole can be attributed to the
high dosing regimen (three times daily) plus its empirical indication as a
broad-spectrum therapy for prophylaxis against anaerobes. IV Ceftriaxone
(dosed once daily) is also being used empirically and for prophylaxis,
especially in surgical cases. IV Ceftriaxone was not available at all from
February 19th to March 1st. Dispensing of IV metronidazole showed
evidence of stock-outs but for shorter periods than ceftriaxone. In the
period between February 15th and 23rd, neither IV metronidazole nor
IV ceftriaxone were available to the PNG wards. Similar falls can be
seen at Christmas and New Year. These dips we would anticipate being
due to lack of doctors on the wards to prescribe (so a human resource
management issue rather than a stock-out issue) (Fig. 6.3).
Dispensing patterns for oral metronidazole show higher utilisation and
longer periods of stock-outs than oral amoxicillin, with an extended stock-
out from January 26th to February 23rd coinciding exactly with the
stock-out of IV metronidazole.
The interview with the hospital administrator raised this issue. He
explains the lack of autonomy the hospital has in relation to procurement:
[Interviewer] The biggest blockage seems to be stock outs of antibiotics,
jik and disinfectant. It seems when they deliver after 1 month it is all gone
so you have a month with none so even if we do the swabbing and testing
if the right antibiotics are not in stock, we can’t do anything. It seems you

















Amoxicillin (Oral) Metronidazole (Oral)
Fig. 6.3 Dispensing of oral Amoxicillin and Metronidazole from in-patient
pharmacy to PNG wards at FPRRH (1 December 2019–29 March 2020)
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are saving a lot of money, but we are not allowed to use this on drugs
and consumables. If that doesn’t improve, I don’t think we can make any
more improvement. Do you have any ideas?
Well NMS should be providing. The funds for buying medicine don’t
come from our account – it comes from NMS. We are tied to NMS.
Concerns about stock-outs were also raised in the IPC Committee. It
was interesting to observe that this issue is so endemic and structural
that it was almost not listed in the meeting minutes and would not have
been if one of the K4C team did not raise it. Concern was also expressed
by a doctor at the IPC meeting about overuse of antibiotics in some
departments contributing to shortages: ‘Can we stop some departments
using antibiotics for everything – coughs … malaria…’. A senior nurse
participant echoed this concern referring to the practice of prolonged
antibiotic use: ‘clinicians prescribe antibiotics for 10 days then the clini-
cian just says ‘continue’. This is one of the practices that we have noticed
to have changed on PNG since culture and sensitivity testing became part
of the ward’s normal practice.
The K4C pharmacist responded to these concerns by expressing the
need for the full institution of a Medicines Therapeutic Committee
(MTC) which would have authority to implement clearer policies on
antibiotic use.
Interpreting In-Patient Pharmacy Data---A Note
Consumption data cannot be interpreted in any direct way as an indi-
cation of prescribing knowledge or stewardship competency. Collecting
and analysing the data on antibiotic ‘consumption’ patterns at FPRRH
have emphasised the dangers of empiricist approaches to data analysis and
presentation and the importance of interrogating data rigorously. In most
cases, data presents a myriad of questions and very few obvious and imme-
diate answers. This is especially the case when attempting to collate data
from public health facilities in Uganda and many other LMICs. Collecting
data has been a continuous process of trial and error merging with the
underlying ethnographic journey. As described, in the case of in-patient
pharmacy, the data is not yet managed electronically via the Rx system.
Rather, individual wards come to a window in the in-patient pharmacy
with paper forms requesting supplies for that day. The pharmacy then
maintains a handwritten record of dispensing in a records book, and
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this data is compiled into forms for the Ministry of Health. In the first
instance, we believed that all wards behaved in this manner, but the initial
data suggested otherwise. The TB ward, for example, appeared to collect
very few drugs. We found that most of the drugs used on the TB ward
are in fact provided by a donor6 and follow a different track. These drugs
pass through the main stores and are directly requisitioned by the TB
ward. As such, they do not pass through in-patient pharmacy and neither
are they recorded as received from NMS on the Rx system, leaving a gap
in overall supply and consumption data.
Other apparent ‘discrepancies’ in the data, including very sporadic and
low use of antibiotics in the neonatal intensive care unit (NICU) and the
paediatric ward, uncovered variances in practice that are undocumented
and apparently do not comply with the published protocol. This was
explained by one respondent as follows:
The paediatric ward gets injectable drugs (directly) from main stores,
including antibiotics, but oral antibiotics and other oral drugs from
in-patient pharmacy.
Our observational work on the wards supplemented by qualitative inter-
views and many emails led us to question the relationship between this
‘consumption’ data and overall consumption patterns. We know, for
example, that since laboratory results have been available, many women
are getting higher-end antibiotics and that this is contributing to short-
ened stays and improved patient outcomes. However, the supplies of these
drugs were not visible in the data. It seems that the pharmacists have
played a critical role in supporting access to these antibiotics through a
combination of ‘borrowing’ from other hospital supplies. The following
excerpt explains this process:
There is a TB focal person who handles all TB related logistics, including
the ordering of TB drugs. These drugs are stored in main stores. Rx
only focuses on drugs from NMS. In most cases, we don’t have the
changed antibiotics in stock or in our procurement plan or we have limited
quantities. Take Amikacin for example. We usually borrow from the TB
6The Ministry of Health’s National Medicines Policy reports that donor support for
medicine financing is more than three times the amount the government invests and
concludes that, ‘heavy dependence on donor funds puts Uganda in a vulnerable position
(2015: 7)’.
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program and give to the patients. The same applies to Moxifloxacin. These
medicines are not available in the inpatient pharmacy. In fact, one time you
had to use K4C money to purchase Amikacin. Because at times we have
septic patients who are only responsive to these drugs, we ‘beg’/borrow
from the TB drugs. Apparently, this has caused audit queries.
This ‘borrowing’ behaviour clearly saves women’s lives; it also compro-
mises the pharmacists under pressure to assist, but potentially contra-
vening donor conditionalities. We can anticipate similar situations in
relation to Anti-Retroviral Therapies (for HIV patients) and, in the case
of FPRRH given its proximity to Congo, some (necessary) stockpiling in
the event of Ebola spread.
Pharmacy Support in Accessing
and Distributing Antimicrobials
It is important to recognise the considerable efforts the pharmacy team
have made to optimise the distribution of and access to supplies within
the hospital. Improved relationships with pharmacy have significantly
improved the ability of staff in the PNG ward to access consumables and
medicines. The hospital pharmacist explains his role and how he has tried
to improve timely access:
I was very happy to be part of the project; most of the things I was trying
to do beforehand but I was focused in stores on the supply chain. This is
a key role for hospital pharmacists in Uganda. Making sure the necessary
consumables are available; that people are using standardised protocols for
theatre, but they often don’t have consumables. I have a level of authority
to ensure consumables are available; to develop good pharmacy distribu-
tion practice. The hospital has supplies for different programmes (ART, TB
and emerging diseases such as Ebola). I can help to move items around
to ensure user access and good distribution. I can ensure different wards
have access to medicine so they can do their job. I am involved in proper
procurement planning for the entire financial year; how do we move drugs
to the user points? I think the commodities for sepsis need to be ring
fenced somehow. Some come under different programs; we use one antibi-
otic that comes here under TB, so we redirected it, and this has been very
beneficial.
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Table 6.5 Patients receiving the prescribed antibiotic dose
Gynaecology (n = 22) Post-natal (n = 20)
No. of patients on antibiotics 10 18
No. of patients documented to have
received all prescribed doses in last
24 hours
4 0
Source Results of G-PPS, May 2019 as reported to FPRRH IPC Committee
The midwives have appreciated the lengths pharmacy have gone to try to
access antibiotics and consumables:
The relationships with pharmacy are working a lot better; they get us
wound dressing materials and [pharmacist] runs to the ward when he is
needed.
There was a case who is only sensitive to amikacin. Getting one dose of
amikacin is very expensive and our population here cannot afford. It isn’t
available in the hospital; they can’t afford to provide it sustainably as it is
very expensive but now [pharmacist] tried hard and we have been able to
provide, and she is greatly improved.
When drugs are prescribed but not in stock, patients are asked to buy
them privately.7 Current recording systems cannot capture the consump-
tion of privately purchased drugs. By way of illustration, the GPPS
‘snapshot’ found that, on the date of the survey, very few of the patients
were receiving the prescribed dose (Table 6.5):
These examples underline the need to exercise caution when inter-
preting data on antibiotic consumption. We have noted how the presence
of laboratory results has facilitated clinical pharmacy on the PNG ward.
The presence of one clinical pharmacist has made a major difference.
Extending this to other wards may, however, require more pharmacists
to be employed.
7The regulation of ‘over-the-counter availability and self–medication with antimicrobial
medicines’ is a key stewardship target of the National Action Plan. We were very aware
of this huge challenge in Uganda and are undertaking some work to assess the quality
of some of these antibiotics. We made the decision not to address this issue in the MSI.
Documentation on the ward was also so weak we decided not to attempt to capture the
role that private purchases play in antibiotic consumption on the ward. This is an area we
would be keen to follow up in future.
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Pharmacy Leadership in a Ugandan
Regional Referral Hospital
Chapter 1 noted the emphasis on pharmacy as a profession in the Call
for Applications and, in the ‘Scoping Requirements’, a preference for
pharmacy leadership of AMS. In order to understand the current and
potential role that pharmacy, as a profession, can play in the manage-
ment of AMR, it is important to understand the constraints on pharmacy
in context. The role of a hospital pharmacist in a Regional Referral
Hospital combines supply chain management with clinical engagement
and includes (in theory):
• Monitoring the supply of all medicines used in the hospital,
purchasing, compounding, dispensing and quality-testing medica-
tion stock.
• Working with the healthcare team to ensure the selection of the best
medication at the correct dose for an appropriate duration.
• Monitoring and preventing or minimising side effects and drug
interactions.
• Providing medication counselling to patients.
• Dispensing medications for patients in wards, the emergency depart-
ment and those attending outpatient clinics.
• Offering specialist drug therapy advice to doctors, nurses and other
healthcare professionals within the hospital.
When the MSI commenced, there was only one senior pharmacist in the
hospital. The Head of Pharmacy in a Regional Referral Hospital also coor-
dinates pharmacy-related activities across the wider region. Fort Portal
Regional Referral Hospital is the referral hospital for the Rwenzori region
comprising 9 health districts and an approximate population of 3 million
people (2014 National Census).8
The hospital also employs a pharmacist, who reports to the senior
pharmacist. Unfortunately, when the project commenced, the pharma-
cist had been transferred to the National Referral Hospital. In addition,
the hospital hosts intern pharmacists allocated by the National Internship
Committee under the Ministry of Health. Internships last 12 months of
8https://www.ubos.org/2014-census/. The National Medicines Policy reports that
only 8% of pharmacy posts in public service are filled (MOH 2015: 10).
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which 6 months must be spent at a hospital with rotations to different
sectors including regulatory bodies, community pharmacies and pharma-
ceutical industries. The hospital usually has four intern pharmacists who
rotate through the major wards, pharmacies and stores under the super-
vision of the pharmacist/senior pharmacist. The hospital also employs
two Pharmacy Technicians and two Pharmacy Assistants who are quali-
fied to diploma and certificate level, respectively, and are mainly involved
in dispensing. A second pharmacist joined the pharmacy team during the
project and was required in the first year of his appointment to develop
systems to improve supply chain management. According to the Ministry
of Health’s9 plan, there is a vacant position at FPRRH for a principal
pharmacist. In this context, there is limited pharmacy capacity to engage
more actively in clinical pharmacy across the whole hospital.
This chapter has outlined the opportunities that more active engage-
ment with the laboratory has brought about particularly in stimulating
the practice of clinical pharmacy on the wards. It illustrates the gains that
can be made from the more effective deployment of just one pharma-
cist. It has also identified key structural weaknesses in the health system
that restrict the opportunity for optimal impact and scale-up. Chapter 7
explores the change process in more detail and the contribution that
multi-disciplinary team working has made to knowledge mobilisation and
change processes on the ward.
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Abstract This chapter examines the importance of multi-disciplinary
team-working to the management of antimicrobial stewardship and
behaviour change processes. MDT has played a major role in improving
communication and reducing professional boundaries that had previously
contributed to high levels of infection; extended use of, often inappro-
priate antibiotics and poor patient outcomes. The functioning of such
teams facilitates the role of clinical pharmacy.
Keywords Multi-disciplinary team working · Behaviour change ·
Huddling
There is a meeting of minds of all the different people so the future for
the work is quite bright. (Hospital Administrator)
The main thing is the excellent team working you have done here. (Intern
Doctor)
One of the anticipated outcomes of the project from the funders’ perspec-
tive was ‘improved knowledge and practice’. Knowledge comes in many
forms and it is often associated too narrowly with forms of explicit scien-
tific or clinical knowledge. The interpretation of laboratory results is an
example of this kind of knowledge. Changing behaviour requires more
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than an increase in this form of knowledge. Explicit knowledge works
hand-in-hand with forms of tacit knowledge and it is these knowledge
combinations that stimulate change. Our research on the gains to NHS
staff from periods of volunteering in Uganda (Ackers et al. 2017) has
emphasised the relative importance of tacit knowledge; of experience in
leadership, cultural understanding, communication, and team working.
Team-working, as much as any gain in scientific or clinical know-how is
the connecting knowledge that has made this project a success. Indeed,
it is the positive experience of team-working that has driven the quest
for scientific knowledge (to know more). This fits with our conceptualisa-
tion of behaviour change; it is not new knowledge that drives motivation;
but motivation that drives the thirst to learn. It is interesting to reflect
here on the assumed knowledge gains to NHS volunteers expressed in
the funding call. The emphasis on these more tacit forms of knowledge
and leadership skills for NHS staff is very evident whilst the knowl-
edge gains to LMIC staff appear to be focused on more explicit skills
(prescribing and IPC). Somekh makes an interesting point about the
relationship between ‘training’ and education or knowledge suggesting
that the concept of knowledge has a more sophisticated tone whilst
‘training has strong cultural associations with the teaching of low-level
skills’ (2006: 19). There may be other ways of understanding this rela-
tionship perhaps seeing training as more linked to technical know-how
and an instruction on what to do in certain circumstances rather than a
more holistic understanding of the knowledge underlying that.
It is resoundingly clear from the interviews, attendance at meetings and
from on-going observational work on the ground that the key success in
this intervention hinges on the achievement of genuine, multi-disciplinary
team-working with each cadre showing mutual respect and willingness to
learn from each other. This level of team-working did not exist prior to
the project and many of the key actors had weak relationships with each
other. They may have known about the existence of the laboratory, for
example, but not developed a relationship with the staff there or under-
stood the kind of contribution the laboratory could make to their work
and their patients. Similarly, they may know that there are pharmacists
at the hospital but did not understand their roles and knowledge and
interact with them in any meaningful way, particularly in clinical decision-
making. There was certainly minimal engagement with the nursing and
midwifery team who are the most present on the ward and have most
direct patient engagement.
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The ‘magic’ that fostered this team working (as one respondent
referred to it) is complex. Many respondents attributed it directly to
the project. However, important structural changes took place in the
hospital at around the same time. A new in-charge had been appointed
on the ward, for example. The (externally funded) laboratory had begun
to function at a much higher level. The decision to appoint an inven-
tory manager in pharmacy stores also released a senior pharmacist with
a passion for clinical pharmacy enabling him to engage directly with the
team. This is an excellent example of effective task-shifting. From a project
perspective, the placement of K4C staff and professional volunteers on the
ward on a continuous basis undoubtedly stimulated team-working and
specifically the empowerment of the nursing and midwifery team. The
involvement of a senior obstetrician volunteer also stimulated the setting
up of daily ward meetings which staff reported to have had an impact of
team working.
The decision to improve the ward infrastructure and basic infection
control; decorate; provide trolleys to enable the nursing and midwifery
staff to work effectively; and the provision of instruments in the evacu-
ation room have made staff feel valued, improving motivation and job
satisfaction enabling them to use the skills they have more effectively. All
of these factors are of great importance. However, we must not under-
estimate the impact of the introduction and embedding of culture and
sensitivity testing to the team-building process. The culture and sensi-
tivity testing process is inherently a team-based activity; it engages all
staff irrespective of cadres. Having the laboratory results provides an
‘objective’ focus for interest to coalesce around; it stimulates team discus-
sions and active pharmacy engagement and creates the environment for
genuinely patient-centred care. Having the evidence-base for rational
prescribing undermines any artificial disciplinary hierarchies (who knows
best). One respondent refers to the impact of having laboratory results
on hierarchies:
Sometimes there can be ego – that the doctor or pharmacist thinks, ‘I am
the overall boss so I can’t be directed on what to do’ but with the data
that goes down.
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Laboratory results provide a critical focal point for what some phar-
macy teams in the UK refer to as ‘huddling’.1 Gardner et al. characterise
huddling as a mechanism to ‘support inter-professional communication
and collaborative practice’ (2018: 16). The consequences of rational
prescribing as a central component of patient care have delivered tangible
and often quite surprising results. Staff all remember and refer directly to
cases where women’s lives have been saved and women have got better
remarkably quickly as a result of this process. The sheer tangibility of these
outcomes has had a major motivational effect on all concerned; so, team-
working becomes enjoyable and immediately rewarding. We cited the
words of a Ugandan health worker in our previous book to illustrate the
devastating impact on health worker motivation of having ‘people dying
in your hands [when] you know what to do but don’t have the things
to help them’ (Ackers and Ackers-Johnson 2016: 96). Seeing patients
survive and leave hospital has a huge motivational impact and drives a
thirst for knowledge. Some of the potential rewards to working on the
PNG wards relates to the nature of the work itself. Many respondents
spoke of the negative aspects of the work before the project in terms
of the offensive smelling wounds. Once this problem was resolved and
women were seen to be getting better quicker, health workers noted the
rewards of working in this area:
The [nurses and midwives] are proud; they really feel good when they say
they don’t have any septic patient on the ward which means they are trying
to prevent sepsis.
When we asked a midwife if she had had experience of this kind of team
working in other areas, she replied that team working did coalesce around
obstetric emergencies on labour ward. But she made the interesting point
that these emergencies are short-lived events and the fact that women
with sepsis stay in the hospital for longer helps to build these relationships
with patients and a more vested interest in, and responsibility for, their
well-being:
[Have you seen that teamwork, motivation, and collective interest in the
patient in any other place you have worked?]
1http://www.pulsetoday.co.uk/pulse-intelligence-your-practice/regulation/how-our-
morning-huddles-improved-practice-teamworking/20037047.article.
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In labour suite when there is an emergency there is teamwork but once
the emergency is over, they move on. But here the patients stay longer so
we see the same patient. We want to know how they are doing – if they
are getting better so there is continuity of care here.
A knock-on consequence of this has been the fact that the ward is no
longer ‘the laughingstock’ of the hospital; and is seen rather as a centre
of excellence to be envied. This has been openly acknowledged in hospital
meetings as having a massively motivational impact on all staff concerned.
The in-charge describes this change:
Things have totally changed. Before the project, the ward faced challenges.
The hospital assesses every unit regularly along various indicators. Before,
the unit always came out badly and we were always hearing our name
in meetings as a result; but now things are much improved. The hospital
director said to me; ‘What’s happening on post-natal? You people are quiet
- the deaths are not there as they used to be’.
The Chair of IPC Committee echoes this view:
Sincerely the trend has changed. Maternity was the ward we laughed at
and now it is the ward we all envy.
When a team is successful, and its success is acknowledged, new members
seek to join the team and gain that experience. And as they leave the ward,
they are motivated to take that experience to their new ward or facility.
The following section explores some of the team working relationships in
more detail and identifies areas for future improvement.
Perceptions of Team Working
Every respondent reported the improvement in teamwork and identified
this as the source of change on the wards.
We are now working hand-in-hand with the pharmacists, the laboratory,
and the doctors’. (In-charge)
I saw a gap with the midwives and doctors. You pass by on a ward round
they don’t always tell you what challenges they face. I found a burst
abdomen and the pus was a lot, so I found myself cleaning the wound.
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On ward rounds you don’t usually see the wounds so you can’t know the
problem. Now I combine the ward round with wound dressing (it can take
me up to 10 pm). We do the wound dressing together with the midwives,
so we work together. (Intern Doctor)
One midwife describes the team-working that has developed. She partic-
ularly emphasises the engagement of doctors which she puts down, in
part, to the sheer tenacity of the K4C midwives which they have now
‘inherited’:
We are working hand-in-hand together as a team. Before the doctor was
not there but nowadays doctors are responding. (The change) is because of
the teamwork those people introduced. They showed us good leadership.
They would follow-up and afterwards they call the doctor and he comes
even if they first deny we call again even the senior doctors. They come
– it is a big change.
The reference here to senior doctors is interesting. The general view
reinforced by observations on the ward and the experience of a strike
by intern doctors, in part due to lack of supervision (in September
2019), is that interns are largely left to cope and the presence of senior
doctors is at best sporadic. The relatively junior status of the intern
doctors may, to some extent, explain their willingness to engage in team-
working, benefit from mentoring by the pharmacist and their appetite for
learning. However, concern was also expressed about intern ‘burnout’ in
the absence of supervision and the challenges of continuity when interns
rotate every 2 months. The professional volunteers play an important role
in supporting interns in the absence of senior Ugandan doctors. The in-
charge nurse took on a major role in orienting new interns on the ward
which will help them to integrate in the team but this puts an additional
burden on the in-charge and could and should be fulfilled by more senior
doctor engagement. It was clear from the discussion in one of the IPC
Committees that the tension between doctors persists in other areas of
the hospital and was previously evident on the PNG ward:
Sometimes you find a pharmacist has changed a prescription and then on
the ward round the doctor changes it back to a drug the patient is resistant
to (Midwife on IPC Committee)
A pharmacy intern reflects on this situation commenting:
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I think it should be teamwork here and respect for each other. If we advise
and then the prescription is changed the clinicians come and undermine
that decision without listening to the pharmacist. We can see that post-
natal is taking the lead in consulting with pharmacy, but other units are
relying on empirical usage designed for health centres and not for hospitals.
If you are rigid on the usage you will not use the pharmacists/laboratory’s
advice.
Another midwife is appreciative of the team-working environment that
has developed. She refers to the presence of pharmacy on the ward and
the lengths the pharmacists have also gone to, to try to secure appropriate
antibiotics:
It has greatly improved because right now we have pharmacists who come
on a daily basis or if not, every day we can’t go 3 days without seeing one
who can guide us on the mothers and which drugs to take. They interact
with the doctors; if you don’t interact there is that collision. Right now,
there is no tension. They say, ‘what if we do this and there is a discussion.’
We never used to have any pharmacists coming on the wards, so it was
majorly the doctors dealing with the prescriptions. We have managed to
reduce the irrational use of antibiotics.
The impact of medicine on multi-disciplinary team working is well estab-
lished internationally. Atwal and Caldwell (2006) identified three barriers
to effective team working in acute care (in the UK): these included, the
‘dominance of medical power that influence interaction in teams’ ((2006):
359). In a more recent editorial with specific reference to models of
antimicrobial resistance in South Africa, Brink et al. consider whether
models of antimicrobial stewardship developed in high-income countries
translate effectively to a South African public health care context. They
underline the lack of understanding of the contextual and behavioural
determinants that influence local prescribing practices and present alterna-
tive models using non-specialist pharmacists, nurses and even community
health workers in key stewardship roles. As doctors themselves they pose
the question; ‘Will doctors, the actual prescribers, and a group notoriously
keen on safeguarding clinicians prescribing autonomy, embrace pharmacists
and nurses as equals in the drive towards optimising antibiotic use?’ (2016:
947).
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The following midwife makes a similar observation and illustrates the
point above about the motivational effects of seeing a patient’s condition
turned around:
Now [the pharmacist] comes in daily and helps us and discusses cases with
us. We had a discussion with him on Friday. He comes and looks at the
files and the wound; the drugs; the length of days the patient has taken
and then he gives us some alternatives. He looks at the laboratory results.
There was a time he prescribed a very expensive drug and the healing
was very fast. We nearly lost that young girl of 16. The baby died. They
took her to theatre twice as her uterus was necrotic, but the moment we
brought that drug she improved. She has her life.
An intern doctor describes how useful he has found the specific expertise
of the pharmacy team on the ward:
It’s changed a lot now; the senior pharmacist comes regularly, and you may
find there are 2 microorganisms sensitive to different antibiotics. Now I
don’t have the time to walk to the pharmacy and those people have studied
medicines. I have textbook knowledge; if someone has a UTI (Urinary
tract infection) I give x. I did study this but as time goes on you get used
to giving certain medicines quite often and you are not so equipped to
understand how one medicine interacts with another one or if a patient
has TB or is HIV positive or how to combine drugs – so a pharmacist
being available on the ward has really brought great improvement.
Evidence suggests that hierarchical structures inhibit junior staff from
challenging their seniors, leaving them to prescribe in a way to suit
conventional senior preference rather than offering evidence-based treat-
ment options (Broom et al. 2014). The MSI has demonstrated that
effective team working challenges professional hierarchies and empowers
lower cadres of staff. When team working is based on collegiality, recog-
nition of respective skills and the role they can play in helping (especially
doctors) to achieve their goals efficiently can drive change. Another
senior doctor (in the IPC Committee) referred to the pharmacists as a
‘tie-breakers’.
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‘We Are a Bridge’: The Changing
Role of Pharmacy in FPRRH
The intern pharmacist who later came to be employed on the project
describes his experience of the role of pharmacy and how that has changed
since the project commenced:
Interns shadow the pharmacists and I shadowed (senior pharmacist) to gain
experience under supervision. Unfortunately, the pharmacists’ role (in an
RRH) is limited to the supply chain. One of the challenges in a hospital job
description – we know we can do a lot but when you get employment in a
hospital there isn’t scope for clinical pharmacy. We try as much as possible
to show what we can do on a clinical side and we want to specialise.
You need to specialise if you want your work to be noticed; at present
people just see us moving around; you are everywhere, and your work isn’t
noticed. There should be different roles for pharmacists within the hospital
and scope for clinical pharmacy. On the post-natal ward, for example, there
are 6 + doctors and 1 pharmacist (shared with the rest of the hospital).
It’s not effective.
[But that means employing more pharmacists?]
We – and the Pharmaceutical Society of Uganda (PSU) are advocating
for specialisation. At present we manage the entire supply chain from plan-
ning, procurement, monitoring use, distribution, some physical inspection
(are they keeping medicines in the right condition) and antibiotic use. We
are supposed to review prescribing in the in-patient pharmacy; was it given
for the right condition? And we should go through the notes, but we
don’t really have time to do 40 files at once. We can’t review so we are
just forced to dispense. So, you end up dispensing which is one of the
key challenges. We want to do more, but you are really limited. It’s frus-
trating for my future career – there is no direct career path in Uganda.
The PSU came up with a draft career plan for pharmacists to discuss with
the Ministry of Health. The government has been giving scholarships for
clinical pharmacy but there are no positions for such people in public or
private hospitals. So, why do a masters if I won’t get employment anyway?
This concern about career paths is echoed in many other professions
in LMICs. Creating new opportunities for higher-level qualifications
and professionalisation—often encouraged by foreign experts seeking
to emulate developments in their own systems (the benefits of which
are often contested)—may have serious unintended consequences when
higher level and remunerated positions do not evolve in parallel. This
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has been the case with degree-level programmes in nursing, midwifery
and biomedical engineering, for example. There are clear benefits to
higher-level capacity-building programmes when appropriate positions are
available. Failing to provide such positions compounds frustration and is
highly demotivating as graduates return to the same badly paid positions.
There are other consequences too as graduates grasp the opportunity to
avoid clinical work and seek out work with foreign NGOs. Expanding
clinical pharmacy in Uganda requires both higher-level qualifications; the
development of appropriate positions AND a significant increase in the
volume of pharmacists in the hospitals to release them from supply chain
management roles.
He then talks about his own experience of working on the project and
the mentoring he has received from the pharmacist:
I’d like to do clinical pharmacy. The pharmacist has lots of experience and
he is biased towards the clinical side. He is a good mentor, but he has the
same frustration. He has made me appreciate the value of pharmacists in
providing clinical services.
The project has changed my role a lot. There is an opportunity to
really delve into what AMR is. We had heard of IPC, but we had not
participated in any. I studied the theory of it at university, but this has made
me learn a lot about culture and sensitivity testing and how to interpret
the results. There is a key role for us (pharmacists) to interpret and guide
clinicians – I’ve really learnt a lot! At university it was all theoretical. Now
we are learning about culture and sensitivity testing and how to interpret
the laboratory results. (The pharmacist) was able to show me some of
things so that is an area I gained a lot. This is the role of the pharmacist
to interpret the results and guide selection of antibiotics.
Pharmacy were not really doing that role before. Their job description
was limited only to supply chain management. This has changed and people
are now very interested – and this is because of our project. We wanted
to do these things, but the project created the opportunity for us to get
involved. We only became involved because of the project; the clinicians
were not so keen before to involve the pharmacists – it wasn’t conflict as
such, but they didn’t appreciate the role that pharmacy brings. At school
we study together but there are no tensions as such now (with the intern
doctors) now they know what pharmacists can do.
The clashes come when you try to perform their roles. For us we don’t
do diagnosis. You should each stick to your sides, but they recognise on
the issues of antibiotic selection, they need our guidance. We are a bridge
and we also know what is available in the stores and they appreciate that.
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We have information about if antibiotics are available and where we can
get them from. They really appreciate it, especially the younger doctors.
His ability to extend himself and engage in clinical pharmacy reflects
his supernumerary status. When we decided to take steps to retain this
pharmacist at the end of his internship and support his salary through
the project, we developed a clear role description so that he did not
just become another pair of hands or substitute labour. This created a
window of opportunity to focus on often neglected aspects of the phar-
macy role and to demonstrate the value and cost-effectiveness of such
roles in a regional referral hospital setting. He describes the importance
of relationships and rapport to team-working:
As for the laboratory, well I know [Lab scientists] now. It is more about
getting to know people who work there and building a rapport. Before-
hand our only previous relationship was to requisition consumables from
the stores for them but now our relationships with the nurses and the
laboratory – because nurses take and collect the samples so there is much
more rapport. The midwives have really appreciated the project – there is
lots of change – they now attend changeover meetings of interns (when
the interns rotate). [They] have stressed the need for interaction, so the
nurses relate to what their colleagues are doing.
Asked to describe what his role now involves on the ward the K4C
pharmacist explains how he and the hospital pharmacist engage on the
ward:
[The pharmacist] has a passion for clinical pharmacy – he prefers to interact
with patients. Until this project there was no other opportunity for him
to engage in this way. He identifies sepsis cases where pharmacy can have
a real input and is working especially with the intern doctors. This was a
chance for him, and he is actively involved. We don’t see all the cases. We
try to pick cases where we feel pharmacists can have an input and that way,
we don’t clash so much with the doctors. We work within our mandates
so there are no clashes. Intern doctors are also using this as a chance to
learn about AMR.
The hospital pharmacist echoes these concerns about hospital pharmacy
in Regional Referral Hospitals. He had previously worked in the national
referral hospital in Kampala and had a more clinical role in that more
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specialised context. He referred to some resistance, in the past, from
doctors to clinical pharmacy:
In the past people didn’t look at pharmacists as people involved in patient
care. Doctors previously felt that undermined their authority. Some even
hid the medical files from pharmacists. They tried to make us complete
separate forms, so we were not working in the patient files.2
Asked to describe his role in FPRRH, he explains how his first year in the
hospital was focused on supply chain management:
I now come in for septic and complex cases. I go on the ward and look
at the entire patient file. I look at the notes, the plan of action, see if
they have culture and sensitivity testing. I even go and see the patient and
look at the timeline since their admission. I started doing that when I was
moved from the Stores in October 2019. I worked there for a full year
which was a good way to get to know the hospital but then they recruited
an inventory manager. Before he came, I was tasked with management of
stores and this enabled me to leave the stores and get more involved on
the wards. The new role is very challenging and very rewarding. You don’t
go there because you have all the answers. I have had to keep reading.
I know what information and online sources to look for and where to
look so we can focus on a specific case and I know how to make that
information relevant to a specific case but in the process I also had to
teach people; nurses and midwives. It has been a continuous conversation.
The patient belongs not just to me but to all of us so we have to engage
in a conversation about the patient and what we can do about it. I have
found this work very motivating. I spend more time on the wards now
than before and every time they have a case, they want me to look at as
a specialist there is now more time on the wards for me. It has been very
encouraging for me and the doctors are appreciating my presence too. In
the past traditionally most resistance to change came from the doctors but
they are more collegial now. They have attached a certain respect to my
presence because we do this in a collegial manner. The different disciplines
are coming together for a common objective with mutual respect and trust.
I don’t come here to criticise or undermine. In fact, when I write in the
notes, I write it not as a prescription but as a recommendation. They
2It was interesting to observe during a visit with this Ugandan pharmacist during a
fellowship in the UK we were shown how pharmacists used a different coloured ink to
make their notes on patient files.
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could disregard it. Then one doctor said, ‘when he comes, and we follow
his advice things turn out very well.’ People’s perception of pharmacy has
changed tremendously. They said to me, ‘we have never seen a pharmacist
do what you do – how do you know to do that’ and I explained to them
that clinical pharmacy is part of our training. For her it was a shock; the
perception was that pharmacists handle the supply chain and dispenses. I
am sure the Director has had her eyes opened to what pharmacists can
achieve. I think she had the same perception of every other person that
pharmacists only manage procurement distribution and dispensing but now
she has seen what 1 pharmacist can achieve on a very sensitive ward. The
maternal mortality rate was very high and not one death has taken place
since the project started. This is in line with the Sustainable Development
Goals. They noted that since you guys started coming as part of our project
you haven’t had a maternal death from sepsis, and it used to be quite
common.
Some concern was expressed at the IPC meeting, perhaps reflecting prac-
tice on other wards and not PNG that doctors were continuing to ignore
the advice of the pharmacy team:
The problem was that some doctors changed the [pharmacy] recommen-
dations and then the patient’s condition did not improve so [the nurses]
complained to the director in a meeting and she was very appreciative of
the progress we have made.
A senior doctor challenged this attitude:
At the end of the day all our efforts should focus on the patient. The best
outcome regardless of your cadre. If everyone plays his or her own role
it will really be good teamwork. Without that we can’t do magic here so
there needs to be comprehensive teamwork and leadership. But there are
issues for the administration and supplies and IPC cuts across this. Can we
have more IPC supplies and more leadership involvement?
The respondent raises an important point here echoing the behaviour
change literature. The development of team-working cannot happen in a
vacuum and if the outcomes of that team-working, in terms of wound care
or prescribing decisions cannot be operationalised due to lack of supplies
then team-working will become frustrating, demotivating and collapse.
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Team-working lies at the heart of the behaviour change that we
have witnessed on the post-natal and gynae wards. Recognition of the
contribution of colleagues from different disciplines—and at lower pay
grades—has generated ‘huddles’ of activity that have proved highly moti-
vational and empowering and driven a quest for more knowledge. It is
important to point out that this change has happened incredibly quickly
and with relatively little investment and has proved highly cost-effective.
Sam Opio notes the benefits during a follow-up visit:
There is great progress. It is clear that the departments outside of maternity
are aware of the work. There is great teamwork. I was aware last time I
came that people were working in silos, the laboratory, pharmacy, and the
nursing team. Everything was in silos. I’ve seen significant teamworking.
The pharmacy profile is much bigger; there is more engagement with the
laboratory and the nursing team, and it is important to build on that. After
documenting and disseminating we need to institutionalise and move out
of silos.
Chapter 8 moves on to consider the knowledge generation and mobili-
sation processes that multi-disciplinary team working has enabled within
the MSI.
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CHAPTER 8
The Knowledge Creation and Transfer
Mechanism
Abstract This chapter reflects on the relationship between the knowl-
edge mobilisation processes that have contributed to behaviour change at
an individual and organisational level. It critiques the traditional emphasis
in international development on one-off, formal, foreign-led ‘training’
episodes and contrasts these with the more fluid, bilateral, approach to
learning through co-working and mentoring.
Keywords Knowledge creation · Knowledge mobilisation · Continuing
medical education · Co-working · Co-presence · Mentoring
Chapter 1 noted the quite prescriptive approach taken, by the funding
partners, to knowledge mobilisation processes and associated log-frame
audit. This chapter examines some of the underlying mechanisms that
have shaped behaviour change in the MSI intervention. Knowledge for
Change has been working to support health systems change in Uganda
for a decade. This has involved huge organisational learning which we
often describe as learning from failure. Rajkotia similarly argues that, ‘the
fear of failure, instilled by the success cartel is one of the key reasons
for why there is so little innovation in the health development sector
arguing that ‘intelligent failures arising from experimentation and explo-
ration are ‘praiseworthy’ (2018: 2). Our first book, ‘Killing me Softly’
(Ackers and Ackers-Johnson 2016) describes the challenges involved in
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foreign engagement to support systems change in Uganda’s public health
system. Through a wide variety of projects, we have tried, with varying
degrees of success, to work collaboratively with an emphasis on medium-
long term sustainability. The book described what we have come to
identify as a key weakness in approaches to foreign engagement, especially
in short-term externally funded projects, namely a tendency to identify
the ‘problem’ as one of the knowledge deficits and attempt to solve that
through fly-in-fly-out short courses delivered by foreign ‘experts’.
Not only has this been seen to fail as a knowledge transfer mechanism;
emphasising explicit (scientific or clinical) knowledge to the detriment of
more implicit implementation knowledge is unlikely to deliver sustained
behaviour change. A briefing document by Jhpiego,1 an affiliate of John
Hopkins University reports that, ‘countries and donors spend significant
amounts of funding on in-service training’ and yet, ‘traditional training
approaches that focus on extended, off-site, group-based workshops have
had limited effectiveness in improving and maintaining provider perfor-
mance after training’. The brief cites a systematic literature review of
interventions to improve healthcare provider performance in LMICs
(Rowe et al. 2019) which found that ‘one-time training interventions
results in very low effect size’. Indeed, they report learning outcomes of
this kind of training as ‘low to none’. The approach specified by Jhpiego
involves the use of ‘low dose, high frequency’ training. Rowe further
contends that (any form of) training alone is not sufficient to improve
quality; ‘when training is combined with Quality Improvement efforts,
such as coaching or supervision, the effect size is significantly greater’.
Building on our mentoring approach, we have applied this through
what we have termed, ‘bite-size, bedside’ reciprocal learning. The
emphasis on formal training in LMICs (CMEs) has also generated unin-
tended consequences associated with encouraging absenteeism and per
diemism. The endemic expectation that staff will be paid for training has
a poisonous effect on everything foreign organisations and volunteers try
to do. In the course of this intervention, this expectation raised its head
on many occasions. The following is a typical response to the proposal to
organise a CME. K4C has always provided refreshments for meetings but
never pays per diems. However, when we proposed to run IPC training,
1https://hms.jhpiego.org/wp-content/uploads/2016/08/LDHF_briefer.pdf
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with attention to COVID-19 preparedness, we were expected to pay staff
to attend:
People were looking forward to being paid even after telling them this is
informal…
The normalisation of this expectation and the contribution such payments
make to livelihoods resulted in a Ugandan colleague suggesting that we
consider making financial payments in place of refreshments. The extent
to which this ‘poison’ has begun to pollute even mentoring relationships
is evident in the following conversation involving a senior doctor, who
is generally absent from the ward, pressurising a Ugandan K4C health
worker for money:
He is saying that he is giving a lot of support to (highly experienced UK
doctor) and therefore he needs some kind of pay for this work.
The use of per diems has commodified and distorted incentives for
training. It often results in the wrong staff (often only senior or manage-
rial staff) being trained and pollutes team relationships. Our previous
book reviewed the effectiveness of these approaches in anything but the
immediate term (where pre- and post-test results, as anticipated in log-
frame approaches, may show knowledge acquisition) when it comes to
understanding behaviour change dynamics. As much behaviour change
theory2 argues, adding knowledge alone (to increase individual ‘capabili-
ties’) will rarely work when the opportunities to exercise that knowledge
are missing. This is particularly evident when it comes to formal training
on hand hygiene, for example, when—as was the case on the PNG ward—
there is no running water, soap, towels or hand gel. In such situations,
training staff in standardised international protocols can be both insulting
and demotivating. We also know from experience that even when the
infrastructure and materials (described in behaviour change theories as
the ‘opportunities’) to utilise knowledge are in place, this often fails
to translate into hoped-for behaviour change. The reasons for this are
2Rather than rehearsing the theoretical arguments, here we refer you to Chapter 4
in our book, ‘Can (imported) knowledge change systems? Understanding the dynamics
of behaviour change’ (pp. 79–113) available as a free download at—Mobile Professional
Voluntarism and International Development: Killing Me Softly? (2017–Open Access)
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highly complex. Michie et al. (2011) focus on the role that motivation
plays in combining knowledge and opportunities to facilitate individual
behaviour change. We felt concerned that many of these theories, rooted
in psychology, tended to overemphasise the individual and gave insuffi-
cient attention to the structural contexts that crush motivation. Turning
to ideas from evolutionary economics, we were captivated by the concept
of ‘imagined realities’. As we framed it in the book: ‘Is it possible in the
context within which Ugandan health workers are placed to imagine a
different reality?’ (p. 103). We contend that only in situations where a
critical mass of people can begin to imagine sustained positive change
can effective knowledge mobilisation and behaviour change take place.
Harding makes a similar point in relation to research methods arguing
that feminist research is, ‘interested in models that stress context rather
than isolated traits and behaviours. Interactive rather than linear rela-
tions, and democratic rather than authoritarian models of order’ (1991:
301). The emphasis on behaviour change needs to be at the level of
the organisation and organisational culture and not specifically, at the
individual.
This experience framed our approach to the MSI. And to that extent,
it cannot be described as strictly ‘inductive’ as we are continually learning
from prior knowledge and associated research review. We proposed to
build on our existing strong relationships with managers and local health
workers established through continuous engagement and strengthened
through the deployment of local and international ‘volunteers’. We did
not conceive of these K4C faculty (and ourselves) as the experts with
solutions, but as colleagues playing a supportive role and engaging in
mutual learning. We were fully aware that the expertise on the ground
is of equal and often greater importance. Each of the participants, what-
ever their cadre or level of seniority, brings new knowledge, ideas, and
enthusiasm to the table. Where specialist knowledge has been required,
this has tended to take the form of multi-disciplinary encounters, of hori-
zontal knowledge exchange with an emphasis on communication skills.
Antimicrobial resistance is highly complex and, from a scientific perspec-
tive, conceptually difficult. Understanding the processes of culturing and
testing bacteria for resistance and the implications of this for prescribing
behaviour is not easy for those of us who are not trained in microbiology
or pharmacy. Wanting to acquire such knowledge demands a real commit-
ment and an ability to imagine a different approach to working. With
this in mind, we designed an intervention based on K4C’s commitment
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to co-presence with continuous project engagement on the ground. This
creates an environment within which carefully managed and planned short
stays can have a high impact and bring new interest into a project. This
applies not only to visiting colleagues from the UK but also to students
and interns passing through the wards. Where the need and interest are
articulated and the timing is right, short stays may provide important
opportunities for more formal training input. Where possible, we have
conducted this in ‘bite-size’ chunks on the ward. And where the opportu-
nity has arisen and the demand was patent, we have provided this through
larger multi-disciplinary formal training sessions. A British volunteer phar-
macist observed the success of this approach and likened it to knowledge
transfer mechanisms in the NHS:
A clear indicator of knowledge change is progress in the hospital and clear
progress has been made. There is clear visibility of pharmacists on the ward
– midwives know what to do with culture and sensitivity tests. The whole
model is mirror like to the NHS. Clearly knowledge exchange has taken
place we have just done it in an unconventional way on the ground; in a
much more informal and effective way.
The following section presents interview data to illustrate the effectiveness
of this approach from a variety of perspectives. We open with the views of
the hospital administrator with whom K4C has had a strong relationship
and who has played a key role in the partnership. Asked to outline what
his experience of this short intervention has been, he immediately refers to
the mentoring/co-working approach distinguishing it from other projects
he has witnessed in the hospital:
The project has made strong inroads. Your approach is very involving.
The people who are on the project are working together. They are part
of it. It’s a real departure from many projects that we have seen where
the people who come with the project go and then the project also goes.
Where aliens are imposed on people; they come with their ideas and then
they go. It’s very involving. The midwives feel part of it. For me it has been
a very exciting project and very successful – we feel a part of it. There has
been a real change in people’s perspectives about how they approach their
practice. No little thing is ignored – the little things that we were ignoring
- like you repair a tap – and yet we had the capacity to do these things,
but we didn’t do them until the project came.
[Why that is the case?]
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We had a laissez-faire kind of attitude when looking at institutional
things – our consciousness has been awakened. Right now, they will say
‘hey can we work on this?’ The training that you have brought with
the project – both the formal way - but you see with [K4C midwives]
they have worked with the team with an in-built training mechanism that
has strengthened our collaboration. They come on board and support
changeovers of staff. We should be able to see change beyond the lifetime
of the project. There seems to have been an integration of minds.
[What are the main benefits for you in administration?]
The project has helped our Human Resource by increasing numbers of
staff on the wards and by improving staff training and guiding people on
how sepsis is to be managed. The hospital now has the resource of more
trained people. When they go, I still have trained staff.
The final part of the Administrator’s comment alludes to the augmenta-
tion of staffing that co-working brings. It raises the question of whether
the benefits have come from simply having more staff time on the ward
and will be extinguished as and when that disappears. Certainly, local staff
welcomed the additional support. During the project, a new in-charge
was placed on the ward, in a Ministry rotation from Kampala. It is clear
from the following midwife’s narrative that the new in-charge had played
a major role in instilling leadership by example and co-working herself:
Since those K4C people came in, they had to unite us. They just go and
give good dressing. You find you are now working as a team. It is because
of the teamwork those people introduced. They showed us good leader-
ship. They would follow-up and afterwards they call the doctor and he
comes. Even if they first deny we call again, we wait and again we call -
even the senior doctors. The good leadership because when those people
came in everyone was willing to act.
[Why wasn’t there some resistance to these people?]
The way how they smell the sepsis cases. We used to say ‘we are not
going there’ but when those people came in, at first it was SMELLING
but you find them really dressing wounds. They were working WITH US
hand in hand. They taught us how to do it, so we gained knowledge and
they are good leaders to us.
[Where did the leadership change come from?]
They were really working alongside us hands on. We saw them dressing
wounds and the in-charge she dresses wounds too, so we are all working
together now. She is the in-charge, but you find her dressing wounds. This
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was not happening before. Before the leader said, ‘I am the leader, so I
am not dressing’.
The new in-charge also noticed the difference between hands-on co-
working and formal training. When asked if running CMEs would have
been as effective as having K4C midwives on the wards, she replies:
I prefer ‘on-the-spot-training.’ This is what has changed attitudes and the
fact that the K4C team are ‘hands-on’ working as part of the team. We have
had CMEs but they heed no results. They listen, hear, but do not imple-
ment. With CMEs there is often no follow up – you need constant follow
up to change behaviour. And how [K4C IPC midwife] is on the wards at
times watching them hand wash and pulling them up – not criticising but
making them constantly aware of the importance of hand washing both to
themselves and to the patients.
Another midwife suggested that there may be some rollback if the K4C
staff are removed from the ward at the end of the project:
We would like it to stay that good. Maybe it won’t be 100% but maybe
50% because when they are there, they are additional. But [they] are not
just numbers. When they are there, they know exactly what to do and you
know that. ‘Hey, [she] is there – let me do this other part’. It is a division
of labour and we work together. They know when I am on the ward then
sepsis is covered!
It is interesting to note that the observation that the K4C midwives ‘know
exactly what to do’ is not a reflection of greater initial knowledge or expe-
rience. None of the Ugandan K4C team had previously worked on AMR
or sepsis management. They have, as many of the local staff have, grasped
the opportunity to learn through co-working. An intern doctor expresses
a view that, although local staff now have the knowledge, further support
on the ward is needed to put it into practice:
The care these ladies (K4C midwives) are doing is making a big difference.
[But are the local staff also doing the same care or do they rely on K4C
staff?]
They would do good but not as much as there is always inadequacy of
staff. You may find only 1 or 2 nurses on the ward and lots of work to do
so they won’t be able to dress the wounds…
[Is that because the local staff lack time or is it skill/knowledge?]
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They have the skills but there are not enough staff on the ground. One
nurse can’t give drugs, receive mums from theatre, manage septic wounds
etc. It is not really knowledge – the big challenge is staff time but when
we have nursing students around that pressure is down. Now it is holidays
so that’s when we have issues.
Another intern doctor observed a benefit arising from having more staff
on the wards which has enabled local midwives to ensure that medica-
tion (and antibiotics) is administered on time. Timely administration is
extremely important to ensure the efficacy of treatment and reduce AMR:
In terms of my observations in post-natal and gynae, I see more timely
medication now; they are still not receiving it on time as desired but there
has been improvement. The K4C staff have taken over the gynae and peri
sepsis cases and wound dressing and it is now done on time. The workload
of the local staff has reduced so that they are now able to administer
medication on time.
[Was only K4C midwives doing the wound dressing now then? Was it
just a question of workload?]
Now – you see swabbing and samples going to the laboratory – doing
a lot of following up is very hard for us to do so now [we have K4C
midwives] – they will withdraw a sample, get it tested – get results in
3 days and change the prescription and you get the patient recovering so
quickly.
[So, is it having more staff or knowledge?]
I think it’s a two-way thing. Let’s say if the MOH gave more staff. If
you had 10 more staff, I don’t think they would take swabs and test them
- they would go back to their old excuses. So, it’s not just a reduction
in workload that brings the change. It is important to note that we need
people employed specifically to do that – to fight infection on the ward –
dedicated people. It means our people have not appreciated the importance
of doing that.
I still think if we don’t have that they will go back to their old ways
– sitting around pressing their phones and not doing their work. It could
slide back if you removed Rachel and Dorothy. There is a solution to that.
I don’t know if it is poor motivation or… you see even Dorothy and
Rachel are not employed as usual nurses – I think if they were not here,
they would not be doing the work they are doing. It’s because it is their
designated job – they are employed by K4C to do this. We need to have
people employed specifically for that.
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At this point in the interview, he seems to suggest that the changes
may lack sustainability. However, his perspective shifts as he refers to the
inheritance of a ‘trait’ on the ward:
Wound management has improved greatly, and mothers are receiving twice
daily dressings, so they improve so quickly. The staff have developed a trait
to inherit. It’s good that the local staff have seen the others. They know
if you have a wound and take good care of it, they will get better quicker.
It’s a great impact. It is even something you can push into other facilities.
In response to a question about the engagement of local midwives, he
explains how one of the local midwives, ‘goes the extra mile to do better.
She keeps reminding me’. He then describes the improvement in team
working and the impact this has had on his own behaviour:
Leadership on the ward – you see the medical profession is hierarchical – a
system without leadership is bound to fail and I think it works now. Yes at
one time Rachel did great work - I spoke rudely to her as she followed me
and insisted I look at a patient who I had already passed by in the ward
round – but they had the results of the tests back after I’d seen her – she
kept pushing me. In the end the senior pharmacist prescribed.
He acknowledges that this pressure (from a midwife) had been a good
thing in encouraging him to respond immediately to the results:
this has been a great thing for me as a doctor – now I have seen how
significant the tests are and prescribing medicines on time I think I will
use that as a skill even when I leave FPRRH.
These reflections are interesting. He attributes the behaviour change on
the ward not simply to having more staff but what he perceives as the
allocation of specialist, dedicated, roles to staff. In practice, this was not
the case. K4C did not allocate designated roles or role descriptions to
our colleagues. They were placed on the ward and, with the support of
a UK (diaspora) nurse who had previously undertaken specialist work on
surgical site infections and wound management, they collectively under-
took a scoping exercise. This identified some key problem areas which
they then started to work on with local staff to resolve. Nevertheless,
his proposal that staff on the ward be given specific roles may be worth
considering. His contention that it is mainly K4C midwives engaging in
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wound management and swabbing is not borne out by the interviews, or
perhaps more importantly by ethnographic observation. Asked whether all
staff or just K4C staff are engaged in these activities, a midwife comments:
We are all doing it and the laboratory is working. I believe we ALL know
what to do now – we can take off the samples – arrange prescriptions – we
can – we are able – we will continue – of course the main thing will now
be staff shortages.
One of the pharmacists commented on the specific value of mentoring
and hands-on co-working suggesting that it was not just the extra staff
but the fact that they engage hands-on alongside the local staff:
Because there are K4C personnel on the ground working with people and
mentoring them. I have a strong suspicion if they were not there, we
would not have seen this change – showing people how to do things and
mentoring them. They are hands-on and people see what they are doing –
how they are cleaning wounds and people will follow their lead – they see
them actually doing the work and feel motivated to join in. You see them
criss-crossing up to the laboratory. If you don’t have people on the ground,
you won’t get accurate information – I’ve noticed that, so presence on the
ground is key.
[Would the same change have come if we had UK volunteers]
You need people on the ground for a long period. The perception if
there are British people, they see whites as only coming for a short time.
They are there but anyway they will go away so they would rather have a
local person who stays longer.
[What about [K4C nurse volunteer]? She came for a short time?]
Well they saw her as local – she was accepted as a local. Even me I
thought she was Ugandan.
As we noted above, the mentoring relationships on the ground are
complex and fluid with knowledge exchange taking place in a variety of
directions. The greater engagement of the pharmacists on the ward has
created new opportunities for active mentoring within the pharmacy team
itself. One of the senior pharmacists describes this process:
The interns are happy to do the clinical work now. It is challenging, moti-
vating, and inspiring but they appreciate my presence and my authority
on the wards. It has opened their eyes to the possibilities in their profes-
sions. Most pharmacists tend to be frustrated when they qualify and there
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is nothing for them to do in the hospital apart from signing requisition
orders… our system does not support our role. It gives them confidence.
The decision, by the project team, to employ one of the pharmacy interns
when his internship came to an end mid-project has stimulated a number
of mentoring opportunities. In the first instance, it has freed up the
hospital pharmacist to engage directly with staff, students and interns on
the wards. Second, it has extended a period of more intense mentorship
and enabled him to get more involved in leadership and research:
[He] was on his way out but he has benefitted from that – he has got what
his colleagues didn’t get. Clinical pharmacy has to be practical; you can’t
sit in the classroom. You have to have the practical relevance and you need
someone who inspires and encourages you.
The expectation that projects such as this must involve formal, off-
ward CMEs, was expressed by a senior pharmacist visiting the hospital
on behalf of the Commonwealth Pharmacy Association who insisted on
knowing what formal training the pharmacy interns had received. The
senior hospital pharmacist replied:
We have had interactive, informal, training. The people on the ward now
ask for the pharmacists – there is real behaviour change – they didn’t used
to ask.
It is interesting to consider how the K4C staff reflected on their own
roles on the ward and the impact of these. One of them used the word
‘training’ when talking about local staff. This triggered a question about
what that involved:
[You refer to them doing ‘what we trained them to do’. When did we train
them as such?]
Well when I do a procedure, I work with one of the staff. We work
together to do the procedure. Wound dressing is a two-person job, so we
work side by side.
[How do you do that? If a wound needs dressing do you go and ask
someone to help?]
Yes, I just go and ask someone to come and help me. Sometimes we
assist them. It doesn’t have to be us doing it all the time. Most of the
time you need an assistant, so you don’t contaminate things around you
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– so each time one person is doing the dressing and the other person is an
assistant.
On rare occasions when there is only one staff on the ward you find
you’re doing it yourself but like yesterday we found a nurse doing a wound,
so I went along to help. She doesn’t see it as a threat, we work together.
It’s the way people come on board that matters because if you come and
they see you as one of them … but if you come at another level and they
look at you as telling them what to do – the working relationship would
be poor – me I see them looking at us to help. As long as were there to
give a hand they will usually come on board.
As noted previously, the K4C team were not themselves experts when
the project commenced. They describe how they have learnt through a
process of mentoring within a multi-disciplinary team:
It is like a continuous update. When I was in (college) training, they did
not go into details about taking samples. Now we have more knowledge
about it, we know how we are doing it and we can interpret the results
and see how to get these isolates causing this problem so somehow, we are
getting knowledge.
[Did you have that knowledge at the start of the project?]
Not as such - somehow - but I know a lot more now about the
microbiology
[So, how have you learnt then?]
Because we have multi-disciplinarity. If it is a new isolate, we can ask in
the laboratory and the pharmacy. If the antibiotic is not working, we can
look at alternatives. Then you get to know.
[So, you have learnt as a team but with them]
Yes, we get knowledge from different cadres – from the doctors – the
laboratory – we have learnt together. And [lab scientists] trained us as a
team on how to take cultures and how to interpret them – he trained
us on the ward. They showed us how to take sterile swabs and avoid
contamination - we have also not got any contamination in our swabs
– according to the results from the laboratory.
Also, because they are changing antibiotics, that is a group thing, so we
learn as a team. We discuss it. We never find just a pharmacist changing the
drug – we all discuss it together. Like when we discussed a patient reacting
to doxycycline, we all discussed it together. So, it is a multidisciplinary
team.
[In the past would you have started to ask such questions about
antibiotics?]
No, but as soon as it started it was a multi -disciplinary approach.
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When you get this patient on the ward, we pull everyone together and
discussion takes place. People realise it is not a one-man job. It is more
interesting as most of the time the interns are on the ward, so everyone
realises this is something we have to do. Ourselves, this has been new to us.
Now there is a lot coming through – now we see the results of teamwork.
Everyone is concerned about a patient wasting away and this has motivated
everyone.
Knowledge Transfer and Behaviour Change
Harding’s work on objectivity in research describes how development
policies targeted at the Global South are imbued with concepts of knowl-
edge deficit and, as a result, failed to achieve their objectives. The ‘strong
objectivity’ approach, on the other hand, she suggests has been more
effective:
The transfer of Western scientific rationality and technical expertise from
the West to “the rest” had always been the “motor” of modernisation
theory and now drives development policy […] many of the assump-
tions about women and poor people in the Global South - were false..[..]
the strong objectivity approach enabled the goals of improving to the
living conditions for poor women and of decreasing poverty overall to
be advanced… (2015: 152)
We have noted in previous work (Ackers and Ackers-Johnson 2016) the
tendency of international development funders to assume an immediate
relationship between behaviour change and knowledge. Describing this
as an example of ‘fetishizing training’, we illustrated the complexity of
apparently simple interventions (in that case operationalising triage) and
the associated behavioural change required. Antimicrobial resistance is a
far more complex concept than triage. Little was known about AMR until
very recently and the language used prohibits multi-professional engage-
ment. Although the science is complex and still emerging, the necessity
of achieving effective science communication is paramount. It has been
inspirational to hear local midwives articulate questions about AMR in
sophisticated scientific terms:
Then of course with the culture and sensitivity – right now we are doing
OK. You have guided us on that one.
[Did you know how to do it before?]
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Not really. We knew how to take swabs, but we didn’t know how to
interpret the results. I have really begun appreciating; now we know which
organisms we are fighting and can give the required antibiotics.
[So, have you had to learn a lot about these organisms and the
antibiotics?]
Yes, we have had to learn a lot. The major thing I’ve learnt is about
how mothers here are resistant to most antibiotics. Before I would hear
but I had not seen it myself but at least now I have observed. Now there
is a case who is only sensitive to amikacin.
The Contribution of Formal
Training in a Mentoring Context
In keeping with an inductive approach, the MSI did not commence
with formal training or efforts to introduce externally produced tools or
protocols but with on the ground relationship-building and co-working.
Towards the end of the project, we have organised more formal training
usually in a small ‘doctors’ room on the ward or in the larger hospital
boardroom. Semi-formal short CMEs on topics such as hand hygiene
or management of the newly organised evacuation room (and associated
cleaning and sterilising procedures) have been bolted onto to clinical audit
meetings which, since the project, occur every time there is a maternal
death or a complex case for discussion. During a project visit in January
2020, the team responded immediately to requests from local midwives
and intern doctors to improve their ability to interpret laboratory results
and provided a short ward-based CME. Strictly speaking, midwives don’t
‘need’ this knowledge; their role in theory is to handover the results to
the doctors and for pharmacists and doctors to deliberate and prescribe.
The desire to know more and understand the processes which had led
to such remarkable improvements in patient outcomes is an indicator
of the motivational impact of change and how that fosters a quest for
knowledge.
Somekh (with reference to educational learning in the UK) does not
use the language of behaviour change that has become so popular in
recent years but links learning closely to notions of personal efficacy and
autonomy: ‘learning is closely related to a sense of personal efficacy – to
learn children need to have autonomy and take responsibility’ (2006: 4).
This has echoes of the idea of imagined realities and the belief that
things can change, and you can be a part of that change. Defining
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‘agency’ as the ‘capability of a self to take actions that will have an impact
on a social situation’, Somekh contends that change processes need to,
‘unlock the agency of individuals and groups so that groups work inter-
actively and reflectively to go beyond their personal learning and aim for a
broader impact on improving working methods and practice across the whole
workplace’ (2006: 21).
Of course, a sense of personal agency is inextricably contingent on
the context (although we would argue that there is always at least some
potential for agency). Whilst behavioural scientists may use the more
benign concept of ‘opportunities’ to capture context, social scientists have
articulated this relationship in terms of structuration theory or structure-
agency models that account in more complex ways for the webs of
constraints that shape individual behaviour.
The final chapter sums up the achievements of the Maternal Sepsis
Intervention approach with a discussion on how you capture change
processes in complex interventions; how you sustain those changes and
how lessons can be applied to other settings.
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Spreading and Researching Change
Abstract This chapter summarises the overall impacts of the Maternal
Sepsis Intervention reflecting on the processes of capturing, sustaining
and spreading best practice in antimicrobial stewardship. It argues that
sustainability is achievable when an intervention reduces hospital costs
and, in such cases, the responsibility or sustainability rests with LMIC
institutions. Key barriers to sustainability include supply chain weaknesses
and human resource limitations. The chapter recommends the use of
Public–Private Partnerships to help to overcome these barriers.
Keywords Sustainability · Public–private partnership · Policy transfer ·
Snagging
Dyar et al. (2017) review the use of the term ‘antimicrobial stewardship’
and conclude that there has been an overemphasis on conceptualisations
focused on ‘individual prescriptions’ and insufficient emphasis on the
societal implications of antimicrobial use. Furthermore, and of particular
relevance to the MSI project, there has been insufficient translation of the
concepts of ‘responsible use’ into context and time-specific actions. The
authors conclude that AMS is not so much a concept as it is a tool to
assess whether organisations are identifying actions to improve responsible
use in the specific context within which they are functioning. This idea fits
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very well with the action-research approach used in our intervention and
the results arising from that.
The final chapter includes three sections. The first section ‘Capturing
Change’ summarises the effectiveness of the intervention identifying key
outcomes and the drivers that have contributed to these. The second
section ‘Sustaining Change’ addresses the issue of sustainability of those
change processes, and the third section ‘Spreading Change’ discusses the
opportunity to translate and transfer aspects of the approach within the
hospital, throughout the country and to other international contexts. We
draw the chapter to a close reflecting on the benefits of the ethnographic
approach and the attention to contextual detail and co-researching that
this has afforded.
Capturing Change
Although we were acutely aware of the importance of Infection Preven-
tion and Control (IPC), the emphasis in the CwPAMS call on more
complex concepts of AMR and AMS distracted us somewhat from the
foundational importance of IPC. Poor attention to IPC in the hospital
clearly contributed to high levels of protracted and expensive hospital-
acquired infection creating more and more unpleasant work for health
workers. IPC improvement has proved to be a key driver of behaviour
change. Health workers have viewed the changes as an immediate invest-
ment in their own health and safety, improving their ability to work
effectively in a safe, supported environment. As such IPC has not just
improved the ‘opportunity’ component of behaviour change, it has
engaged directly in health worker motivation. Attempting to address AMS
without full attention to IPC would, we believe, have failed to capture the
imagination and commitment of ward staff. Capability (or lack of knowl-
edge or skill) did not emerge as a key factor in behaviour change, and
where knowledge mobilisation has taken place, it has occurred primarily
through mentoring and role modelling with some attention to specifics
(like when hand gel should be used in relation to washing or what
concentration of JIK should be used to clean mattresses). Nurses and
midwives have emerged as the natural leaders in these areas playing a
key role in shaping organisational culture and orienting rotating doctors
and students. The financial costs of implementing major improvements in
the IPC infrastructure have been minimal in comparison with the savings
9 CONCLUSIONS: CAPTURING, SUSTAINING … 163
achieved through shorter hospital stays, reductions in re-admissions and
use of theatre for secondary wound closures.
Change has come about over time through a myriad of small changes
and attention to the limitations or unintended consequences of these.
The process has generated active and positive dialogue and collegiality.
Once the ‘obvious’ issues around hand hygiene and equipment sterility
had been resolved, the management of attendants emerged as a key and
stubborn weakness in IPC systems. Whilst progress is being made and
has been accelerated in the COVID-19 environment, further work needs
to be done in this area throughout the hospital and at national level. The
impact of stock-outs on the ability to maintain basic hygiene on the wards
is another structural issue requiring intervention at the level of national
and institutional supply chains. We return to this issue below.
The IPC work focused attention on wounds and wound care on
the wards. On one level, this was very much an IPC issue; improving
IPC reduces the risk of wounds becoming infected on the wards in the
first place. Managing those that do become infected (or arrive infected)
reduces the risk of sepsis and the need for secondary closure. Cleaning
and dressing wounds emerged as a key, if unforeseen, dimension of infec-
tion control; it also provides the opportunity for swabbing and, with
that, for complex multi-disciplinary ‘huddling’. At this point, the nurses
and midwives hand the baton to the laboratory and microbiology results
create a unique opportunity for multi-disciplinary dialogue grounded
in scientific results. Once these results are available, so the opportu-
nity for clinical pharmacy emerges with pharmacists engaging actively
with intern doctors to support evidence-based, ‘rational’ prescribing. The
overwhelmingly positive impacts of these processes on patient outcomes,
the environment on the ward and the satisfaction at being able to save
lives and shorten hospital stays feeds back into the loop creating an
active momentum for change. This in turn generated an appetite for
knowledge, to breach disciplinary boundaries, share a new language of
communication and experience mutual respect.
The findings evidence significant and impactful behaviour change on
the wards with genuine multi-disciplinary team working contributing
to changes in prescribing behaviour and AMS. Wound care and labo-
ratory testing lie at the heart of these changes centre staging nurses,
midwives and laboratory scientists in stewardship processes. The results
of the microbiology testing then provide a platform for genuine multi-
disciplinarity and, specifically, the first opportunity for clinical pharmacy
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engagement. This is true both at the level of rational (evidence-based)
prescribing for individual patients and in improving the evidence base
behind empirical prescribing (through an understanding of resistance
patterns). If access to a full range of antibiotics were available, this plat-
form of behaviour change would transform antimicrobial use patterns,
reduce the over- and inappropriate use of antimicrobials, improve patient
outcomes and deliver significant cost-benefits.
The changes described above are essential to achieving ‘responsible
use’ in a Ugandan public hospital; but they are not sufficient. Cox
et al. make the important point that, ‘delayed or no access to antibi-
otics kills more people than antibiotic resistant bacteria. … AMS is not
only about reducing inappropriate use, but also assuring access to effec-
tive treatment’ (2017: 813). The changes create the opportunity for
active pharmacy engagement in multi-disciplinary decision-making. This
achievement could have a major impact on antibiotic use as post-natal
and gynae wards consume by far the largest volume of antibiotics at the
hospital. The cost-effectiveness of this intervention underlines the sustain-
ability potential and the immediate opportunity for scale-up across the
hospital as a whole and to other public health facilities in Uganda and
beyond.
Chapter 6 has elaborated the complexity and opacity of the supply
chain system in a public hospital setting in Uganda. In the absence of
effective supplies not only will these cost savings elude facilities; the
patients involved will fail to thrive and the motivation of health workers
to apply the skills and knowledge they have demonstrated will inevitably
decline. We have explained in detail the complex dynamics of supply
chain management. Understanding and piecing together these processes
have required painstaking ethnographic research to unpick major errors in
record-keeping and interpret the trends observed. In the first instance, the
very centralised system creates huge dependency on the functionality of
National Medical Stores and the adequacy of Ministry budgets. Central-
isation may be seen as necessary in systems so damaged by corruption
but where this undermines flexibility and responsiveness and generates
extended and predictable stock-outs, the systems put in place to improve
antimicrobial stewardship will, inevitably, fail.
The lack of supervision of rotating intern doctors by their senior
colleagues restricts the effectiveness of the approach and the osmotic
potential of continuous multi-disciplinary engagement. Nurse and phar-
macy leaders have filled the knowledge gap through orientation and
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mentoring of intern doctors demonstrating the potential of task shifting in
practice. Further improvement to prevent surgical site infection requires
attention in the operating theatre as women undergo caesarean sections or
laparotomies and in complex secondary wound closures. The deployment
of a UK doctor in theatre had a very positive effect often substituting
for the absence of senior doctors. Ultimately, this is unsustainable, and
measures need to be taken to ensure the constant presence of senior
doctors in obstetric theatre and in a supervisory capacity in public
hospitals.
The change mechanism deployed in the MSI is grounded in a partic-
ular approach to knowledge mobilisation and behaviour change. Building
on extensive experience of project operationalisation, the team was acutely
aware of the limited efficacy of fly-in-fly-out formal training programmes
organised by foreign teams and lubricated by opportunities to leave the
ward or receive per diems. We have established the working principle
of co-presence with colleagues working side by side on the wards in
more democratic and genuinely bilateral1 mentoring relationships. Where
Ugandan health workers have articulated a desire to gain new knowl-
edge, the project has mobilised to provide that. In some cases, this has
involved short sessions led by UK experts—such as the interpretation of
laboratory results, for example. In others, the whole group of pharmacy
interns presented a workshop on AMR to the hospital. Horizontal knowl-
edge mobilisation between different disciplinary groups is a feature of this
process rather than a comparison of protocols or practices in high- and
low-income countries.
Co-presence is not only a principle to be applied to health worker
training; it also forms the basis of ethical and equitable approaches to
co-researching.
Sustaining Change
Sustainability has become a key concept in overseas development inter-
ventions. As with most things, sustainability needs to be understood in
context; it is also highly contested. Sustainable Development is defined
1The team have been allocated Commonwealth Fellowships to support 5 Ugandan
health workers to come to the UK for 3 months to develop their learning around tissue
viability and wound management.
166 L. ACKERS ET AL.
in the 1987 Brundtland Report (United Nations 1987) as: ‘Develop-
ment that meets the needs of the present without compromising the
ability of future generations to meet their own needs’. Thwink.org2
provides a very simple definition that resonates with the objectives of
the MSI, describing sustainability as, ‘the ability to continue a defined
behaviour indefinitely’. The powerful emphasis on sustainability in inter-
national development has arisen largely due to increasing recognition of
the ineffectiveness of aid and, in some cases, the damaging externality
effects associated with aid dependency (Moyo 2010). We have noted the
limited evidence of the impact of many foreign-supported training initia-
tives including the many that have failed to mobilise knowledge from
theory into practice and impact behaviour. The MSI has demonstrated
genuine and sustained behaviour change in Infection Prevention Control
and rational prescribing. But can this behaviour be sustained?
Implicit in many discussions of sustainability is the notion of an ‘exit-
strategy’ to guard against funding dependency. Whilst we are very aware
of the damaging effects of foreign aid dependency, we would argue
that exit is not a zero-sum game. Continuity of relationships and part-
nership has been the hallmark of K4C’s engagement in Uganda. It is
the quality of transitions from a phase of more intense engagement
to a more routine maintenance that is of importance here. Many aid
interventions are characteristically brief resulting in rapidly designed inter-
ventions followed by immediate withdrawal. The CwPAMS funding is
typical in that regard; the funding period was extremely short with no
lead time and discrete measurable and attributable outcomes expected
within 15 months. The co-creation and co-working model has ensured
high levels of local engagement and genuine team working both within
the hospital and between project partners (in Uganda and the UK).
Sustainability and Human Resource Augmentation
There can be no doubt that individual capability (knowledge and skill)
to improve AMS exists amongst all cadres. In many areas, this existed
prior to intervention particularly in relation to a fundamental under-
standing of infection prevention control and wound management. Health
workers also referred to gaining new, more specialist, knowledge and
2https://www.thwink.org/sustain/glossary/Sustainability.htm.
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implementation skills which would ensure continuity and were clear that
the work would continue after project funding ends. The feedback from
ward midwives evidences their recognition of the new knowledge that has
come with the project and their belief that they are now able to maintain
the behaviour change on the ward. However, they all expressed concerns
about the impact that staff shortages will have on their ability to deliver a
quality service. In some respects, the project has increased the complexity
of tasks on the ward; midwives are now more actively engaged in new
tasks such as swabbing; managing the process of sending samples to the
laboratory and receiving them (which used to be the role of the doctors);
and then pulling the teams together to act on lab results. There is also an
increased burden on the staff and the in-charge to manage patients and
visitors and ensure all new students and interns are effectively oriented in
the culture and practices of the ward. There is an important task-shifting
component here as the in-charge and pharmacist are effectively fulfilling
the role of the senior doctor in orienting intern doctors. On the other
hand, measures to enable midwives to work more effectively, reducing
frequent visits to surgical theatre for sterilising equipment and gauze and
physically visiting the lab for test results, have reduced demands on staff.
In reality, the K4C staffing team settled into a routine of having one
person on the ward every day of the week (mornings only at weekends
and no nights). The costs of this additional and perhaps dedicated midwife
could be considered money well spent by the hospital if they are keen to
maintain the model and the cost savings it has brought.
The success of the MSI is not contingent on the skills or knowledge
of short-stay foreign volunteers, or on foreign income sources. Critically,
the intervention has been recognised by the hospital as cost saving:
When sepsis is managed then the resources used to manage these patients
reduce drastically. By reducing long stays which brings about savings. You
have contributed to the hospital budget with real term savings (Hospital
Administrator).
The findings evidence the overwhelming success of the approach in
terms of reducing infection risks; managing infections more effectively;
improving prescribing behaviour; and reducing maternal morbidity and
mortality. In the process, the evidence of reductions in patient stays, use
of operating theatres and readmissions represent significant cost savings
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for the hospital. Asked about the sustainability of the model at an IPC
meeting, Professor Ackers replied:
Everything we have done here is completely sustainable. We have not put
in big fancy investments or one-off trainings. We have saved the hospital
considerable funds; the responsibility for sustainability now rests with the
hospital. I don’t think having one extra member of staff is too difficult for
the hospital to maintain. We have not brought in some big thing that we
are now taking away.
Indeed, to push this point further, an extension of the MSI approach
to other wards in the hospital would result in further cost savings. In
this context, where an intervention has improved outcomes whilst also
reducing costs, the responsibility for sustainability rests with the hospital
and health system to put systems in place. This would imply some invest-
ments and delegation of national autonomy—particularly in employing
more nurses/midwives in place of the K4C staff and more pharmacists
to support clinical pharmacy on other wards. These measures are within
the hospital plans and jurisdiction and fully actionable. More detailed
exposure of costs may lubricate the politics of internal decision-making.
A discussion about the mechanics of undertaking meaningful and accu-
rate cost-benefit analysis to identify the financial impact of the project
has taken place with hospital management. Certainly, accurate assessment
of costs would facilitate evidence-based human, and overall, resource
management. And failure to make these decisions and augment staffing
to protect the model, post-project, will undoubtedly result in cost esca-
lation as patient stays begin to increase. The Health Partnership team
are committed to supporting this process. There can be no doubt that
managing the volume of patients on the wards presents serious challenges.
One option for the hospital management to consider is the use of creative
financial management to reinvest a portion of the cost savings achieved
through the intervention model to employ additional staff.
The impact of damaged referral systems and the ability of referring
hospitals and health centres to bump patients on to referral hospitals with
impunity and take no responsibility for the mortalities and morbidities
they contribute to require the engagement of the Ministry of Health.
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Sustainability and Access to Supplies
Access to supplies, in relation to IPC, wound management and antimicro-
bials, has proved an ongoing concern. Although substantial improvements
have been made, these are sub-optimal and realising the full impact of the
approach depends on improving access to supplies. Aid dependency is not
simply about the size of financial commitments in relation to local income;
it is also about the mode of engagement. The concept of ‘conditionalities’
has been deployed in an attempt to reduce no-strings-attached ‘giving’ or
‘donations’ which undermine sustainability. In general, simply ‘donating’
consumables can never be sustainable and it can and does encourage new
forms of corruption. It is for this reason that K4C as a charity does not
routinely engage in these forms of support.
We are acutely aware that our ability to make even very small payments
can save lives. During the MSI, we made one such payment (of £30) to
purchase amikacin when we knew that, in the absence of that payment,
the mother would almost certainly die. The problem here is not just about
costs; it is structural. Amikacin is not currently available through National
Medical Stores, and as the hospital budget for drugs is held at NMS,
the solution requires more structural changes which we hope to support
through active advocacy work (see below). K4C also gave the ward two
bottles of JIK when supplies ran out. This cost £6 but safeguarded the
improvements in basic IPC on the ward. The problem here was caused
by NMS stock-outs. K4C has also been supplying hand gel to the ward
for the duration of the intervention. The decision to engage in what looks
like unsustainable investments was made cautiously; K4C has the ability to
manufacture hand gel locally and the costs of doing so are quite low.3 The
decision was made to provide it given the total lack of supplies and the
fundamental importance of hand hygiene to the achievement of behaviour
change.
Concerned about the ability to sustain hand gel production in the
previous project (funded by the Tropical Health and Education Trust),
K4C proposed a Public–Private Partnership agreement with FPRRH.
K4C generates income to sustain its own activities between project
funding, through its student placement programme (Ahmed et al. 2017).
In most hosting facilities, K4C makes investments, based on Fair Trade
Principles, including the provision of staff and infrastructure, etc., on
3The costs of providing hand gel to the PNG during the project came to around £100.
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a pro-rata basis in recognition of support for the placements. FPRRH
had insisted on cash payments (of £150 per student placement) rather
than the in-kind investments deployed in other health facilities. K4C had
proposed that at least some of this payment could be made into a PPP
account, especially as K4C provides supervision for students through its
own staff co-working on the wards. This income could then be utilised
to underwrite the costs of IPC. At the time, this proposal was rejected
by the hospital director. The proposal was raised again during the MSI
and the start of the COVID-19 pandemic. At this point, K4C was keen
to support the hospital to put IPC systems in place across all its wards. A
Public–Private Partnership agreement has now been signed generating a
more sustainable and integrated mechanism for supply chain augmenta-
tion with an emphasis on IPC and antimicrobials. This provides a unique
opportunity for foreign organisations to cooperate on a co-decision
and co-funding basis, guided by the hospital’s Medicines Therapeutic
Committee and supported by a reputable not-for-profit supplier, Joint
Medical Stores. The objective will be to move away from dependency-
generating donations to a more integrated approach with the agility to
respond to local needs.
O’Neills review of AMR (2016) identified a number of ‘guiding
principles’ for implementation. These included an emphasis on cost-
effectiveness and the identification of ‘market failures affecting resource
allocation, regulation and price mechanisms’. Most of the solutions advo-
cated in his review engage at international level; the proposed PPP
mechanism we identify operates at micro-institutional level4 and we hope
will become a scalable model. This represents an important opportunity to
improve sustainability at the local level. Detailed evaluation of this mech-
anism will contribute to a wider dissemination strategy that will support
advocacy work at national and international levels.
4The MOH, Uganda has recommended to development of PPP as part of its Health
Strategic Health Policy. This is echoed in the National Medicines Policy (2015: 30) that
promotes PPP in the pharmaceutical sector.
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Spreading Change
The MSI has demonstrated the potential for change and the efficiencies
associated with this. We hope that publication of this evidence will stimu-
late discussion at national level amongst all key stakeholders and generate
a momentum for change.
Policy Transfer Opportunities Within the Hospital
The most immediate opportunity to scale up and apply the MSI approach
lies with the hospital itself. The Infection Prevention Control (IPC)
Committee has already played an important role in exposing key players
in the hospital to the changes in practice introduced on the post-natal and
gynae wards. It is interesting to note that some of the concerns expressed
on PNG wards about the fluidity of intern rotations have created an
interest in and appetite for change as health workers who have spent
time on PNG subsequently move to other wards. From a governance
perspective, further work needs to be done to fully establish and insti-
tutionalise the hospital Medicines Therapeutic Committee (MTC). This
process has been complex and circuitous. The pharmacy team acknowl-
edged the central importance of the MTC in policy implementation
processes. Whilst FPRRH is one of only very few RRHs in Uganda to
have functionalised the Rx medicines management system, the pharmacy
team expressed concern that, in the absence of an MTC, the full impact
of this could not be realised:
Before we didn’t have the people to operate the Rx system. It helps us
know about the supply chain and which drugs are about to expire. In
theory we should be doing reports and submitting them to the MTC, but
the committee is still not functioning.
There is also concern that some of the measures developed are not fully
recognised by hospital doctors because they have not been validated
through an established MTC:
The ‘Antibiotic Selection Tool’ we had designed has been removed from
the wall; we think it is because it has not gone through the MTC.
This illustrates the importance of the MTC to the validation and endorse-
ment of policy and medicines management. Whilst considerable efforts
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have been made on the post-natal and gynae ward to block the prescrip-
tion of high-end antibiotics without lab tests, extending this policy across
the whole hospital requires MTC endorsement. The project co-lead and
Secretary General of the Pharmaceutical Society of Uganda expressed a
similar concern about the role of the MTC as a platform for the utilisa-
tion and dissemination of data and the institutionalisation of the model
used on post-natal and gynae wards. We propose a stepwise cautious
incremental approach to the scaling up in other wards commencing in
either surgical ward or paediatrics. The COVID-19 pandemic has thrown
a light on supply chain efficacy and the impact of weak supply chains
on global and national inequalities. Although the poorest in societies will
suffer disproportionately, the tentacles of antimicrobial resistance, as with
all global pandemics, will reverberate across the globe.
There is a growing concern embodied in evolving research governance
that ethical research demands attention to dissemination. This includes
active engagement with stakeholders and policymakers and aligns with the
principles of partnership commitment. This also extends to a commitment
to accessibility as Harding suggests:
Research should not be elite [..] it would have to be accessible – phys-
ically and intellectually to anyone interested. It would be humble and
acknowledge that each new “truth’ is partial; that is incomplete as well
as culture-bound’ (1991: 300).
Open access publishing plays a key role in this process; it also demands
attention to the use of language to ensure that all actors in multi-
disciplinary audiences are able to make sense of research whilst also not
over-simplifying key messages.
Researching Change: Ethnography and ‘Snagging’
Providing the evidence base to inform and facilitate behaviour or systems
change processes is notoriously complex even when researchers are
working in their own country and institutions. Add to that the complexity
of power relations and the dynamics of organisational culture in very
different national contexts, and it is easy to understand how interventions
in global health can fail. Co-working and co-researching have combined
in this study through a form of action-oriented ethnography. Ethnog-
raphy, as a profoundly inductive and intuitive approach has enabled a
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whole series of small ‘snags’5 or ‘knots’ to be identified and responded to
with a level of agility that has enabled the intervention to move forward
in a reflexive process. And this has made people feel that the interven-
tion and research have been attentive; that their views have been listened
to, respected, and responded to. Challenging AMR demands attention to
detail, to the minutiae and mundane features of health workers’ everyday
lives.
The next section reflects on some of the prescriptions and assump-
tions that shape the global and national response to AMR and are echoed
in the CwPAMS ‘positioning’ that framed the funding programme. We
outlined the Ugandan National Action Plan—itself an implementation
device of the Global Action Plan. Certainly, all five areas resonate with
our intervention findings as key priorities. Whilst it is valuable to distin-
guish the areas, they are essentially indivisible and interrelated. With the
exception of surveillance, where scientific methodologies can help shed
light on the mechanisms, transmission patterns and origins of bacteria
and resistance, we would argue that any intervention must span all 5
areas. Cox et al.’s review (2017) identifies the lack of evidence on AMS
derived from highly contextualised interventions. The focus on maternal
sepsis in our work will, we hope, represent a response to that call with
context here not referring simply to work taking place in LMICs but
to work closely engaged with health system priorities and a patent local
need. Embedding AMR/AMS work in this way creates a powerful reso-
nance and tangibility about the impact of what are, in many ways, quite
intangible concepts. The CwPAMS call, with funding of £1.3 m, repre-
sents a ‘drop in the ocean’ in the wider AMR funding landscape both
in terms of UK funding to LMICS and that of other foreign actors.
On that basis, we can understand the desire for focus. There is much
discussion about partnerships in intervention delivery but less attention
to partnerships between funding bodies. In many respects, the growing
tendency for funding bodies to come together to support ‘real-world’
problems and combine interventions with greater attention to evalua-
tion is to be welcomed. Disciplinary and professional boundaries have
generated myopic impressions of the world. However, there are some
unintended consequences of these partnerships that demand careful and
honest reflection. Funding is fundamentally a political process. Chapter 2
5The term ‘snag’ is often used in building contracts to refer to ‘a problem or difficulty
that stops or slows the progress of something’.
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referred to the dominance of certain paradigms in global health and the
heavily prescribed nature of many funding calls. Inevitably, these lead to a
deductive approach shaped by powerful normative assumptions. Shiffman
discusses the role that power plays in shaping global health agendas. At
one level, power shapes health priority-setting and this is clearly seen in
instruments such as the Sustainable Development Goals. Reflecting on the
role that the Lancet has played in global health agenda-setting, Shiffman
poses the question: ‘Why do some individuals become recognised as
global health experts’? (2014: 297). We have noted the dominance of
medical and pharmaceuticalisation paradigms that have come to shape
discourses around AMR and global health more generally. Our work
has challenged these paradigms both from a methodological perspective
(what constitutes knowledge in this context) and from a task-shifting
(clinical) perspective (which cadres have the greatest potential to support
antimicrobial stewardship in LMICs?).
The team have worked with THET for many years and we share many
of the values embedded in the principles of health partnership working.
We feel these align closely with an action-research and fundamentally
inductive approach and support the concept of locally grounded, highly
contextualised, case studies. They also support the need for more demo-
cratic knowledge mobilisation mechanisms formed around continuous
mentoring and co-working relationships. This concurs with the ethos of
the Sustainable Development Goal 17 (global partnerships). The Depart-
ment of Health and Social Care is a very different organisation with its
primary objectives, necessarily (and rightly in our view) focused on the
needs of the UK in what are very challenging times. AMR is posing
a genuine and immediate threat to the UK economy and the health
and well-being of its citizens. It goes without saying that any funding
committed to LMICs must at least demonstrate ‘mutual interest’. Our
own previous work funded by Health Education England (Ackers et al
2017) reported on the benefits to the NHS from professional volun-
teering identifying gains in key areas such as leadership, communication
and managing in resource-constrained environments. The Common-
wealth Pharmacist Association, as a body representing the interests of
pharmacy as a profession inevitably and necessarily, has vested interests
too. The CPA describes its role in terms of: ‘Empowering pharmacists to
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improve health and wellbeing throughout the Commonwealth’.6 Once
again, this is an important and much needed perspective. There is substan-
tial under-investment in pharmacy in Uganda, so much so that it is
impossible for pharmacists to utilise their clinical pharmacy knowledge
and skills in public facilities. Our ongoing engagement with FPRRH made
us very aware that this was the case prior to project inception and the
impacts of this emerged over the project, as did the potential for change
when employing just one more pharmacist to support the work. What
became profoundly clear though was that engagement of clinical phar-
macy in the ways that the CPA planned required the engagement of
laboratory scientists. Without laboratory, testing the potential for clinical
pharmacy on the wards is severely compromised. And the opportunity to
take samples for laboratory testing rested on the respect for and active
co-working with those cadres that are continually present on the wards.
In the Ugandan context, this means midwives and nurses.
The funding bodies necessarily had their own, political, objectives
arising from the need to demonstrate impact on an increasingly cynical
and cash-limited environment. These objectives combined in complex and
‘clunky’ ways to make project specification, management and evidence-
generation extremely difficult. The final component of the AMR NAP
(and GAP) refers to research. Good research needs space to define
and change priorities, and research excellence is increasingly associated
with ‘impact’. Evaluation is research and should be distinguished from
accountability mechanisms. It is interesting to note that little, if any, of
the log-frame ‘evidence’ we were required to provide at regular inter-
vals to the funding bodies has been used in this book, and little, if any,
of the key evidence presented in the book could be squeezed into the
log-frames.
The experience of managing this project has been characterised by
ongoing creative tension with the funding bodies and managing agents
bound by (and required to police) highly prescriptive, inflexible and
deductive log-frame systems. Somekh describes ‘episodes of substantial
friction’ as ‘the starting point for deeper collaboration […] co-labouring
with partners involves encountering many ‘knots’ associated with discom-
fort, difficulty and frustration’ (2006: 23). Friction, she argues, reflects
the deep seriousness that partners attach to their work. We hope that
6https://commonwealthpharmacy.org.
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the outcomes achieved will encourage a debate in Overseas Development
Assistance work to allow projects and researchers to breathe, innovate,
show the humility to acknowledge intervention failure and prepare to be
surprised.
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For clinical isolates, the responsibility of diagnosing patients and
requesting/taking the samples remained with local healthcare workers.
Samples assessed in the hospital laboratory included wound and blood
samples. Anonymised isolates were passed on for further investigation as
part of this study.
Collection of blood sample: Blood (8–10 ml) was withdrawn from the
patient, after the proposed area of skin had been sterilised with ethanol.
The blood was contained in a standard BACTEC blood culture bottle,
which was transported to the on-site microbiology laboratory where it
was cultured in the automated BD BACTEC FX40 machine (37 °C, 5%
CO2) for up to 72 hours to assess any bacterial growth. At the end of the
time limit, if no growth was detected, the blood samples were discarded
as negative. If growth was present as indicated by the BACTEC FX40
machine, then the bacteria were isolated by streaking onto sheep blood
agar plates (BAP) (Sigma-Aldrich) and identified as noted below in isolate
confirmation.
Collection of wound samples: A sterile cotton swab was used to gently
swab the area of the wound. The swab was transported to the laboratory
where it was streaked on to BAPs. The plates were incubated for up to 48
hours and assessed for any growth as noted below in isolate confirmation.
Community isolates were collected from healthcare workers and
members of the public through the use of hand swabs.
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Hand swabs: Sterile cotton swabs were first moistened in phosphate
buffered saline (PBS) (LabM), then used to swab in between the fingers
and across the fingertips of participants. The end of the cotton swabs was
broken off and stored in 1ml of PBS for transportation to the labora-
tory (within 6 hours). All swabs were then streaked on mannitol salt agar
(MSA)(LabM) and incubated for up to 48 hours at 37 °C to assess for
any growth.
Isolate Confirmation
Identification of Clinical Isolates
Bacterial identification: Positive cultures were identified by picking single
colonies from BAPs and performing a series of tests. First, single colonies
were sub-cultured onto three different agar plates: sheep blood agar
(BAP), chocolate agar (CHOC) (Sigma-Aldrich) and MacConkey agar
(MAC). These plates were incubated for 48 hours (35–37 °C, 5% CO2).
Colony colour and morphologies were recorded and assessed by Gram’s
staining.
Oxidase test: A loop of bacteria was added to the test disk; the colour
would change to a dark blue for positive samples and would have no
colour change for negative samples.
API strips: Analytical profile index strips contain multiple wells each
with different chemicals. A bacterial suspension was added to each well
and the results compared to an online database to give a preliminary
identification
Catalase test: A small amount of 3% H2O2 and fresh bacterial colony
were mixed on a glass slide. A positive result was indicated by the
production of bubbles of oxygen.
Staphaurex agglutination test: The test reagent was added onto the
reaction card followed by the addition of bacterial culture. The mixture
was emulsified, and the reaction card gently rotated for up to 20 seconds.
Positive samples showed signs of agglutination.
PYR test: Pyrrolidonyl Aminopeptidase test is used for the detec-
tion of pyrrolidonyl arylamidase. 5–10 colonies of bacteria were
added to the test disk and incubated for 1 minute. 1 drop of N-
dimethylaminocinnamaldehyde was added, with positive samples showing
the development of a red colour within 1–2 minutes.
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Antibiotic Resistance Profiling
The antibiotic sensitivity profile of each bacterial isolate was tested using
standard disk diffusion assays following EUCAST guidelines (http://
www.eucast.org/ast_of_bacteria/disk_diffusion_methodology/). A
suspension of each bacterial isolate was prepared in sterile PBS to
McFarland Standard 0.5 and then swabbed for semi-confluent growth
onto Mueller Hinton agar (LabM). Antibiotic disks (Oxoid) were added
to the plate and incubated for 24 hours. Following incubation, the
diameter of zones of inhibition was measured and compared to EUCAST
breakpoint tables to assess whether the bacteria were resistant. The
antibiotics that were assessed included: ampicillin (AMP), ceftriaxone
(CEF), chloramphenicol (CMP), ciprofloxacin (CIP), gentamicin (CN),
cefoxitin (FOX), cotrimoxazole (COT), erythromycin (E), tetracycline
(TE) and ceftriaxone (CRO).
References
Ackers, H. L., Ackers-Johnson, G., Seekles, M., & Opio, S. (2020). Opportu-
nities and challenges for improving anti-microbial stewardship in low- and
middle-income countries: Lessons learnt from the maternal sepsis interven-
tion in Western Uganda. Antibiotics, 9, 315. https://doi.org/10.3390/ant
ibiotics9060315.
Ackers, H. L., & Ackers-Johnson, J. (2016). Mobile professional voluntarism and
international development: Killing me softly? Palgrave PIVOT. http://link.spr
inger.com/book/10.1057%2F978-1-137-55833-6.
Ackers, H. L., Ackers-Johnson, J., Tyler, N., & A. Chatwin, J., (2017). Health-
care, frugal innovation, and professional voluntarism: A cost-benefit analysis.
Cham: Palgrave PIVOT.
Ackers, H. L., Ioannou, E., & Ackers-Johnson, J. (2016). The impact of delays
on maternal and neonatal outcomes in Ugandan public health facilities: The
role of absenteeism. Health Policy and Planning, 31, 1152–1161.
Ackers-Johnson, G. (2020). Comparing the antimicrobial diversity of Staphylo-
coccus aureus strains isolated from clinical cases of infection and those found as
a commensal organism in Fort Portal, Uganda and further investigating the
potential mechanisms of resistance present (PhD research on-going).
Ahmed, A., Ackers-Johnson, J., & Ackers, H. L. (2017). The ethics of health-
care education placements in low-income countries: First do no harm? Cham:
Palgrave PIVOT.
Allegranzi, B., Nejad, S. B., Combescure, C., Graafmans, W., Donaldson, L.,
& Pittet, D. (2011). Burden of endemic health-care-associated infection in
developing countries: Systematic review and meta-analysis. Lancet, 377, 228–
241.
© The Editor(s) (if applicable) and The Author(s) 2020




Allegranzi, B., Aiken, A. M., Zeynep, K. N., Nthumba, P., Barasa, J., Okumu,
G., et al. (2018, May). A multimodal infection control and patient safety
intervention to reduce surgical site infections in Africa: A multicentre, before-
after, cohort study. The Lancet Infectious Diseases, 18(5), 507–515. https://
doi.org/10.1016/S1473-3099(18)30107-5.
Atwal, A., & Caldwell, K. (2006). Nurse’s perceptions of multidisciplinary team-
work in acute health care. International Journal of Nursing Practice, 12(6),
359–365.
Baine, S. O., Kasangaki, A., & Baine, E. M. M. (2018). Task shifting in health
service delivery from a decision and policy makers’ perspective: A case of
Uganda. Human Resources for Health, 16, 20. https://doi.org/10.1186/s12
960-018-0282-z.
Bates, P. (2014). Context is everything. Perspectives on Context. London: Health
Foundation.
Brink, A. J., van de Bergh, D., Mendelson, M., & Richards, G. A. (2016).
Passing the baton to pharmacists and nurses: New models of antibiotic
stewardship for South Africa. South African Medical Journal, 106(10),
947–948.
Broom, A., Broom, J., & Kirby, E. (2014). Cultures of resistance? A Bourdieu-
sian analysis of doctors’ antibiotic prescribing. Social Science and Medicine,
110, 81–88.
Bua, J., Mukanga D., Lwanga M., & Nabiwemba, E. (2015). Risk factors and
practices contributing to newborn sepsis in a rural district of Eastern Uganda:
A cross sectional study. BMC Res Notes, 8, 339. Published online 2015,
August 9. https://doi.org/10.1186/s13104-015-1308-4.
Cox, J. A., Vlieghe, E., Mendelson, M., Wertheim, H., Ndegwa, L., Villegas,
M. V., et al. (2017, November 1). Antibiotic stewardship in low- and middle-
income countries: The same but different? Clinical Microbiology and Infection,
812–818. https://doi.org/10.1016/j.cmi.2017.07.010.
Cronk, R., & Bartram, J. (2018, April). Environmental conditions in health
care facilities in low- and middle-income countries: Coverage and inequal-
ities. International Journal of Hygiene and Environmental Health, 221(3),
409–422.
Denyer Willis, L., & Chandler, C. (2018). Anthropology’s contribution to AMR
control. Investment and Society, 104–108. http://resistancecontrol.info/wp-
content/uploads/2018/05/104-08-chandler.pdf.
Denyer Willis, L., & Chandler, C. (2019). Quick fix for care, productivity,
hygiene and inequality: Reframing the entrenched problem of antibiotic
overuse. BMJ Global Health, 4(4), e001590. https://doi.org/10.1136/
bmjgh-2019-001590.
Dyar, O. J., Huttner, B., Schouten, J., Pulcini, C., & ESGAP (ESCMID Study
Group for Antimicrobial stewardshiP). (2017). What is antimicrobial steward-
ship? Clinical Microbiology and Infection, 23(11), 793–798. https://doi.org/
10.1016/j.cmi.2017.08.026.
REFERENCES 185
Filippi, V., Ronsmans, C., Gohou, V., Goufodji, S., Lardi, M., Sahel, A., et al.
(2005). Maternal wards or emergency obstetric rooms? Incidence of near-miss
events in African hospitals. Acta Obstet Gynecol Scand, 84, 11–16.
Gardner, A. L., Shunk, R., Dulay, M., Strewler, A., & O’Brien, B. (2018,
September). Huddling for high performance teams. Federal Practitioner,
16–22. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366795/.
Gould, S. J. (1981). The mismeasure of man. New York: Norton.
Government of Uganda. (2018). Antimicrobial Resistance National Action Plan
2018–2023.
Halbfinger, D. M. (2020, April 21). Hospitals in Israel let relatives say goodbye
to loved ones up close. New York Times.
Hantrais, L. (2009). International comparative research: Theory, methods and
practice. London: Palgrave Macmillan.
Harding, S. (1991). Whose science? Whose knowledge? Thinking from women’s lives.
Ithaca, NY: Cornell University.
Harding, S. (2015). Objectivity and diversity. Another logic of scientific research.
London: University of Chicago Press.
Hoonhout, L., de Bruijne, M. C., Wagner, C., Zegers, M., Waaijman, R.,
Spreeuwenberg, P., et al. (2009). Direct medical costs of adverse events in
Dutch hospitals. BMC Health Services Research, 9, 27. https://doi.org/10.
1186/1472-6963-9-27.
Hsieh, Y.-H., Lui, J., Tzeng, Y.-H., & Wu, J. (2014). Impact of visitors and
hospital staff on nosocomial transmission and spread to community. Journal
of Theoretical Biology, 356, 20–29.
Hsu, Y.-C., Liu, Y.-A., Lin, M.-H., Lee, H.-W., Chen, T.-J., Chou, L.-F., et al.
(2020). Visiting policies of hospice wards during the COVID-19 pandemic:
An environmental scan in Taiwan. International Journal of Environmental
Research and Public Health, 17, 2857.
Kluytmans, J., van Belkum, A., & Verbrugh, H. (1997). Nasal carriage of Staphy-
lococcus aureus: Epidemiology, underlying mechanisms, and associated risks.
Clinical Microbiology Reviews, 10(3), 505–520.
Kongnyuy, E. J., Mlava, G., & van den Broek, N. (2009). Facility-based maternal
death review in three districts in the central region of Malawi: An analysis of
causes and characteristics of maternal deaths. Women’s Health Issues, 19(1),
14–20.
Maina, M., Tosas-Auguet, O., McKnight, J., Zosi, M., Kimemia, G., Mwaniki,
P., et al. (2019). Evaluating the foundations that help avert antimicrobial
resistance: Performance of essential water sanitation and hygiene functions
in hospitals and requirements for action in Kenya. PLoS ONE, 14(10),
e0222922. https://doi.org/10.1371/journal.pone.0222922.
Mawalla, B., Mshana, S. E., Chalya, P. L., Imirzalioglu, C., & Mahalu, W.
(2011). Predictors of surgical site infections among patients undergoing major
surgery at Bugando Medical Centre in Northwestern Tanzania. BMC Surgery,
11, 21.
186 REFERENCES
Mbabazi, W. (2018). Assessing compliance with infection prevention and control
guidelines among various cadres of healthcare workers at a regional referral
hospital in Uganda (Unpublished MSc thesis).
McCormack, B. (2015). Action research for the implementation of complex
interventions. In D. A. Richards & I. R. Hallberg (Eds.), Complex inter-
ventions in health: An overview of research methods (pp. 300–311). London:
Routledge.
Meyer, J. (1993). New paradigm research in practice: The trials and tribulations
of action research. Journal of Advanced Nursing, 18, 1066–1072.
Meyer, J. (2000). Using qualitative methods in health-related action research.
British Medical Journal, 320, 178–181.
Michie, S., van Stralen, M. M., & West, R. (2011). The behaviour change wheel:
A new method for characterising and designing behaviour change interven-
tions. Implementation Science, 6, 42. https://doi.org/10.1186/1748-5908-
6-42.
Ministry of Health, Uganda. (2015). Uganda National Medicines Policy.
Ministry of Health, Uganda. (2019, September). The National Annual Maternal
and Perinatal Death Surveillance and Response (MPDSR) Report FY
2018/2019. Ministry of Health Uganda.
Monistrol, O., Calbo, E., Riera, M., Nicolas, C., Font, R., Freixas, N., et al.
(2011). Impact of a hand hygiene educational programme on hospital-
acquired infections in medical wards. Clinical Microbiology and Infection, 18,
1212–1218.
Moore, F. G., Audrey, S., Barker, M., Bond, L., Bonell, C., Hardeman, W.,
et al. (2015). Process evaluation of complex interventions: Medical Research
Council Guidance. BMJ , 350. https://doi.org/10.1136/bmj.h1258.
Moyo, D. (2010). Dead aid: Why aid is not working and how there is another
way for Africa. London: Penguin.
Mutale, W., Balabanova, D., Chintu, N., Mwanamwenge, M. T., & Ayles, H.
(2016). Application of system thinking concepts in health system strength-
ening in low-income settings: A proposed conceptual framework for the
evaluation of a complex health system intervention: The case of the BHOMA
intervention in Zambia. Journal of Evaluation in Clinical Practice, 22(1),
112–121. https://doi.org/10.1111/jep.12160.
Ngonzi, J., Tornes, Y. F., Mukasa, P. K., Salongo, W., Kabakyenga, J., Sezalio,
M., et al. (2016). Puerperal Sepsis, the leading cause of maternal deaths
at a Tertiary University Teaching Hospital in Uganda. BMC Pregnancy and
Childbirth, 16, 207.
Oakley, A. (1974). The sociology of housework. Oxford: Blackwell.
O’Neill, J. (2016). The Review on Antimicrobial Resistance. 2016. Tackling drug-
resistant infections globally: Final report and recommendations. The Review on
Antimicrobial Resistance, Chaired by Jim O’Neill. Report commissioned by
the UK Prime Minister.
REFERENCES 187
Rajkotia, Y. (2018). Beware of the success cartel: A plea for rational progress in
global health. BMJ Global Health, 3(6), e001197.
Reddy, E. A., Shaw, A. V., & Crump, J. A. (2010). Community-acquired blood-
stream infections in Africa: A systematic review and meta-analysis. Lancet
Infectious Diseases, 10(6), 417–432. https://doi.org/10.1016/S1473-309
9(10)70072-4.
Reinhart, K., Damiles, R., Kisson, N., Machado, F. R., Schachter, R. D., &
Finfer, S. (2017). Recognizing sepsis as a global health priority—A WHO
resolution. New England Journal of Medicine, 377, 414–417.
Richards, D. A., & Hallberg, I. R. (2015). Complex interventions in health.
London: Routledge.
Rochford, C., Sridhar, D., Woods, N., Saleh, Z., Hartenstein, L., Ahlawat,
H., et al. (2018). Global governance of antimicrobial resistance. Lancet,
391(10134), 1976–1978.
Rowe, S. Y., Peters, D. H., Holloway, K. A., Chalker, J., Ross-Degnan, D.,
& Rowe, A. K. (2019). A systematic review of the effectiveness of strate-
gies to improve health care provider performance in low- and middle-income
countries: Methods and descriptive results. PLoS ONE, 14(5), e0217617.
Saha, A., & Alleyne, G. (2018). Recognising noncommunicable disease as a
global health security threat. Bulletin of the World Health Organisation, 96,
792–793.
Seni, J., Najjuka, C. F., Kateete, D. P., Makobore, P., Joloba, M. L., Kajumbula,
H., et al. (2013). Antimicrobial resistance in hospitalised surgical patients: A
silently emerging public health concern in Uganda. BMC Research Notes, 6,
298.
Shafquat, Y., Jabeen, K., Farooqi, J., Mehmood, K., Irfan, S., Hasan, R., et al.
(2019). Antimicrobial susceptibility against metronidazole and carbapenem in
clinical anaerobic isolates from Pakistan. Antimicrobial Resistance and Infec-
tion Control, 8, 99. Published 2019 June 14. https://doi.org/10.1186/s13
756-019-0549-8.
Shiffman, J. (2014). Knowledge, moral claims and the exercise of power in global
health. International Journal of Health Policy and Management, 3(6), 297–
299.
Slawomirski, L., Auraaen, A., & Klazinga, N. (2017). The economics of patient
safety. OECD.
Smith, A. (2018). Metronidazole resistance: A hidden epidemic? British Dental
Journal, 224(6), 403–404. https://doi.org/10.1038/sj.bdj.2018.221.
Somekh, B. (2006). Action research: A methodology for change and development.
Maidenhead: Open University Press.
Storeng, K. T., & Palmer, J. (2019). When ethics and politics collide in donor-
funded global health research. Lancet, 394, 184–186.
Tong, S. Y., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V.
G. (2015). Staphylococcus aureus infections: Epidemiology, pathophysiology,
188 REFERENCES
clinical manifestations, and management. Clinical Microbiology Reviews, 28(3),
603–661.
Tweheyo, R., Reed, C., Campbell, S., Davies, L., & Daker-White, G. (2019). ‘I
have no love for such people, because they leave us to suffer’: A qualitative
study of health workers’ responses and institutional adaptations to absenteeism
in rural Uganda. BMJ Global Health, 4, e001376. https://doi.org/10.1136/
bmjgh-2018-001376.
United Nations. (1987). Report of the World Commission on Environment and
Development: Our common future.
Uganda National Academy of Sciences. (2015). Antimicrobial resistance in
Uganda: Situation analysis and recommendations. Centre for Disease
Dynamics, Economics & Policy. ISBN: 978-9970-424-10-8.
Vogel, I. (2012). Review of the use of ‘Theory of Change’ in inter-
national development. Review Report Department for International
Development https://assets.publishing.service.gov.uk/media/57a08a5ded91
5d3cfd00071a/DFID_ToC_Review_VogelV7.pdf.
Weber, N., Patrick, M., Hayter, A., Martinson, A. L., & Gelting, R. (2018). A
conceptual evaluation framework for the water and sanitation for health facility
improvement tool (WASH FIT). Journal of Water, Sanitation and Hygiene for
Development, 9(2). https://doi.org/10.2166/washdev.2019.090.
Wee, L. E., Conceicao, E. P., Sim, X., Y. J., Aung M. K., Tan, K. Y., Wong, H.
M., et al. (2020). Minimizing intra-hospital transmission of COVID-19: The
role of social distancing, Journal of Hospital Infection, 105, 113–115.
Welsh, J. (2019). Providing an evidence base for antibiotic stewardship for
midwives in the Kabarole District of Uganda: A modified action research study
(Unpublished PhD thesis).
World Bank. (2017). Drug-resistant infections: A threat to our economic future.
Washington, DC: World Bank.
World Health Organisation. (2007). Task shifting to tackle health worker short-
ages. Retrieved from: http://www.who.int/healthsystems/task_shifting_book
let.pdf. Accessed 4 March 2017.
World Health Organisation. (2008). Task shifting. Global recommendations and
guidelines. Geneva: World Health Organisation.
World Health Organisation. (2012). Optimizing health worker roles to improve
access to key maternal and new-born health interventions through task shifting.
Retrieved from: http://apps.who.int/iris/bitstream/handle/10665/77764/
9789241504843_eng.pdf;jsessionid=876E08C843C919EA6CE890EB370
BEAB8?sequence=1. Accessed 1 February 2018.
World Health Organisation. (2019). Patient safety fact file.
Wright-Mills, C. (1959). The sociological imagination. New York: Oxford Univer-
sity Press.
Zulfiuqar, B., Salam, A., Firoz, M., Fatima, H., & Aziz, S. (2013). Effects of
inflow of inpatients attendants at a tertiary care hospital—A study at civil
hospital Karachi. Journal of Pakistan Medical Association, 63(1), 143–147.
Index
A
Action research, 16, 28, 30–32, 34,
38
Antibiotic prescribing
antibiogram, 89, 95, 98, 100, 109
empirical therapy, 83, 89, 100
rational prescribing, 84, 87, 114,
116, 118
Antibiotic resistance, 3, 5, 41, 92, 93,
95, 96, 98
rates of, 96
Antibiotic stewardship, 26, 58
Antimicrobial Resistance, 2, 5, 6, 15,
57, 74, 78, 135, 148, 157, 172
prevention, 2, 55, 78
Antimicrobials
access to, 82, 108, 114
consumption/dispensing to ward,
20, 22, 37





COM-B model, 23, 59
evolutionary economics, 148
formal training, 59, 147, 155, 158,
165
knowledge combinations, 130
knowledge mobilisation, 8, 145,
148, 162, 165
leadership, 23, 130
learning from failure, 145
motivation, 114, 130, 148, 162
personal agency, 159
resource shortages, 59, 167




(CwPAMS), 6, 18, 23, 24
Commonwealth Pharmacists
Association (CPA), 6, 18, 19
Communication, 3, 70, 84, 86, 130,
132, 148, 157, 163, 174
Cost savings, 49, 104, 167
© The Editor(s) (if applicable) and The Author(s) 2020








Feminism, 7, 14, 148
Fleming Fund, x, 6, 18–22, 82
Funding bodies/systems, 7, 8, 16, 17,
24, 38, 55, 74, 106, 173, 175
G
Global Action Plan, 5, 6, 173
Global health, 2–4, 12, 17, 18, 53,
103, 172, 174
H
Healthcare associated infections, 44
I
Infection Prevention Control (IPC)
hand hygiene, 7, 56, 58, 60, 61,
66, 163, 169
infrastructure, 59, 66, 162
in the maternal sepsis intervention,
7, 56, 57
Uganda National Action Plan, 81







International development, 7, 8, 11,
13, 15, 17, 34, 157, 166
K
Knowledge, 12, 13, 16, 17, 21–23,
28, 59–61, 67, 68, 70, 76, 83,
104–106, 121, 126, 129, 130,
132, 136, 142, 146–149, 151,






impact of geography and delays, 40
maternal deaths from sepsis at
FPRRH, 38
maternal deaths in Uganda, 26
Maternal sepsis
maternal sepsis intervention
hospital budgets, 37, 49
patient experiences, 50
reduced patient stays, 48, 49
reduced readmissions, 78
wound care, 30, 45
Microbiology, 22, 33, 82–84, 86, 88,
91, 95, 97, 148, 163
culture and sensitivity, 82, 84, 108
O
Objectivity, 14, 15, 17, 157
One Health, 2, 6, 56
P
Partnership, 7, 15, 16, 18, 19, 25, 28,
34, 149, 166, 173, 174
Public–Private Partnership, 60, 169,
170
working in partnership, 16, 19
Per diems, 146, 147, 165
Pharmacy
clinical pharmacy, 8, 22, 100, 106,
111, 124, 126, 131, 137–141,
155, 163, 168, 175
INDEX 191
engagement, 100, 106, 107, 131,
164, 175
leadership, 125
pharmacist, role of, 8
supply chain, 100, 110, 123, 125,





Surgical site infection, 27, 54, 74, 93,
97, 118, 153, 165
Sustainable Development Goals, 4,
13, 15, 141, 174
T
Task shifting, 103, 104
Team working, 8, 33, 56, 60, 70, 77,
84, 129, 130, 132, 135, 136,
142
huddling, 132, 163
Training, 8, 13, 19, 25, 39, 59, 61,
66, 70, 73, 75, 76, 83, 107,
130, 141, 146, 147, 149–151,
155–158, 165, 166
assessment of, 24
Tropical Health Education Trust, 6,
19, 20, 25, 30, 174
U
Uganda National Action Plan, 81
UK Department of Health and Social
Care, 6, 18
Universal health coverage, 4, 15
W
Water, Sanitation and Hygiene
(WASH), 5
Wound management, 7, 8, 50, 57,
74–76, 78, 88, 100, 106, 153,
165, 169
